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Abstract 
 
Introduction: People with Parkinson’s disease require individualised 
medication regimens to achieve symptomatic control whilst managing 
complications of the treatments and the underlying disease. Patients 
should continue to receive their individualised regimen when they are 
admitted to hospital but studies have highlighted that this may not 
happen. There is a paucity of research about patients’ perceptions of the 
management of antiparkinsonian medicines during a hospital admission 
and the aim of this study was to explore the perceptions of Parkinson's 
disease patients admitted to Leeds Teaching Hospitals about the 
management of their antiparkinsonian medications. 
 
Method: Grounded theory methodology was used to allow detailed 
exploration of patients’ perceptions and to generate theory about this 
under-researched area. Face to face, semi-structured interviews were 
conducted with 13 Parkinson’s disease patients during their hospital 
 - ii - 
admission, fully transcribed and analysed using the constant comparative 
approach.  
 
Results: Categories contributing to the core category of ‘patient anxiety’ 
were identified as ‘maintaining usual medication routine’, ’access to 
antiparkinsonian medications’, 'accuracy and consistency', 'trust in 
healthcare professionals' and ‘staff knowledge about Parkinson’s 
disease’. Strategies used to manage the anxiety were related to the 
categories ‘utilising expertise’ in Parkinson’s disease and ‘patient 
involvement’ in their care. 
 
Discussion: The theory suggests that some patients have negative 
perceptions about the management of their medicines during a hospital 
admission. Areas for practice development are presented along with 
areas for future research. 
 
Conclusion: This study provides new insight into the perceptions of 
patients with Parkinson’s disease about the management of their 
medicines during a hospital admission. 
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Layout of the thesis 
Chapter 1 of the thesis provides information about the pathophysiology of 
Parkinson’s disease and the pharmacological treatments that can be 
used to achieve symptomatic control whilst managing complications of 
the treatments and the underlying disease. Chapter 2 details the first 
literature review for the study and contains a critical appraisal of the 
information identified during the literature search. The purpose statement 
for this study is detailed in Chapter 3 and this chapter also explains the 
methodology chosen for this study. Chapter 4 details the data analysis 
process and Chapter 5 discusses the theory that was generated from the 
data provided by the study participants. This theory is explored using 
available literature in Chapter 6 and this chapter also discusses the 
implications of the findings for clinical practice and future research.  
 
Style notes 
Direct quotes are shown in italics and have double quotation marks. A 
direct quote from a participant is annotated with the symbol '#X' where 'X' 
is a unique number that was assigned to a participant during the analysis 
process. In these quotes the use of the symbol (.) represents a pause of 
less than 0.5 seconds, the symbol (..) represents a pause of less than 1 
second (Bailey, 2008) and bold text denotes statements made by the 
interviewer. 
 
Referencing in this thesis follows the APA 6th Edition standard. 
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1 Introduction 
Parkinson’s disease is a progressive neurological condition that affects 
more than one million people in Europe and this number is expected to 
double by 2030 due to many countries having an ageing population 
(European Parkinson’s Disease Association, 2011). The European 
Parkinson's Disease Association proposes that the estimated total annual 
cost of managing the care of patients with Parkinson’s disease in Europe 
is €13.9 billion (Gustavsson et al., 2011). There is currently not a cure for 
the disease and the purpose of pharmacological and non-
pharmacological interventions is to achieve and maintain symptomatic 
control whilst managing any complications that may be caused by the 
treatments and the underlying disease. 
 
There are approximately 120,000 people with Parkinson's disease in the 
UK (Tugwell, 2008) and healthcare professionals can encounter people 
with this chronic disease in both primary and secondary care settings. 
The diagnosis of Parkinson's disease must be made by an expert in the 
disease (The National Collaborating Centre for Chronic Conditions, 2006) 
who will continue to support the patient to develop treatment plans to 
manage their symptoms and any complications that they develop during 
the course of their disease. 
 
The purpose of this introduction is to provide information about the 
pathophysiology of Parkinson’s disease and the pharmacological 
treatments that can be used to manage the symptoms of the disease. 
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Non-pharmacological therapies are not discussed in this chapter. The 
role of individualised medication regimens in the symptomatic 
management of patients with Parkinson’s disease and the complications 
that can occur due to deviations from these regimens will also be 
discussed within this chapter. 
 
1.1 Parkinson’s disease is one cause of parkinsonism 
Parkinsonism is a collective term used for the “signs resulting from low 
dopaminergic input from the substantia nigra (pars compacta) to the 
striatum” (Hughes & Miller, 2007 pp 88). These signs include akinesia, 
rigidity, postural instability and abnormal reflexes (Hughes & Miller, 2007; 
Quinn, 1995). Some patients with parkinsonism may also have a resting 
tremor. 
 
Parkinson’s disease is the commonest cause of parkinsonism (Quinn, 
1995). The other causes of parkinsonism are: 
 
x medication (the second commonest cause of parkinsonism in 
adult patients (Thanvi & Treadwell, 2009)) e.g. neuroleptics, 
metoclopramide, prochlorperazine and methyldopa (Thanvi & 
Treadwell, 2009; Tugwell, 2008), 
x other neurodegenerative conditions e.g. multiple system 
atrophy and progressive supra-nuclear palsy (Quinn, 1995), 
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x rare causes e.g. encephalitis, space-occupying lesions, 
hydrocephalus, stroke and carbon-monoxide poisoning (Quinn, 
1995). 
 
The onset of signs and symptoms and the management of the condition 
varies depending on the cause of the patient’s parkinsonism.  
 
1.2 Pathophysiology of Parkinson’s disease 
Parkinson’s disease is a progressive neurodegenerative condition and 
people with the disease have characteristic changes within their brain 
(Clarke, 2007b; Lees et al., 2009; Tugwell, 2008) which include: 
 
x loss of dopaminergic neurons containing neuromelanin from the 
substantia nigra pars compacta, and, 
x the presence of intraneuronal inclusions (including Lewy bodies). 
 
These changes are the causes of the motor features of Parkinson’s 
disease and some of the non-motor features of the disease including 
Parkinson’s disease dementia (PDD). 
 
Death of dopamine containing cells within the substantia nigra pars 
compacta leads to dopamine deficiency within the nigrostriatal pathway. 
The depleted dopamine levels cause alterations in activity within 
dopamine mediated pathways in the brain (both direct and indirect 
pathways) and this leads to inhibition of the thalamus and ultimately 
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reduced stimulation of the motor cortex which causes the motor features 
of Parkinson’s disease (Tugwell, 2008).  
 
Lewy bodies are eosinophilic intraneuronal inclusions that are found 
within damaged neurons. People with Parkinson’s disease can have 
Lewy bodies within the brainstem, cerebral cortex, thalamus, spinal cord 
and in the myenteric plexus of the gastrointestinal tract but the role of 
Lewy bodies in Parkinson’s disease is unknown. Many people that 
develop PDD have Lewy bodies in the cerebral cortex but the role of 
cortical Lewy bodies in PDD also remains unknown (Burn, 2004).  
 
1.3 Features of Parkinson’s disease 
The signs and symptoms of Parkinson’s disease, often described as 
features of the disease, do not become noticeable in most people until 
they have lost about 80% of the dopamine that they had within the 
striatum (Clarke, 2007b). The features of the disease are classified as 
either motor or non-motor features and initially the features will be 
unilateral but as the disease progresses they become bilateral (Clarke, 
2007a).  
 
1.3.1 Motor features 
The motor features of Parkinson’s disease can be divided into the 
cardinal features of Parkinson’s disease and secondary motor features 
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(Jankovic, 2008; Tugwell, 2008). The cardinal features of Parkinson’s 
disease are: 
 
x tremor at rest,  
x bradykinesia,  
x rigidity, and, 
x postural instability. 
 
The secondary motor features of Parkinson's disease include: 
 
x freezing (akinesia which can occur when a patient is starting to 
walk or when moving into specific situations e.g. walking through a 
narrow doorway), 
x hypomimia (the reduced degree of facial expression can lead to 
people with Parkinson's disease being described as having a 
'mask like face'), 
x micrographia, 
x monotonic and hypophonic dysarthria, 
x dysphagia and sialorrhoea due to impaired swallow, 
x word finding difficulties, 
x neuro-opthamological abnormalities, 
x respiratory disturbances, and, 
x falls. 
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During the course of their disease a person with Parkinson's disease can 
develop many motor features. The management of motor features of 
Parkinson’s disease is discussed in section 1.4 below. 
 
1.3.2 Non-motor features 
The non-motor features of Parkinson’s disease include (Grosset et al., 
2010; Jankovic, 2008): 
 
x neuropsychiatric symptoms,  
x anosmia, 
x autonomic disturbances (including postural hypotension, bowel 
dysfunction and bladder dysfunction), and, 
x sleep disturbances (including hypersomnolence and insomnia). 
 
1.3.2.1 Neuropsychiatric symptoms in people with Parkinson’s 
disease 
People with Parkinson's disease may develop a range of mental health 
problems during the course of their disease including cognitive 
impairment, affective disorders or psychosis. These conditions can 
significantly impair a person's quality of life if the condition is not 
recognised or treatment is not effective (Hobson et al., 1999; Martinez-
Martin et al., 2011; Quelhas & Costa, 2009; Weintraub et al., 2008). 
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1.3.2.1.1 Cognitive impairment 
Many people with Parkinson's disease have a slow decline in cognitive 
function during the course of their disease which may present as reduced 
short-term memory, visual hallucinations, confusion or a reduced ability to 
make decisions. Between 20% and 40% of people with Parkinson's 
disease experience a decline in cognitive function that allows them to 
meet the diagnostic criteria for PDD (Aarsland et al., 2002; Burn, 2004; 
Emre, 2003; Lennox & Lennox, 2002). 
 
The clinical presentation of PDD differs to Alzheimer’s because people 
with PDD often retain a large proportion of their memory but have 
difficulty planning tasks. Work is on-going to explore the similarities and 
differences between PDD and dementia with Lewy bodies (DLB) but it is 
known that people with PDD have Lewy bodies present within their brain 
which is similar to the pathophysiology of DLB (Burn, 2004). 
 
The pharmacological management of PDD is intended to provide 
symptomatic management of the condition and the cholinesterase 
inhibitor rivastigmine has been shown to provide improvement in the 
cognitive activity and behavioural symptoms of patients with PDD (Emre, 
2007; Maidment et al., 2006).  
 
1.3.2.1.2 Psychosis 
Psychosis affects one third of people with Parkinson’s disease (Naimark 
et al., 1996; Thanvi et al., 2005) and the symptoms can range from vivid 
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dreams and visual hallucinations that are not frightening to disturbing 
visual hallucinations and paranoia.  
 
In recent years the pathophysiology of psychosis in people with 
Parkinson’s disease has been recognised as multifactorial. The 
underlying neurotransmitter disturbances associated with Parkinson's 
disease and the dopaminergic medications used to manage the 
symptoms of the disease have been proposed as possible causes of 
psychosis. 
 
The risk factors for people with Parkinson’s disease developing psychosis 
include other mental health conditions (e.g. cognitive impairment or 
depression), old age and sleep disorders (Lennox & Lennox, 2002; 
Thanvi et al., 2005) but young people without co-morbidities can develop 
psychosis. In these cases the psychosis may be caused by dopaminergic 
medications or the pathophysiology of the disease (Graham et al., 1997; 
Zahodne & Fernandez, 2008). Inadvertent changes to the dose of a 
dopaminergic medication can also lead to the occurrence of symptoms of 
psychosis in some people with Parkinson's disease. 
 
Psychosis caused by dopaminergic medication may be managed for 
some people with small dose adjustments but whilst reducing the dose of 
the dopaminergic medication may alleviate their symptoms of psychosis it 
can lead to a loss of control of their motor features of Parkinson's 
disease. People with Parkinson's disease who develop psychosis may 
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require treatment with antipsychotic drugs if their symptoms fail to 
respond to changes in their antiparkinsonian medications. The choice of 
antipsychotic therapy will be individualised for each patient. 
 
1.3.2.1.3 Affective disorders 
Many people with Parkinson’s disease will develop an affective disorder 
(either depression or anxiety) during the course of their Parkinson’s 
disease but some people may develop both depression and anxiety.  
 
Depression has been reported as affecting between 40% and 50% of 
people with Parkinson’s disease during the course of their disease (Allain 
et al., 2000). This may be an underestimation of the incidence of 
depression because diagnosis of depression in people with Parkinson's 
disease is complicated due to some of the features of Parkinson’s 
disease being similar to symptoms of depression (Ghazi-Noori et al., 
2003; Schrag, 2006).  
 
The pathology of depression in people with Parkinson’s disease remains 
unknown and there is uncertainty regarding whether the depression is 
exogenous or endogenous or a combination of these two types of 
depression (Burn, 2002; Habermann-Little, 1991). There is also limited 
evidence available regarding the efficacy and safety of antidepressant 
medications in people with Parkinson's disease with depression (Ghazi-
Noori et al., 2003) therefore patients should receive individualised 
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pharmacological and non-pharmacological interventions to support them 
in the management of their depression.  
 
Generalised anxiety disorder (GAD), panic attacks and social phobias are 
recognised conditions in people with Parkinson’s disease (Richard, 2005; 
Schapira, 2005) but the pathology of anxiety in Parkinson’s disease is 
unknown. The symptoms of anxiety disorders can present before the 
development of motor features of Parkinson’s disease therefore the 
trigger in some people is not believed to be the diagnosis of Parkinson’s 
disease (Schrag, 2006). 
 
The incidence of anxiety disorders in people with Parkinson’s disease is 
estimated to be 40% (Marsh, 2000; Quelhas & Costa, 2009; Walsh & 
Bennett, 2001) but this may be an underestimate because many people 
with Parkinson's disease may have social phobias that have not been 
formally diagnosed by clinicians (Stein et al., 1990).  
 
It is estimated that 30% of people with Parkinson’s disease have GAD 
(Leentjens et al., 2008). People with GAD experience excessive worry 
and their symptoms can cause them clinically significant distress. The 
management of these symptoms requires the development of an 
individualised treatment plan (The National Collaborating Centre for 
Mental Health & The National Collaborating Centre for Primary Care, 
2011). 
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Approximately 10% of people with Parkinson’s disease are diagnosed 
with panic attacks during the course of their disease (Leentjens et al., 
2008). Some people can have panic attacks that develop at any time 
without a trigger and the attacks can be prolonged (lasting several hours) 
with symptoms that are severe and disturbing for the patient. Others only 
have panic attacks when their dopaminergic medications are ‘wearing off’ 
and they are becoming what is known as being ‘off’ (discussed below in 
section 1.4.2) (Maricle, Nutt, & Carter, 1995; Maricle, Nutt, Valentine, et 
al., 1995). People with Parkinson's disease that have been diagnosed 
with panic attacks require personalised therapeutic interventions to 
manage their condition.  
 
1.4 Pharmacological management of the motor features of 
Parkinson’s disease 
The guidance published by the National Institute of Health and Clinical 
Excellence (NICE) about the diagnosis and management of Parkinson’s 
disease refers to the management of motor features in patients with 
‘early’ and ‘later’ Parkinson's disease (The National Collaborating Centre 
for Chronic Conditions, 2006). Patients with ‘early’ disease are defined as 
“those patients who have developed functional disability and require 
symptomatic therapy” (The National Collaborating Centre for Chronic 
Conditions, 2006 pp 12). Patients with 'later' disease are patients taking 
“levodopa who have developed motor complications” (The National 
Collaborating Centre for Chronic Conditions, 2006 pp 12). 
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These classifications may be utilised by some neurologists and 
Parkinson's disease nurse specialists (PDNS) to describe the stage of a 
patient's disease but others may describe their patient’s condition utilising 
a paradigm which consists of four stages of disease progression 
(MacMahon & Thomas, 1998). The four stages are: 
 
x diagnosis stage, 
x maintenance stage, 
x complex stage,  
x palliative stage. 
 
A patient will require different medical and nursing interventions in each 
stage of the paradigm, for example in the diagnosis stage they may 
require symptomatic support for the cardinal motor features and a range 
of non-motor features, whereas in the complex stage they may require 
adjunctive therapy to manage the symptoms caused by the wearing off 
effect of doses of levodopa based medications. 
 
For consistency, this thesis will utilise the 'early' and 'later' disease terms 
referred to within the NICE guidance for Parkinson's disease but it is 
acknowledged that healthcare professionals may utilise other terms when 
they are discussing the progress of their patient’s disease. 
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1.4.1 Pharmacological management of motor features in people with 
‘early’ Parkinson’s disease 
The aim of treatment for people with 'early' Parkinson's disease is to 
manage the motor features of their disease. Treatment will be 
commenced when the symptoms have become problematic for the 
person. 
 
The NICE guidance for the diagnosis and management of Parkinson's 
disease (The National Collaborating Centre for Chronic Conditions, 2006) 
provides guidance about the pharmacological therapy that could be used 
to manage the motor features of patients with ‘early’ disease. This 
information is only intended to advise clinicians about treatment options 
for this patient group because each person will require an individualised 
medication regimen to manage their features. The dopaminergic agents 
that could be used include levodopa (in combination with a dopa-
decarboxylase inhibitor), dopamine agonists (e.g. ropinirole, pramipexole) 
and monoamine oxidase type B inhibitors (MAOB inhibitors) (e.g. 
rasagiline or selegiline).  
 
1.4.2 Pharmacological management of motor complications in ‘later’ 
Parkinson's disease 
Managing the motor symptoms experienced by a person with 'later' 
Parkinson's disease requires managing both the motor features caused 
by the underlying disease and the motor complications caused by the 
levodopa based medications within their medication regimen. 
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Most people with Parkinson's disease receive treatment with levodopa 
based medicines during the course of their disease to improve motor 
function but long-term treatment with levodopa can lead to complications 
which include unpredictable fluctuations in symptom control and end of 
dose wearing off effects (Thanvi & Lo, 2004). Unpredictable fluctuations 
in symptom control are also known as 'on-off' fluctuations and they cause 
a person to unexpectedly change from having symptom control (often 
referred to as being 'on') to experiencing a lack of control with recurrence 
of the motor features of their disease e.g. freezing, rigidity or tremor 
(often referred to as being 'off'). An adjustment of the dose of levodopa 
based medicine and the introduction of adjuvant medications may be 
required to manage these fluctuations in symptom control. 
 
The end of dose wearing off effect means that over time "the useful 
antiparkinsonian effect of each levodopa dose lasts a progressively 
shorter time" (Thanvi & Lo, 2004 pp 455). Initially, in order to maintain the 
effectiveness of levodopa, the dosing interval of the levodopa based 
medicine will be adjusted and a dose of the medicine will be taken more 
frequently to reduce the time between doses. For many people 
experiencing the end of dose wearing off effect these adjustments alone 
will not provide symptom control and they require the introduction of 
adjuvant drugs to manage the motor complications of levodopa as well as 
the features of their progressing Parkinson’s disease.  
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The adjuvant medications may be dopamine agonists, MAOB inhibitors 
and catechol-O-methyl transferase (COMT) inhibitors (e.g. entacapone 
and tolcapone) (The National Collaborating Centre for Chronic 
Conditions, 2006). These medications can have multiple therapeutic 
effects in people with 'later' disease (Clarke & Deane, 2001; Clarke et al., 
2000a, 2000b; Koller et al., 2005) and these effects include: 
 
a) managing the motor features that are caused by the progressing 
Parkinson’s disease,  
b) reducing the ‘off’ time that a person experiences due to the effects 
of their levodopa dose wearing off, and, 
c) allowing a reduction in the levodopa dose which may help reduce 
any dyskinesias that the person has developed.  
 
People with 'later' disease that are unable to achieve control of their 
symptoms with a combination of oral medications, or those people that 
are unable to tolerate oral medications, may require the use of parenteral 
apomorphine (The National Collaborating Centre for Chronic Conditions, 
2006). Co-careldopa intestinal gel (brand name Duodopa®) provides a 
therapeutic option for people that fail to respond to or are unable to 
tolerate apomorphine.  
 
1.5 Individualised management plans 
Each person with Parkinson’s disease has an individualised medication 
treatment plan that is designed to manage their motor and non-motor 
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features (including neuropsychiatric symptoms). This treatment plan 
should be developed following discussions between the doctor and the 
patient which consider the patient’s previous experience with 
antiparkinsonian medications, their preference about route of 
administration of medications and their ability to manage a complicated 
medication regimen. The known efficacy and adverse effect profile of the 
medications should also be considered during the development of the 
treatment plan (Scottish Intercollegiate Guidelines Network, 2010). 
 
The combinations of medications and the doses and frequency of dosing 
for each medication are different for each person with Parkinson's 
disease and will change as the person's disease progresses. People with 
‘early’ disease may require the use of one or two antiparkinsonian 
medications administered a small number of times a day to achieve 
symptom control and may not require medications to manage the non-
motor features of their disease. Many people with ‘later’ disease will have 
an intricate medication regimen to control their motor symptoms. These 
regimens may involve doses of levodopa based medicines being 
administered at specific times or require specific time intervals to elapse 
between the medication doses. They may also involve some 
antiparkinsonian medicines being administered simultaneously, for 
example entacapone must be given at the same time as levodopa based 
medicines, or the administration of medications via different routes (e.g. 
parenteral apomorphine and oral levodopa based medications). People 
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with 'later' disease may also require medications to manage their non-
motor features of the disease. 
 
1.6 Complications associated with inappropriate administration of 
antiparkinsonian medicines  
A person's medication regimen may have been refined over a prolonged 
period of time in response to their features of Parkinson's disease and the 
complications that they have developed from their medications. Once a 
medication regimen has been established any inadvertent deviations from 
this regimen could cause complications. These deviations can be 
omission or delayed administration of doses of antiparkinsonian 
medications or administration of reduced or excessive doses of these 
medications. 
 
Omission of doses or administration of reduced doses of levodopa based 
medicines, dopamine agonists, MAOB inhibitors or COMT inhibitors can 
lead to loss of control of motor features (Grosset, 2010). In some cases 
this can lead to the person developing a tremor but others may become 
unable to move (known as 'freezing') which can cause them to fall and 
limits their ability to engage in physiotherapy, occupational therapy and 
activities of daily living e.g. eating, washing and being able to walk to the 
toilet. Omission of doses of antiparkinsonian medications may also cause 
a person with Parkinson's disease to develop dysphagia which can 
reduce their ability to swallow their oral medications. This may lead to 
omission of further doses of medication and a further deterioration in the 
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person’s symptom control. In rare cases, omission of doses of 
antiparkinsonian medication may trigger neuroleptic malignant syndrome 
which can be fatal (Maule, 2009). 
 
Delayed administration of doses of antiparkinsonian medications can lead 
to a loss of control of motor features, particularly in those people where 
the dose interval for their levodopa based medications has been 
shortened in response to them experiencing end of dose wearing off 
effects. They may experience a recurrence of motor features including 
bradykinesia, stiffness and tremor and may develop non-motor features 
including anxiety, memory problems and confusion.  
 
Omission of doses of medicines used to manage the non-motor features 
of a person's disease (e.g. antidepressants, antipsychotics or anxiolytics) 
can lead to worsening of the non-motor features of the person's condition. 
This can cause their anxiety to become uncontrolled or they may develop 
psychosis. Psychosis may also occur following the administration of large 
doses of antiparkinsonian medications. Administration of large doses of 
levodopa based medicines can also cause motor complications, including 
dyskinesias (Grosset, 2010; Grosset et al., 2005).  
 
1.7 Chapter summary 
Each person with Parkinson's disease will have their own medication 
treatment plan which has been developed to manage their motor and 
non-motor features of the disease. Inadvertent changes to their 
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medication regimen can alter the person's symptom control and lead to 
complications including 'freezing', dyskinesias, anxiety and psychosis.  
 
Most hospitals have implemented processes to ensure that any patient 
admitted to hospital continues to receive their usual medications, where 
this is clinically appropriate, but information is required about how 
patients with Parkinson's disease perceive the management of their 
antiparkinsonian medications during a hospital admission. Information 
about patients' perceptions related to this topic would allow healthcare 
professionals to develop an understanding about areas of concern for 
patients related to the management of their medicines and identify 
methods that could be used to address these concerns. 
 
1.8 Reflexivity 
The researcher for this study is an advanced pharmacist for 
neurosciences within a teaching hospital in the UK. Prior to the start of 
the study, the researcher had two years experience of being involved in 
the care of people with Parkinson's disease that are admitted to hospital. 
The advanced pharmacist role has supported the development of strong 
professional relationships with the consultant neurologists and PDNS at 
Leeds Teaching Hospitals NHS Trust (LTHT). 
 
The researcher’s background includes experience of working as a clinical 
pharmacist in a range of clinical areas including care of the elderly 
patient, critical care, orthopaedic surgery and paediatrics. 
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The role of advanced pharmacist for neurosciences requires that the 
pharmacist has an awareness of current research related to the area of 
practice therefore at the start of the research process the researcher was 
familiar with the professional literature related to the medical 
management of patients with Parkinson's disease. The author of this 
thesis has contributed to the available literature by being a co-author of 
an article about Parkinson's disease for the journal Clinical Pharmacist, 
(Kearney & Dunsmure, 2011) which is a journal for pharmacists and 
pharmacy technicians in the UK. 
 
The lead researcher is a committee member within the United Kingdom 
Clinical Pharmacy Association (UKCPA) neurosciences group and 
attempts to use this platform as a way to contribute to the education of 
other pharmacists about the pharmacological management of 
neurological conditions. An example of sharing knowledge with others is 
the preparation of an article for the UKCPA magazine about managing 
the care of patients with Parkinson's disease that are nil by mouth 
(Dunsmure & Dorward, 2010). This magazine is distributed to all UKCPA 
members. 
 
The lead researcher has previous experience of designing and 
conducting a qualitative research study (Dunsmure, 2010). The study 
population was composed of healthcare professionals and data was 
collected using face to face individual interviews, focus groups and a 
questionnaire. Data was analysed utilising thematic analysis. The study 
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was designed and data was collected and analysed as part of the 
DPharm programme. 
 
The lead researcher also has experience of designing and conducting a 
small scale quantitative study (Dunsmure, 2002). The study was 
conducted as part of an undergraduate MPharm degree programme and 
the study population was composed of inpatients and patients attending 
outpatient clinics at a large teaching hospital in the UK. Data collection 
involved meeting with each patient and supporting the patient to complete 
a questionnaire which had been designed to collect quantitative data.  
 
In summary, the lead researcher's pharmacy career has allowed the 
development of a detailed knowledge about the pathophysiology of 
Parkinson's disease and the pharmacological treatments that can be 
used to manage a patient's features of the disease. They have 
experience of managing the care of patients with Parkinson's disease in a 
hospital setting and have familiarity with the medical and pharmacy 
literature related to this disease. The lead researcher’s experience of 
designing and conducting qualitative and quantitative research is limited 
but does include developing research proposals and applications for 
ethics committees.  
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2 Literature review 
2.1 Introduction to chapter 
A literature review involves identification and critical appraisal of 
information related to a topic of interest in order to identify existing 
knowledge and determine any gaps in this knowledge (Holloway & 
Wheeler, 2010). The initial literature search for this study was designed to 
highlight the available information related to the management of 
medication when a person with Parkinson’s disease is admitted to 
hospital and the literature review involved critically appraising this 
information to identify gaps in the current knowledge. 
 
Throughout this chapter existing literature will be used to demonstrate 
why patients’ perceptions of the management of antiparkinsonian 
medication when they are admitted to hospital require further 
investigation and will describe how the study could complement or 
challenge the existing understanding about the topic. 
 
2.2 Purpose of a literature review in a study with grounded theory 
methodology 
The central research question for this study was addressed through the 
use of grounded theory methodology and the rationale for this choice of 
methodology is discussed in chapter 3. The purpose of a literature review 
in a qualitative research study with grounded theory methodology has 
been debated for many years since Glaser and Strauss stated that a 
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researcher should “ignore the literature of theory and fact on the area 
under study, in order to assure that the emergence of categories will not 
be contaminated by concepts more suited to different areas” (Glaser & 
Strauss, 1967 pp 37).  
 
Glaser and Strauss (1967) proposed that existing literature should only 
be identified and appraised after the researcher has analysed the data 
and identified the categories that are present. This allows the researcher 
to approach the data without preconceived ideas and enables them to 
identify any themes that are present rather than interpreting the data to 
support or contest existing theories and hypotheses (Glaser & Strauss, 
1967). Once the categories have been identified the researcher can then 
use existing literature to support the generation of theory from the data.  
 
The original guidance from Glaser and Strauss (1967) did not 
acknowledge that professionals conducting research within their area of 
practice may have an awareness of the professional literature related to 
the topic of interest or practical experience related to the research topic. 
Following the separation of the Glaser and Strauss partnership, Strauss 
and Corbin (1990) advised researchers to use their current knowledge to 
identify gaps in the existing knowledge about the topic of interest but 
recommended that they should avoid undertaking a comprehensive 
literature review until data analysis had been completed. This approach 
would prevent the researcher forming preconceived ideas which could 
adversely influence the inductive process of grounded theory 
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methodology. The researcher would then review the literature in detail 
following the data analysis process and use this literature to explain the 
theories that emerge from the data. 
 
Strauss and Corbin (1990) proposed that a researcher's experience and 
pre-existing knowledge, which they described as theoretical sensitivity, is 
useful and can support theory generation rather than adversely 
influencing the process. They suggested that a researcher's theoretical 
sensitivity can help them to understand the meaning of information 
provided by a participant and recognise connections between concepts 
that become apparent within the data. Strauss and Corbin (1990) advised 
researchers to acknowledge their background knowledge, opinions, 
biases and experiences at the start of the research process. The previous 
knowledge and experiences of the lead researcher for this study that are 
relevant for this study are detailed in section 1.8.  
 
Some qualitative researchers utilising grounded theory methodology do 
not adhere to the original recommendations by Glaser and Strauss (1967) 
and conduct a detailed literature review before data analysis has been 
completed (Charmaz, 2006; Lempert, 2007; Stern, 2007). These 
researchers utilise the literature review for different purposes. Some 
conduct a detailed literature review at the start of the research process to 
allow them to develop a detailed understanding about subjects related to 
the study whereas others utilise the information to support the processes 
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of data collection and analysis (Charmaz, 2006; Holloway & Wheeler, 
2010; Lempert, 2007).  
 
A detailed literature review was conducted at the start of the research 
process in this study to support the preparation of a research proposal 
and an ethics application. The review was used to identify existing 
information related to the topic of interest, identify gaps in the current 
knowledge and develop a rationale that the research question was an 
area that required exploration. The literature review also supported the 
selection of research methods for the study. This use of a literature 
review is recognised by other qualitative researchers (Charmaz, 2006; 
Lempert, 2007) and provides a method for the researcher to justify the 
research study and situate it in the context of existing work.  
 
A second literature review was conducted in this study after categories 
had become apparent within the data provided by the study participants. 
This review was related to the categories emerging from the data and 
considered literature from a range of disciplines to support the generation 
of a theory which was embedded in the data (Stern, 2007). The literature 
review conducted at the start of the research process is discussed 
throughout this chapter. The information identified during the second 
literature review that was used to support data analysis and theory 
generation is referred to throughout chapter 6. 
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2.3 Approach to the review process 
A systematic approach to a literature review utilises a clearly defined 
search process and includes a description of the methods used to 
analyse the studies. This approach provides a reproducible literature 
review which supports the demonstration of validity of the findings of the 
study (Hek et al., 2000). In contrast, a narrative approach to a literature 
review involves an unstructured literature search which could fail to 
identify pertinent information. The lack of structure for both the literature 
search and the critique process prevents the review being repeatable and 
this can lead to criticisms about the rigour of the research study. Narrative 
reviews can also be associated with bias in the selection of literature to 
be considered in the search process and this can lead to an inaccurate 
representation of the situation under investigation.  
 
A systematic approach was chosen for this study. The literature search 
was comprehensive to ensure that all pertinent references were identified 
and the search strategy was clearly documented with defined inclusion 
criteria for the search. The review process is detailed in the following 
sections. 
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2.4 Scope of the review 
The literature review had a broad scope and was designed to provide a 
comprehensive review of the areas of interest which included: 
 
x perceptions and attitudes of patients with Parkinson’s disease 
towards hospital admissions,  
x perceptions and attitudes of patients with other chronic diseases 
towards hospital admissions, 
x perceptions of patients about the management of medication when 
a patient with a chronic disease (including Parkinson’s disease) is 
admitted to hospital, and, 
x patient satisfaction related to hospital admissions.  
 
The literature review involved consideration of studies, articles and 
editorials published in journals and grey literature. The inclusion criteria 
for documents considered during the literature review is detailed in 
appendix 2. Medical, nursing and pharmacy professional journals were 
searched to ensure that the review process reflected the multidisciplinary 
contributions to a patient’s hospital admission.  
 
Grey literature is material that is not formally published by commercial 
publishers or peer reviewed journals and includes government 
publications, conference proceedings and unpublished dissertations and 
theses. Historically, unpublished studies were not included in systematic 
reviews due to concerns about the quality of methodology used within the 
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studies but this has changed since a Cochrane review considering the 
role of grey literature in meta-analyses of randomised trials of health care 
interventions reported that there is limited evidence that demonstrates 
that grey trials are of poorer methodological quality than published trials 
(Hopewell et al., 2007). Data from unpublished studies (including 
conference presentations) was considered during this literature review to 
ensure that the review had a broad scope and considered current 
research related to the topic of interest. Grey literature in the form of 
government publications and literature produced by specialist interest 
groups was also considered during the literature review.  
 
2.5 Search strategy 
The search strategy for this study involved identifying peer reviewed 
literature by searching specific databases using key words and identifying 
grey literature by searching a range of databases, government 
documents and publications prepared by special interest groups. 
 
2.5.1 Peer reviewed literature  
The systematic approach to the literature review involved searching 
specified databases utilising key words, screening the abstracts of 
documents identified and then critically appraising studies or reading 
articles which satisfied the inclusion criteria for the review. 
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A range of databases were utilised during the review process to ensure 
that the process reflected the multidisciplinary approach to managing a 
patient's care during a hospital admission. The databases searched were: 
 
x Medline, 
x Embase, 
x CINAHL (Cumulative Index to Nursing and Allied Health 
Literature), and, 
x ASSIA (Applied Social Sciences Index and Abstracts). 
 
Medline and Embase were searched for literature relating to the areas of 
interest because they cover the majority of the medical and 
pharmaceutical press. CINAHL was searched because this database 
includes the majority of literature related to nursing and allied health care 
professions. The ASSIA database includes social science and health 
information and was included in the literature search because this 
resource considers literature related to nursing and health.  
 
The specific search terms varied for each database because the Medical 
Subject Headings (MeSH) used with the Medline database are different to 
the terms used in Embase, CINAHL and ASSIA but the terms used were 
variations on the themes of: 
x health knowledge, attitudes and practice, 
x patient expectations and satisfaction with health care, 
x patient acceptance of health care, 
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x hospital admissions, 
x patient perceptions, 
x patient attitude, 
x patient participation,  
x sick role, 
x medication administration. 
These points were explored for patients with Parkinson’s disease and 
patients with other chronic conditions (including neurological conditions). 
The search strategy used for each database is detailed in appendix 3. 
The abstracts for all journal articles that had been identified during the 
literature search were read and the article was rejected if the study did 
not have a connection with this research study. All of the remaining 
articles were obtained (where a full article had been published) and the 
full article was read. The reference sections of these articles were also 
reviewed to identify other relevant references that had not been identified 
during the initial search.  
 
Articles were discarded at this point if they did not satisfy the inclusion 
criteria for the literature review (detailed in appendix 2). Studies that met 
the inclusion criteria for the literature review and were related to the topic 
of interest were critically appraised using methods relevant to the nature 
of the research being evaluated. The methods used to critically appraise 
these studies are detailed in appendix 4. When a key article was 
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identified a citation alert was set up to provide notification of new papers 
citing that work.  
 
2.5.2 Grey literature 
A review of grey literature related to this area of practice involved:  
 
x searching a range of databases including System for Information 
on Grey Literature in Europe Archive (SIGLE), the Open University 
grey literature site, GreyNet International, Open Grey, DIRLINE, 
Networked digital library of theses and dissertations (NDLTD) and 
the British Library,  
x accessing specific government documents (e.g. publications from 
Department of Health and NICE), and,  
x searching publications prepared by special interest groups (e.g. 
Parkinson’s UK (formerly the Parkinson’s Disease Society) and 
European Parkinson’s Disease Association). 
 
Publications from special interest groups were included in the review 
process because they may contain information related to the perceptions 
and attitudes of patients with Parkinson’s disease about experiences 
related to a hospital admission. Discussion articles and letters to journals 
were also included to ensure that the views and priorities of individual 
patients, members of special interest groups and healthcare 
professionals managing the care of patients with Parkinson’s disease 
were considered during the review process (Dowrick et al., 2009). 
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Government documents specifying the care that should be available to 
patients with long-term conditions, including Parkinson’s disease, were 
also searched. These documents were identified by searching websites 
for the Department of Health, NICE, Scottish Intercollegiate Guidelines 
Network (SIGN) and National Patient Safety Agency (NPSA).  
 
Publications and guidance related to the medicines management 
processes that should be implemented within all hospitals in the UK that 
were issued by the pharmacy governing body (the Royal Pharmaceutical 
Society of Great Britain (RPSGB) became the General Pharmaceutical 
Council (GPhC) during the literature review process), the General 
Medical Council (GMC) or the Nursing and Midwifery Council (NMC) were 
also considered during the review process. These documents allowed the 
researcher to identify the core standards related to medicines 
management that should be met by all hospitals.  
 
The medicines management policies implemented within LTHT were also 
considered during the literature review because they state the standards 
related to medicines management that should be implemented within all 
clinical areas within the hospital trust. 
 
2.6 Summary of search results  
The literature search identified three studies with qualitative methodology, 
one study with quantitative methodology, one study with mixed methods, 
four discussion articles, two editorials, one letter to the editor and two 
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abstracts for national conferences that met the inclusion criteria for the 
search and were relevant to the research question. Government 
publications and publications from specialist interest groups were also 
identified during the search of the grey literature. 
 
2.7 Findings of the literature review  
The information that was identified during the literature search appeared 
to be related to the processes and behaviours associated with prescribing 
medications and administering medicines to a patient. These activities 
are essential elements of medicines management within a hospital which 
was defined by the Audit Commission (2001) as: 
 
"the entire way that medicines are selected, procured, delivered, 
prescribed, administered and reviewed to optimise the contribution 
that medicines make to producing informed and desired outcomes 
of patient care" (Audit commission, 2001 pp 5). 
 
Literature suggesting that patients may feel anxious during a hospital 
admission was also identified during the search process. This literature 
and the literature related to prescribing and administering medications is 
discussed in the following sections of this chapter.  
 
  - 34 - 
2.7.1 Prescribing a patient's usual medicines when the patient is 
admitted to hospital 
People with Parkinson's disease have individualised medication regimens 
to manage the motor and non-motor features of their disease (discussed 
in section 1.5). When a person with Parkinson’s disease is admitted to 
hospital inadvertent changes to their antiparkinsonian medicines or 
medicines used to manage the non-motor features of their disease can 
lead to complications, including loss of symptom control (discussed in 
section 1.6). To ensure that the patient is able to maintain their usual 
medication regimen during their hospital admission a patient's hospital 
prescription should have the correct medication prescribed at the correct 
dose for administration at patient specific times.  
 
The importance of each person receiving the correct dose of their 
antiparkinsonian medication at the correct time during a hospital 
admission, where this is clinically appropriate, was highlighted to 
healthcare professionals in the NICE guidance for the diagnosis and 
management of patients with Parkinson’s disease (The National 
Collaborating Centre for Chronic Conditions, 2006) and Quality 
Requirement 11 of the National Service Framework (NSF) for Long-Term 
Neurological Conditions (Department of Health, 2005).  
  
The literature search identified one published study (Magdalinou et al., 
2007) where the objectives of the study included reviewing whether a 
patient’s usual medication regimen (antiparkinsonian medications only) 
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was prescribed accurately when the patient was admitted to hospital. 
Magdalinou et al. (2007) conducted a retrospective case note audit for 
people with Parkinson’s disease admitted to a district general hospital 
during a twelve month period to determine whether the correct 
antiparkinsonian medications were prescribed at correct doses and 
administered on time. The authors also collected information about the 
reasons for delay in administration or omission of doses. Thirty five 
patients (26 medical and 9 surgical patients) were considered in the study 
and the results suggested that 74% of patients (26 out of 35 patients) had 
their medications inappropriately prescribed (including incorrectly 
stopping medication) or omitted during their hospital admission. The 
researchers did not provide information about how many of these patients 
had medicines inappropriately prescribed and how many of the patients 
had omitted doses. The reasons for stopping medication when the patient 
was admitted to hospital or prescribing medications at incorrect times 
were not considered.  
 
Magdalinou et al. (2007) suggest that the researchers contacted the 
patients identified during the audit (and their carers where this was 
appropriate) by telephone but the purpose of the telephone conversation 
and the information obtained is not reported.  
 
Writing a prescription that reflects a patient's usual medication regimen 
requires the hospital prescriber to have access to information about this 
regimen including medications, formulations, doses and times of 
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administering these doses. Patients (or their carers) are often best placed 
to provide this information due to their familiarity with the patient's usual 
medication regimen but there is limited information available about 
whether patients with any chronic disease (including Parkinson's 
disease), or their carers, believe that they contribute to the process of 
prescribing a patient's medications when the patient is admitted to 
hospital.  
 
Currently there are no studies that explore the perceptions of patients 
with neurological conditions, including Parkinson’s disease, about the 
prescribing of their medications when they are admitted to a UK hospital. 
Buetow et al. (2010) conducted a qualitative study which explored the 
opinions of patients with Parkinson’s disease (and their carers) in New 
Zealand about antiparkinsonian medication timing errors in the 
community setting and during hospital admissions (Buetow et al., 2010). 
Telephone interviews were conducted with thirteen patients and seven 
carers to collect information about occasions when they believed that 
they had experienced mistakes associated with the patient's 
antiparkinsonian medications. Thirteen participants provided information 
about experiences related to admission to a hospital. 
 
The researchers report that one participant proposed that “timing errors 
could have been avoided ‘if they (hospital staff) had only asked me (the 
caregiver) – I had the latest script’" (Buetow et al., 2010 pp 3). This 
participant proposed that if they had been involved in the prescribing 
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process they could have given the prescriber the information required to 
write a prescription chart that accurately reflected the patient's usual 
medication regimen. The authors do not provide further information about 
whether other participants believed that hospital staff engaged them in 
the prescribing process. 
 
One participant reported that their husband’s antiparkinsonian 
medications had been inappropriately stopped on admission to hospital 
and they believed that the patient had experienced deterioration in 
symptom control as a consequence of this deviation. The authors state 
that other participants reported omission of doses of medications but the 
participants' feelings about these experiences are not reported. 
 
Participants for the study were recruited either by being invited to 
participate in the study by a field officer or by contacting the researchers 
after reading an article in Parkinson’s New Zealand’s quarterly magazine. 
Patients were suitable to participate in the study if they had Parkinson’s 
disease and had a previous experience of a possible mistake related to 
their medication for Parkinson’s disease (Buetow et al., 2010). The 
patient selection criteria meant that only patients and carers with a 
negative experience of medicines management were included in the 
study. The researchers acknowledged this bias during a discussion of the 
findings of the study.  
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Although Buetow et al. (2010) only considered negative experiences, the 
study highlighted that some people with Parkinson's disease and their 
carers believe that there are problems associated with the management 
of medications when a person with Parkinson's disease is admitted to 
hospital. A study that has the potential to explore both positive and 
negative perceptions about the management of medicines during a 
hospital admission is required to provide a comprehensive understanding 
of patients’ perceptions about the management of antiparkinsonian 
medications during a hospital admission. 
 
Participants in the study conducted by Buetow et al. (2010) were able to 
share experiences about any hospital admission where they believed that 
an error had occurred. The duration of time between the hospital 
admission that the participant was reflecting upon and their interview for 
the study was not reported. The period of time that elapsed between 
discharge from hospital and the interview could affect the quality of the 
data collected because: 
 
a) the participant may not accurately remember events that 
happened during their admission, or, 
b) the participant’s recollection of events may be altered over time 
and they may only recall the negative events that occurred during 
their admission. 
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The five themes that Buetow et al. (2010) identified in the data provided 
by participants included "instructions wrong, vague or misread" (Buetow 
et al., 2010 pp 2) and "lack of both professional knowledge and caring 
behaviour” (Buetow et al., 2010 pp 3). The data presented by the authors 
to explain these themes included data which suggested that some 
participants thought that a patient's medications were being administered 
at times that did not correspond with their usual regimen due to their 
prescription failing to reflect their usual medication regimen. One 
participant said:  
 
"they would have 8.00, 8.30 … and I would say, "He is supposed 
to get his pergolide on a full stomach." "Oh, no, no, it's charted 
for ..."" (Buetow et al., 2010 pp 2). 
 
Some participants' statements suggest that they felt frustrated and angry 
due to their belief that a patient's prescription chart did not accurately 
reflect the patient's usual medication regimen.  
 
The problems related to prescribing antiparkinsonian medications that 
were highlighted by participants in the study conducted by Buetow et al. 
(2010) may be similar to problems perceived by patients admitted to 
hospitals within the UK, including LTHT. Further work is required to 
explore patients' perceptions of the processes used by healthcare 
professionals when they are prescribing antiparkinsonian medication for a 
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patient admitted to LTHT. The data obtained can be used to identify 
areas of good practice and highlight areas that require development. 
 
Buetow et al. (2010) recommended that actions are required to improve 
the delivery of antiparkinsonian medication to patients admitted to 
hospital and suggested that these actions should be developed through 
discussion with people with Parkinson’s disease. Enabling patients with 
Parkinson’s disease admitted to LTHT to highlight areas of practice that 
require development and suggest methods to achieve this will facilitate a 
collaborative approach to improving the processes used to manage a 
patient's medicines when they are admitted to LTHT. 
 
2.7.2 Medicines reconciliation 
Unintentional changes to medication regimens when a patient with a 
chronic disease is admitted to hospital is an internationally recognised 
problem (Bell et al., 2011; Cornish et al., 2005). For many years the 
specialist interest group Parkinson’s UK, and its international equivalents, 
have recognised that some people with Parkinson’s disease do not have 
the correct antiparkinsonian medication prescribed at the correct time 
when they are admitted to hospital (European Parkinson’s Disease 
Association, n.d; Parkinson's UK, 2006). Parkinson's UK highlighted to 
healthcare professionals their concerns about the lack of agreement 
between medications prescribed when a patient is admitted to hospital 
and their usual medications through the ‘Get it on time’ campaign 
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(Parkinson's UK, 2006). The specialist interest group continues to actively 
promote this campaign to patients, carers and healthcare professionals. 
 
It is estimated that between 30% and 70% of patients admitted to hospital 
have at least one unintentional discrepancy between the medication 
regimen prescribed on their hospital inpatient prescription chart and their 
usual medication regimen (National Institute for Health and Clinical 
Excellence and National Patient Safety Agency, 2007). The process of 
medicines reconciliation was proposed by NICE as a method that could 
be used to ensure that the medicines taken by a person prior to 
admission to hospital are continued at the same dose and administered 
at appropriate times when they are admitted to hospital, provided that this 
is clinically appropriate (National Institute for Health and Clinical 
Excellence and National Patient Safety Agency, 2007).  
 
Medicines reconciliation involves using a variety of information sources to 
develop a detailed understanding about a patient’s medication regimen 
prior to admission to hospital and then using this information to ensure 
that this regimen is delivered during their hospital admission, where it is 
clinically appropriate to do so (National Institute for Health and Clinical 
Excellence and National Patient Safety Agency, 2007). Following the 
publication of the guidance by NICE, the process of medicines 
reconciliation should be conducted for all adult patients admitted to 
hospital and it has become an essential element of medicines 
management within LTHT. 
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Medicines reconciliation is a method that supports the prescribing of the 
correct antiparkinsonian medication at the correct times for a person 
admitted to hospital because it supports collection of detailed information 
about their medication regimen prior to admission and ensures that it has 
been prescribed correctly. Being aware of the patient's usual medication 
regimen allows detection of inadvertent discontinuation of regular 
medications when the patient is admitted to hospital and identification of 
inappropriate changes to the dosing regimens of their medications. Once 
these discrepancies have been identified they can be corrected to ensure 
that the patient is able to maintain their usual medication regimen during 
a hospital admission. 
 
Patients and carers should be involved in the medicines reconciliation 
process (where this is possible) due to their detailed knowledge about the 
patient’s medication regimen prior to admission to hospital. The 
information about a patient's medication regimen provided by the patient 
or their carer should be considered in conjunction with information 
obtained from the patient's General Practitioner (GP), their PDNS or their 
consultant neurologist (where this is information is available) (National 
Institute for Health and Clinical Excellence and National Patient Safety 
Agency, 2007). 
 
Currently there are no studies that explore the perceptions of patients 
with neurological conditions, including Parkinson’s disease, about the 
process of medicines reconciliation. An understanding of patients' 
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perceptions of the processes used within LTHT to obtain information 
about their usual medicines will provide patient insights into the process 
of medicines reconciliation and, where appropriate, identify methods to 
improve practice. 
 
2.7.3 Administration of medication to a patient 
The process of administering a medication involves introducing the 
medication into the patient’s body e.g. injecting a dose or giving a patient 
an oral dosage form to swallow (Nursing and Midwifery Council, 2010). In 
most clinical areas within LTHT this process involves a nurse 
administering the medication to the patient at the time prescribed on the 
prescription chart. A small number of patients admitted to LTHT may self-
administer their medication from their own supplies that are stored in a 
locked cupboard by their bedside.  
 
Most hospital wards have medicine rounds at specific times of the day 
and during these medication rounds the nurse, or another appropriate 
healthcare professional, will offer a patient a dose of each of the 
medications that are prescribed for administration at that time. Many 
patients will require administration of doses of antiparkinsonian 
medication at times that do not correspond to the times of the ward 
medicine round (e.g. levodopa based medications given two or three 
hourly). Administration of medication by nurses at times outside of the 
medication rounds requires awareness of these timings and remembering 
to administer the dose at these times. 
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Pearce (2010) wrote an editorial for the Nursing Standard which 
discusses work undertaken by a PDNS to support nurses to administer 
antiparkinsonian medications at patient specific times. The nurse 
specialist produced an education pack for ward nursing staff which 
discusses how to manage the care of patients with Parkinson’s disease 
and provided ward staff with pill-timers which would alert the nursing staff 
when a dose of antiparkinsonian medication was due. The intervention 
was derived from an individual nurse’s perception of the barriers present 
in a clinical area to administering antiparkinsonian medication at specific 
times. The attitudes of patients towards this intervention have not been 
explored.  
 
The omission or delayed administration of medication doses is a problem 
that can be experienced by any person that is admitted to hospital. 
Patients with Parkinson's disease require consistent administration of 
their medications to prevent loss of symptom control therefore omission 
or delayed administration of antiparkinsonian medication can lead to 
complications for these patients (discussed in section 1.6). The adverse 
effects that can occur due to omission of doses or delayed administration 
of doses of antiparkinsonian medications were highlighted to healthcare 
professionals by the NPSA Rapid Response Alert considering the 
reduction of harm from omitted and delayed medicines in hospital 
(National Patient Safety Agency, 2010). The alert presents examples of 
the consequences of delayed administration and omissions of dose of 
medications and includes antiparkinsonian medications in a list of critical 
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medicines that once prescribed should not be omitted and administration 
of doses should not be delayed.  
 
There are a small number of published studies, abstracts and editorials 
that consider the administration of medication to people with Parkinson’s 
disease during their hospital admission. These publications highlight 
problems with the accuracy of timing of doses of antiparkinsonian 
medications that are administered by nursing staff and provide evidence 
that some patients do not receive every prescribed dose of their 
antiparkinsonian medication during a hospital admission.  
 
Derry et al. (2010) conducted a retrospective case note and medicine 
chart review for 54 patients with Parkinson’s disease admitted to surgical 
wards in a teaching hospital (total of 59 surgical admissions) during an 
eighteen month period. The results of this study indicate that in 27 
admissions over 5% of the prescribed doses of antiparkinsonian 
medication were not given to the patient and in 18 admissions over 10% 
of the prescribed doses were not given to the patient (Derry et al., 2010). 
Late doses were reported in 26% of admissions. The average length of 
time of the delay in receiving doses is not reported by the authors. The 
healthcare professionals managing the care of those participants that 
missed doses of antiparkinsonian medications or had their doses 
administered at incorrect times reported that some of these patients 
developed neuropsychiatric complications and motor deterioration. 
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The study highlights that some patients do not receive all of the 
prescribed doses of their antiparkinsonian medication during their 
admission and some patients do not receive their medication doses at the 
correct time. The authors did not explore patients’ opinions about 
omission of doses or delays in administration of doses of their 
medications.  
 
Omissions and delayed administrations of doses of antiparkinsonian 
medications were also identified in the study conducted by Elphick, 
Madan, et al. (2006) which considered the provision of Parkinson’s 
disease medications to patients admitted to a teaching hospital during a 
four month period. A case note and medicine chart review was conducted 
for 104 patients with Parkinson’s disease and 81% of patients 
experienced at least one dose omission during their hospital admission. 
The data also suggests that 70% of patients (73 patients out of 104 
patients) experienced a delay before they received the first dose of their 
antiparkinsonian medication following admission to hospital. The authors 
report that this delay was longer for patients requiring dopamine agonists 
than those requiring levodopa based medications (Elphick, Madan, et al., 
2006). The authors did not explore how participants felt about the delayed 
administration or omission of doses of their medications or whether 
participants believed that they had experienced adverse effects due to 
the delayed or omitted doses.  
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The reason for the delayed administration of the first dose of medication 
after admission was not reported by Elphick, Madan, et al. (2006) but in 
clinical practice the unavailability of medication on a ward is a common 
cause of delayed or omitted medication doses (Green et al., 2009). Derry 
et al. (2010) reported 12% of the participants in their study that missed a 
dose of medication did not receive that dose because the medication was 
‘out of stock’ at the time that the dose was required. The authors did not 
explore the perceptions of study participants about the lack of availability 
of their medications.  
 
The complications that can occur due to inappropriate delay or omission 
of doses of antiparkinsonian medications when a patient is admitted to 
hospital have been recognised by the specialist interest group 
Parkinson’s UK for many years. The ‘Get it on time’ campaign was 
launched by the specialist interest group to highlight to healthcare 
professionals the importance of administering antiparkinsonian 
medications at patient specific times (Parkinson's UK, 2006). The 
specialist interest group report that the campaign was created in 
response to members of the specialist group believing that they had 
experienced problems with the prescribing and administering of 
medication during hospital admissions. The literature search for this 
current study has not highlighted any publications that discuss the 
specific patient experiences that led to the development of the ‘Get it on 
time’ campaign.  
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In 2010, Parkinson’s UK developed a questionnaire that hospital staff 
could send to patients after their discharge from hospital to collect 
information about the patient’s experience of the hospital admission. The 
questionnaire included questions which asked the patient about their 
opinions related to the administration of their medications during the 
admission. Most of the questions allowed collection of quantitative data 
but five questions were designed to allow participants to provide 
comments about their hospital admission. The decision to administer this 
questionnaire to patients was made locally at each hospital and the 
feedback about the services at a specific hospital was collated by staff at 
that hospital. Parkinson’s UK was not collecting national data about 
patients' experiences of a hospital admission at the time of preparing this 
thesis (Parkinson’s UK, 2010) and there are currently no publications 
considering the findings from individual hospitals that issued the 
questionnaire to their patients. 
 
The development of a questionnaire by the specialist interest group 
demonstrates that members of the group believe that there is a need to 
collect information about the experience of a hospital admission from a 
patient’s perspective. The group proposed that the information provided 
by patients should be used to develop the services offered to people with 
Parkinson’s disease and improve the methods used to manage a 
patient's medicines during their hospital admission. The questionnaire 
provided a simple method to collect quantitative data and a small amount 
of qualitative data. A study with qualitative methodology is required to 
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allow healthcare professionals to develop a detailed understanding of 
patients' perceptions of the management of their medicines during a 
hospital admission. The collection of rich data about patients' perceptions 
will help healthcare professionals to understand the problems related to 
the management of their medicines that patients believe that they 
encounter during a hospital admission. Understanding the problems that 
patients perceive related to medicines management will support 
healthcare professionals to develop methods to address these causes of 
concern for patients. 
 
2.7.4 Self-administration of medicines schemes 
Many hospitals throughout the UK have schemes which allow patients to 
self-administer their medication during their hospital admission. A 
patient’s medicines are locked in a patient specific bedside locker and the 
patient has the key to their cupboard. The patient administers their own 
medication at times specific to their treatment plan and compliance aids 
or reminder charts can be utilised to support the patient to self-administer 
their medication. Elphick, Madan, et al. (2006) and Derry et al. (2010) 
proposed that this approach to administering medication could be a 
method to address the problem of omission and delayed administration of 
doses of antiparkinsonian medication that they had identified through 
their research studies.  
 
Government organisations and the specialist interest group Parkinson's 
UK have suggested for many years that self-administration schemes 
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allow patients with Parkinson's disease that administered their own 
medications at home to continue to do whilst they are admitted to hospital 
and facilitate the patient to receive the correct dose of medicine at the 
correct time. The role of self-administration of medicines in supporting a 
person with Parkinson's disease to maintain their usual antiparkinsonian 
medication regimen during a hospital admission has been highlighted in 
many government publications including: 
 
a) NSF for Long-Term Neurological Conditions (Department of 
Health, 2005),  
b) the NICE guidance for the management of Parkinson’s disease 
(The National Collaborating Centre for Chronic Conditions, 2006), 
c) the Healthcare Commission report ‘The best medicine – the 
management of medicines in acute and specialist trusts’ 
(Healthcare Commission, 2007), and, 
d) the Department of Health policy regarding self-administration of 
medicines in hospital (Department of Health, 2007). 
 
Following the launch of the 'Get it on time' campaign and in response to 
these government publications, some hospitals have implemented a self-
administration of medicines scheme specifically for use by patients with 
Parkinson’s disease to improve patient access to their antiparkinsonian 
medications (Parkinson's UK, 2006). LTHT has not developed a specific 
self-administration scheme for patients with Parkinson's disease. Patients 
with the disease are able to self-administer their medications using the 
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trust wide self-administration of medicines scheme. The policy for self-
administration of medications at LTHT requires the patient to be 
assessed by a pharmacist or nurse as being competent to self-administer 
their medication. A patient can be approved to self-administer a specific 
medicine or class of medicines, e.g. antiparkinsonian medications, or the 
patient may be assessed to administer all of their regular medicines 
(except for controlled drugs). The number of patients admitted to LTHT 
that choose to self-administer their antiparkinsonian medication is small 
but the reasons for the low use of the scheme have not been explored. 
 
The study population of 104 patients with Parkinson’s disease recruited 
by Elphick, Madan, et al. (2006) were admitted to a large teaching 
hospital that is comparable in size to LTHT and the authors reported that 
only 6 patients self-medicated (i.e. administered their own medicines) 
during their hospital admission. The authors presented a conclusion that 
“self-medication is uncommon” for patients with Parkinson’s disease 
admitted to the hospital where the study was conducted (Elphick, Madan, 
et al., 2006) but the authors do not state the reasons for the small use of 
the self-medication scheme. The researchers did not explore the study 
participants’ desires to self-administer their medications during their 
hospital admission or their reasons for choosing not to self-administer 
their medications. 
 
Comments from people with Parkinson's disease and their carers 
included in publications for the ‘Get it on time’ campaign suggest that 
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some people believe that self-administration of medication is a possible 
solution to the problem of delayed administration and omission of doses 
of antiparkinsonian medications during a hospital admission (Parkinson's 
UK, 2006). There are currently no studies that explore the factors that 
influence a patient's decision about whether to self-administer their 
medication during a hospital admission. This area requires further 
investigation to allow healthcare professionals to develop an 
understanding about these factors and identify methods to support those 
patients that would prefer to self-administer their medication. 
 
Self-administration of medication may be appropriate for those people 
with Parkinson’s disease who managed their own medication prior to 
admission to hospital but this method of administering medication may 
not be appropriate for people who usually rely on carers to manage their 
medication. These patients rely on nursing staff to administer the doses 
of their antiparkinsonian medication during their hospital admission 
therefore methods to improve delivery of medication at the correct time to 
this patient group also require further exploration to ensure that all 
patients with Parkinson’s disease receive their medications at the correct 
patient specific time. 
 
2.7.5 Anxiety associated with an admission to hospital 
Any patient admitted to hospital may develop anxiety due to a range of 
factors including the reason for the hospital admission, being in an 
unfamiliar environment and loss of independence (Johnston, 1980; Scott, 
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2004). Parkinson's UK (2010) proposes that patients with Parkinson’s 
disease may have additional sources of anxiety during the hospital 
admission due to concerns about the management of their medication. 
 
Elphick, Bolam, et al. (2006) collected information about the experience 
of members of a specific branch of the Parkinson’s Disease Society who 
had been admitted to hospital between 2002 and 2005. The findings of 
the study were presented as an abstract for an oral presentation at a 
conference. The study participants were administered a questionnaire 
which had been designed to collect both qualitative and quantitative data 
about a patient's experience related to the administration of medication 
during a hospital admission. The study considered patients admitted to 
hospital prior to the launch of the ‘Get it on time’ campaign by Parkinson’s 
UK and the release of the government publications discussed in section 
2.7.4 above which highlighted the importance of continuing the treatment 
plans of patients with Parkinson’s disease when the patient is admitted to 
hospital. 
 
Two of the themes identified within the data provided by the participants 
were “anxiety regarding medication provision and potential or actual 
worsening of function consequent upon sub-optimal medication provision” 
(Elphick, Bolam, et al., 2006). The number of participants that provided 
information related to these themes is not reported and it is not known if 
deviant cases were considered during data analysis. The authors 
suggested that their findings show that people with Parkinson's disease 
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may develop anxiety during a hospital admission due to concerns about 
the availability and accessibility of their antiparkinsonian medicines. 
These findings highlight an area that requires further work to explore if 
these are causes of anxiety for patients with Parkinson's disease 
admitted to hospital and identify methods to address the concerns raised 
by patients. 
 
Most people with Parkinson’s disease that are admitted to hospital for 
indications that are not related to their Parkinson’s disease will be 
admitted to wards with staff (medical and nursing) that do not regularly 
manage the care of patients with the disease (Pearce, 2010). In 2007 
Parkinson’s UK surveyed 13,000 people with Parkinson's disease about 
their experience of a hospital admission and identified that 27% of those 
that replied thought that hospital staff did not understand Parkinson’s 
disease or how a patient can be affected by the disease (Parkinson’s 
Disease Society, 2008b). Further information about the patients' 
experiences that led to this belief is not provided by Parkinson’s UK. A 
perception that staff have a lack of knowledge about Parkinson’s disease 
was also suggested by the data collected by Buetow et al. (2010) with 
one of the themes generated from the data being a “lack of both 
professional knowledge and caring behaviour” (Buetow et al., 2010 pp 3). 
One of the participants thought that "staff "do not always understand the 
way the (PD) medications work"" (Buetow et al., 2010 pp 3). 
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Currently there are no published qualitative studies which explore how 
people with Parkinson’s disease admitted to a hospital in the UK feel 
about their care being managed by healthcare professionals who are not 
experts in the management of the disease. The findings from Buetow et 
al. (2010) suggest that further information is required about patients’ 
perceptions of the knowledge of healthcare professionals about 
Parkinson’s disease and the impact of these perceptions on their 
experience of a hospital admission. Understanding patients' opinions 
about the knowledge of ward staff about the disease will allow hospital 
staff to consider methods that can be used to address these concerns 
and try to improve a patient’s experience when they are admitted to 
hospital. 
 
2.7.6 Opinions of healthcare professionals about the management of 
antiparkinsonian medication by hospital staff 
Barber et al. (2001) expressed concerns about the management of 
people with Parkinson’s disease admitted to hospital for a surgical 
procedure in a letter to a journal editor. They presented the findings of a 
survey of people with Parkinson's disease that had been admitted to 
Scottish hospitals for surgical procedures during a specific time period. 
Patients had been sent a questionnaire by the authors and there were 92 
respondents (describing 125 procedures). Sixteen respondents reported 
problems with the timing of doses of their antiparkinsonian medication 
and 15 of these respondents reported that they believed that they had 
developed confusion or experienced deterioration in the symptoms of 
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their Parkinson’s disease during their hospital admission (Barber et al., 
2001). Twenty three respondents reported that they had to prompt 
doctors about when to restart their medication after the operation. Barber 
et al. (2001) recommended that a prospective study should be conducted 
to determine the reasons for the problems with medication administration 
that the respondents had reported. 
 
Donaldson (2010) explored problems associated with antiparkinsonian 
medication management during hospital admissions in an editorial which 
was designed to raise awareness of the problems and provide a 
discussion about methods to address these issues. Donaldson referred to 
the problems with administration of medicines that had been highlighted 
in the studies conducted by Elphick, Madan, et al. (2006) and Derry et al. 
(2010) (discussed in section 2.7.3) and highlighted the principles 
underlying the Parkinson’s UK ‘Get it on time’ campaign.  
 
Donaldson (2010) acknowledged that there is limited research that 
examines patients’ experiences of hospital admissions or the clinical 
effect of inadvertent changes to a patient’s medication regimen when they 
are admitted to hospital and suggested that this was an area that required 
further investigation to highlight practices that cause concern for patients 
and identify methods to address these concerns. 
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2.7.7 Summary of findings 
A small number of quantitative studies have highlighted that some 
patients experience problems with the prescribing and administration of 
their antiparkinsonian medication when they are admitted to hospital. 
These problems include the patient's antiparkinsonian medications being 
inappropriately stopped when the patient is admitted to hospital, the 
prescribed dose times being different to the times that that the patient 
usually takes a dose of their medication and doses of medicines being 
administered at times that do not reflect the patient's usual regimen. 
 
The findings of these quantitative studies and publications issued by the 
specialist interest group Parkinson's UK have highlighted that some 
patients with Parkinson's disease are unable to maintain their usual 
medication regimen during a hospital admission. The information 
available also suggests that some patients have lost symptom control due 
to deviations from their usual medication routine. The authors of these 
studies suggested that further work is required to identify methods to 
address the problems associated with prescribing and administering 
antiparkinsonian medicines. They recommended that this work should 
consider patient concerns related to the prescribing and administration of 
antiparkinsonian medication to ensure that any solutions that are 
developed address the causes of these concerns. 
 
The information available about how patients perceive the processes 
used to manage their medicines during a hospital admission suggests 
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that patients may have concerns about the management of their 
antiparkinsonian medicines during a hospital admission. Further work in 
the form of a qualitative study is required to generate theory about 
patients’ perceptions of the management of antiparkinsonian medications 
when a patient is admitted to hospital. The study should involve 
participants that are admitted to hospital at the time of the data collection 
to avoid the detrimental effect on data accuracy that was evident in the 
Buetow et al. (2010) study discussed above. Participants that may 
provide either positive or negative comments about their experience of a 
hospital admission should be recruited to the study to ensure that the 
theory generated from the data is comprehensive and considers a diverse 
range of patients’ perceptions. 
 
2.8 Chapter summary  
A systematic approach was utilised to search for literature related to the 
perceptions of patients with Parkinson’s disease about the management 
of their antiparkinsonian medications when a patient is admitted to 
hospital. A clearly defined search strategy was developed to ensure that 
all relevant literature was identified.  
 
The literature review highlighted that there are concerns from specialist 
interest groups and healthcare professionals about patients’ experiences 
of medicines management during a hospital admission but there is 
currently a paucity of data about patients’ perceptions of the processes 
used to manage their medicines during a hospital admission.  
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Further work in the form of a study with qualitative methodology is 
required to develop a detailed understanding about patients’ perceptions 
of the processes used to manage their antiparkinsonian medicines during 
a hospital admission. Understanding patients’ perceptions about this topic 
will allow healthcare professionals to identify both good practice and 
areas of concern for patients and use patient insights to aid the 
development of solutions to these concerns. 
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3 Purpose statement and methodology  
3.1 Introduction to chapter  
The literature review discussed in chapter 2 highlighted that there is a 
paucity of research about patients’ perceptions of the management of 
antiparkinsonian medicines during a hospital admission and explained 
why healthcare professionals require an understanding about these 
perceptions. This chapter defines the central research question for the 
study and discusses the methods of data collection and analysis chosen 
to support answering this question. 
 
3.2 Purpose statement and research questions 
3.2.1 Purpose statement 
The purpose of this grounded theory study is to generate theory about 
patients' perceptions of the management of antiparkinsonian medications 
when a patient is admitted to Leeds Teaching Hospitals NHS Trust. For 
the purpose of this study, the term 'management of medicines' refers to 
processes and behaviours related to the prescribing and administration of 
antiparkinsonian medications and the process of medicines reconciliation 
(a formal definition of medicines management is provided in section 2.7). 
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3.2.2 Central question 
What are the perceptions of patients with Parkinson’s disease admitted to 
Leeds Teaching Hospitals NHS Trust about the management of 
antiparkinsonian medications during a hospital admission?  
 
3.2.3 Sub-questions 
a) How do patients with Parkinson’s disease participate in the 
process of prescribing their usual antiparkinsonian medication 
when they are admitted to hospital? 
b) How do patients with Parkinson’s disease participate in the 
process of medicines reconciliation? 
c) What are the perceptions of patients with Parkinson’s disease of 
the process of administering antiparkinsonian medications to 
patients admitted to Leeds Teaching Hospitals NHS Trust? 
d) What are the opinions of patients with Parkinson’s disease about 
their Parkinson’s disease being managed by ward doctors, nurses 
and pharmacists? 
 
3.3 Research strategy 
Corbin and Strauss (2008) propose that the research strategy for a study, 
including the methods chosen for data collection and analysis, is 
dependent upon:  
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a) whether the purpose of the study is to generate theory or verify 
existing theory, and, 
b) the type of data required to answer the research question for the 
study e.g. numerical data or a description of a patient’s feelings. 
 
The strategy for this current study, which is designed to generate theory 
about the topic of interest, is explained throughout the rest of this chapter.  
 
3.3.1 Qualitative or quantitative methodology? 
The majority of research studies can be broadly classified as using either 
qualitative or quantitative methodology but some studies utilise a 
combination of qualitative and quantitative methods to collect and analyse 
data (mixed methods research) (Creswell, 2003; Dieppe, 2005; Pope & 
Mays, 2006). Quantitative methodology is primarily used to verify existing 
theory whereas qualitative methodology allows the generation of theory. 
 
Qualitative methods are typically utilised when answering a research 
question requires the researcher to develop an understanding about an 
unknown or poorly understood phenomenon or explore a situation from 
the perspective of study participants (Creswell, 1998; Smith, 2006). 
Quantitative methods, including surveys and non-participant observation, 
are utilised in studies where answering the research question requires 
measurement or quantification of a specific phenomenon (Smith, 2006). 
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For many years research studies utilising quantitative methodology 
dominated published research within medical and pharmacy journals. 
During this time there were many studies utilising qualitative methodology 
published in nursing journals. The infrequent use of qualitative 
methodology in studies conducted by doctors and pharmacists might 
have been caused by a lack of familiarity with the methodology or an 
awareness of concerns raised by members of the medical profession 
about the quality of the information generated from studies utilising this 
methodology (Britten, 1995). These concerns were related to the 
subjective nature of qualitative research studies, the potential for 
researcher bias and the perceived lack of reproducibility of studies 
utilising qualitative methodology (Mays & Pope, 1995).  
 
During the last two decades there has been an increase in the number of 
studies using qualitative methodology published in both medical and 
pharmacy journals (Britten, 2005; Harding & Gantley, 1998; Kairuz et al., 
2007) which may be due to many doctors and members of the pharmacy 
profession developing an understanding about the role of qualitative 
methodology in research related to healthcare and the validity of 
information generated from studies utilising this methodology. Mixed 
methodology is also used in many studies considering practice within the 
NHS. In these studies qualitative methods are used to generate a theory 
and quantitative methods are used to verify the theory and allow the 
theory to become transferable to multiple populations (Barbour, 1999). 
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Answering the central question for this study required the generation of 
theory about a topic where there was limited existing knowledge and the 
data required to answer the question was related to participants' 
perceptions about the management of their antiparkinsonian medication 
during their hospital admission (Marshall & Rossman, 1999; Pope & 
Mays, 2006). Qualitative methodology was chosen for this study because 
this approach supports the collection of information about participants' 
perceptions and facilitates the generation of theory from this data.  
 
Quantitative methodology was not appropriate for this study because 
numerical data could not answer the central research question. Utilising 
mixed methods would provide an opportunity to both generate and verify 
theory related to participants' perceptions about the management of 
antiparkinsonian medication during their hospital admission but the 
purpose of this study was to exclusively generate theory therefore mixed 
methods were not used in this study. 
 
3.3.2 Type of qualitative research methodology used in this study 
The methodological approaches to conducting qualitative research can 
be classified in many ways. Creswell (1998) refers to five ‘traditions' of 
qualitative research (biography, phenomenology, grounded theory, 
ethnography and case studies). Each ‘tradition’ allows the collection of 
different types of data and the approach used within a study should be 
chosen after consideration of the central research question for the study 
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and identification of the type of data needed to answer this question 
(Creswell, 1998). 
  
Phenomenology and grounded theory were possible methodological 
approaches for a study considering patients’ perceptions of a situation. 
The other 'traditions' would not support collection of the type of data 
required to answer the central question of this study.  
 
The focus of a phenomenological study is to identify and describe the 
meaning of a lived experience to a group of participants. Although this 
methodological approach would allow a researcher to develop a detailed 
understanding about the meaning of an experience to a group of people 
(Creswell, 1998; Holloway & Wheeler, 2010) this approach would not 
allow generation of theory about a topic of interest. Due to the paucity of 
information available about the perceptions of patients with Parkinson's 
disease about medicines management in a hospital environment there 
was a need to generate theory about this topic. Grounded theory 
methodology was chosen for this study to allow the generation of theory 
about patients’ perceptions of the management of antiparkinsonian 
medication when a patient is admitted to hospital (Charmaz, 2006; 
Chenitz & Swanson, 1986). 
 
3.3.3 What is grounded theory methodology? 
The original approach to grounded theory methodology was described by 
Glaser and Strauss (1967) and involved the generation of theory from 
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data utilising specific methods of data collection and analysis. Glaser and 
Strauss (1967) provided clear guidance for other qualitative researchers 
about how to conduct studies with grounded theory methodology and 
they proposed that the key elements of the methodology include:  
 
x theoretical sampling (including theoretical saturation), 
x simultaneous data collection and analysis, 
x data collection using methods that support the collection of 
qualitative data, 
x using the constant comparative method of data analysis, including 
developing analytical codes and forming categories from the data,  
x generating theory from the data, and,  
x supporting the research process with the preparation of memos. 
 
Following separation of the Glaser and Strauss partnership, both 
researchers developed their own guidance about how to conduct studies 
with grounded theory methodology. The two approaches continued to 
recommend the use of coding of data and constant comparison analysis 
but they offered different interpretations on the coding process and 
utilised different methods to generate theory from the data (Glaser, 1978; 
Strauss & Corbin, 1990). 
 
Glaser (1978) suggested that the data should be initially coded using 
‘substantitive’ codes and explained that categories should be generated 
through the process of constant comparison analysis. Comparing pieces 
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of data allows a researcher to generate several categories and begin to 
identify properties of these categories. ‘Theoretical’ codes should then be 
used to start to link the categories together and support the generation of 
theory from the data. Theoretical sampling is utilised to support the 
collection of data that may help the researcher to develop a detailed 
understanding about each category and the relationships between 
categories. Theoretical memos are used to capture the thought and 
decision making processes utilised throughout the data collection and 
analysis process. 
 
Strauss and Corbin (1990) also recommended coding data and using 
constant comparison analysis during the process of data analysis. The 
approach to coding data developed by Strauss and Corbin (1990) utilises 
an initial coding process that combines the use of open coding and axial 
coding. Open coding is used to label data and axial coding is used to 
generate categories and to start to identify relationships between these 
categories. The coding process is supported by the use of a range of 
analytical tools (e.g. questioning data to identify the meaning contained 
within the information provided by the participant) to help researchers 
understand the data and generate appropriate open codes. The role of 
analytical tools during data analysis was further developed by Corbin 
after Strauss's death (Corbin & Strauss, 2008). 
 
Strauss and Corbin (1990) proposed that during axial coding a framework 
known as the paradigm model should be used by researchers to explore 
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the relationships between categories. The model encourages researchers 
to think about linking "subcategories to a category in a set of relationships 
denoting causal conditions, phenomenon, context, intervening conditions, 
action/interactional strategies, and consequences" (Strauss & Corbin, 
1990 pp 99) and can be used to support the integration of categories 
which is a key step in the generation of theory from the data. The role of 
the paradigm model in supporting the identification of relationships 
between categories continued to be promoted in the later work by Corbin 
and Strauss (2008).  
 
Both the Glaserian approach and the Straussian approach to grounded 
theory methodology support the generation of theory from the data 
collected during the study but the divergence in opinion about the 
processes that should be used during data coding, category generation 
and category integration means that qualitative researchers are 
presented with two distinct approaches to data collection and analysis. 
 
Many researchers choose to follow one approach during their research 
career and remain committed to that approach. A researcher's choice of 
approach is often affected by their supervisor's experience of qualitative 
research. A research supervisor may be familiar with the methods of a 
particular approach and use this knowledge to guide their student about 
how to conduct a qualitative research study. 
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Other researchers adapt elements of either the Glaserian or Straussian 
approach to develop their own approach to grounded theory 
methodology. Charmaz (2006) adapted the methods used by Glaser to 
produce an approach that generates theory by labelling data with ‘initial’ 
codes, uses data comparison to develop focused codes and describes 
the possible relationships between these focused codes using theoretical 
codes which are utilised to generate theory.  
 
3.3.4 Criticisms of the Glaserian and Straussian approaches to 
grounded theory methodology 
The approach to grounded theory methodology proposed by Strauss and 
Corbin (1990) has been criticised by some qualitative researchers as 
being a "didactic, step-by-step" approach (Kelle, 2007 pp 210) to data 
analysis but this structured approach may be useful for a novice 
qualitative researcher (Kelle, 2007). Glaser (1992) suggested that the 
Straussian approach does not allow categories to emerge from the data 
and stated that Strauss and Corbin have developed "a method to produce 
full scale conceptual forced description" (Glaser, 1992 pp 62) which 
imposes categories on the data. Glaser also criticised the approach 
because he believed that it allowed a researcher to use their 
preconceptions to link the categories "together however the analyst 
wants" (Glaser, 1992 pp 62) which is contrary to the underlying principles 
of grounded theory that rely on the researcher having no preconceptions 
and generating theory from the data collected during the study.  
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The Glaserian approach to grounded theory has also been criticised by 
some qualitative researchers (Charmaz, 2006; Kelle, 2007). Many of the 
criticisms are directed towards the theoretical coding families that are 
used to support the generation of theory by integrating the categories that 
are present in the data. Glaser (1978) initially suggested eighteen 
different methods to develop theoretical codes but the number of coding 
families has increased over time and a researcher is required to choose a 
coding family or a combination of coding families depending on the data 
being analysed in their study. 
 
Charmaz (2006) proposes that the coding families described by Glaser 
(1978) do not include a number of useful conceptual families and 
suggests that the list needs to be updated to reflect the evolving nature of 
qualitative research studies. Kelle (2007) challenges the principles 
underlying the coding families and suggests that the coding families 
"utility for the development of theoretical relations between the 
'substantive codes' is limited" (Kelle, 2007 pp 200) because the codes do 
not consider sociological and psychological concepts which are 
essentially linked to understanding data provided by participants. 
 
Kelle (2007) also suggests that choosing the appropriate coding family for 
a study may be a challenge for a novice qualitative researcher who "does 
not have a very broad theoretical background knowledge ... concerning 
the different theoretical perspectives" associated with each family (Kelle, 
2007 pp 200). The ability of a novice researcher to utilise a Glaserian 
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approach was also challenged by Holton (2007) who supports the use of 
a Glaserian approach to qualitative research but expressed concerns that 
new researchers may not be able to recognise categories within the data, 
understand how to choose a coding family or recognise that they may 
need to integrate several coding families in one study to analyse the data 
appropriately. 
 
In summary, both approaches to conducting a grounded theory study 
allow detailed analysis of the data and the theoretical coding proposed by 
Glaser (1979) and the paradigm model proposed by Strauss and Corbin 
(1990) fulfil the same role of exploring relationships between categories 
that have emerged from the data. Glaser’s approach is less formulaic and 
supports researchers to analyse the data and try to develop relationships 
between codes using information contained within the data whereas 
Strauss and Corbin's paradigm model offers a structured approach to 
ensure that each category is considered in detail. 
 
3.4 Study design 
Grounded theory methodology is associated with a specific approach to 
sampling and data collection and analysis. The sampling methods and 
methods of data collection and analysis utilised in this study are 
discussed in the following sections. 
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3.4.1 Setting for the study  
The setting for the study was adult ward areas within LTHT. LTHT is one 
of the largest hospital trusts in the UK and over one million patients are 
treated within the hospital each year, either as day case patients or 
patients admitted to a hospital ward. There are two acute hospitals within 
the trust, Leeds General Infirmary and St James University Hospital, and 
these hospitals together contain over 100 wards that care for adult 
patients. Patients with Parkinson’s disease could be admitted to any of 
these wards. 
 
3.4.2 Sampling strategy 
The sampling strategy for this study is discussed below. 
 
3.4.2.1 Participant selection 
A combination of purposeful and theoretical sampling was used to select 
participants for the study. Initial participants for the study were 
purposefully selected to ensure that the participants were able to provide 
an insight into the area under investigation (Kuper, Reeves, et al., 2008; 
Silverman, 2010). Patients were assessed for their suitability for the study 
using the inclusion and exclusion criteria detailed in appendix 5.  
  
As categories became apparent from the data then further participants for 
the study were selected using theoretical sampling. Theoretical sampling 
is an essential element of grounded theory methodology (Creswell, 1998; 
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Glaser & Strauss, 1967; Strauss & Corbin, 1990) and allows selection of 
participants for the study who may aid the researcher to understand the 
theories emerging from the data (Bowling, 2009; Creswell, 1998; Glaser 
& Strauss, 1967; Silverman, 2010; Strauss & Corbin, 1990). 
 
The inclusion and exclusion criteria for this study were chosen to allow 
the study population to be composed of participants that may be able to 
offer an insight into the area of interest. The study is focused upon 
patients admitted to adult medical or surgical wards within LTHT therefore 
patients admitted to other clinical areas (e.g. care of the elderly wards) 
were excluded from the study population. 
 
Participants were asked to explain their perceptions of the processes 
used to manage their medicines during their hospital admission therefore 
the participant must have been involved in these processes. Most 
patients that are immediately transferred to an intensive care unit when 
they are admitted to hospital are not actively involved in the admission 
process therefore this patient group were excluded from the study.  
 
3.4.2.2 Sample size 
Grounded theory methodology does not support the specification of a 
particular sample size for a study. Theoretical sampling requires that new 
participants are recruited into a study to explore and modify the theories 
emerging from the data until theoretical saturation has been achieved 
(Charmaz, 2006; Glaser & Strauss, 1967; Strauss & Corbin, 1990). 
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Strauss and Corbin (1990 pp 188) explain that theoretical saturation 
occurs when: 
 
"(1) no new or relevant data seem to emerge regarding a category; 
(2) the category development is dense, insofar as all of the 
paradigm elements are accounted for, along with variation and 
process; (3) the relationships between categories are well 
established and validated". 
 
It was intended that theoretical saturation would be achieved in this study 
with all of the categories emerging from the data being considered in 
detail and participants being recruited into the study until no new 
information emerged during data analysis (Charmaz, 2006). 
 
3.4.3 Identification and recruitment of participants 
People with Parkinson’s disease admitted to adult medical and surgery 
wards were identified by the ward pharmacist that was a member of their 
clinical team. The pharmacist explained to the patient that this research 
study was ongoing within the clinical area and requested that the 
researcher could approach the patient to discuss the study further. 
Written consent for the researcher to make contact with the patient was 
obtained by the ward pharmacist (the initial consent form is included in 
appendix 6). 
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The patients that had consented to being approached by the researcher 
were contacted and those that fulfilled the study inclusion and exclusion 
criteria were invited to participate in the study. These patients were given 
a participant information sheet for the study (included in appendix 7) to 
discuss with their carers, family or other appropriate individuals. The 
researcher visited the potential participant the following day to establish if 
they had chosen to participate in the study. Informed written consent to 
take part in the study was obtained by the researcher for those patients 
that agreed to participate in the study (consent form is included in 
appendix 8). Most interviews occurred within the 24 hours following the 
provision of written agreement by the patient to participate in the study. 
 
3.4.4 Methods of data collection 
Grounded theory methodology is associated with a specific approach to 
data collection and analysis. The data collection methods of participant 
observation, textual analysis (including participant journals) and 
interviewing are appropriate for use in a study with grounded theory 
methodology (Charmaz, 2006; Creswell, 1998) but Bluff (2005) proposes 
that data collection in a study with grounded theory methodology usually 
"involves collecting data by means of interviews and/or observation of the 
phenomenon that is being researched" (Bluff, 2005 pp 151). 
 
The methods of data collection used in a study should be selected after 
considering the information that is required to answer the central research 
question for the study. The data required to answer the central question 
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for this study was information provided by participants about their 
perceptions of a situation and this data could be obtained by interviewing 
the study participants.  
 
Interviews are a recognised method to explore patients’ perceptions, 
attitudes and beliefs (Creswell, 2003; Seidman, 2006). Interviews allow 
the researcher to question the participant about their opinions related to a 
particular situation and then explore specific points that were raised by 
the participant (King & Horrocks, 2010).  
 
Participant observation was not an appropriate method for this study 
because although direct participant observation would allow a researcher 
to develop an understanding about a patient’s behaviour during a hospital 
admission and identify patient and staff interactions that occur within the 
specific setting, it would not provide data about a patient’s perception of 
the situation (Green & Thorogood, 2004; Marshall & Rossman, 1999; 
Mays & Pope, 2006).  
 
Textual analysis in the form of analysis of patient journals or letters of 
complaint could provide a source of information about a patient’s opinion 
of a situation (Prior, 2003) but this method was not selected for this study 
because: 
 
a) asking a participant to write a journal about specific topics could be 
a significant burden to a patient that is acutely unwell. Prior to this 
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study patients admitted to the hospital were not required to keep a 
journal therefore this would be an additional task for a patient to 
undertake during their hospital admission, and, 
b) the purpose of the study is to understand patients’ perceptions 
about specific events during a hospital admission. Letters of 
complaint are often written when a patient is discharged from 
hospital and are about a specific problem therefore they would not 
provide adequate information to answer the central question for 
this study.  
 
3.4.4.1  Interviews 
Interviews used in qualitative studies can be either one to one interviews 
which involve an interaction between the researcher and one participant 
or focus group interviews which allows the researcher to collect 
information from a large number of participants in a single event (Britten, 
2006; Kitzinger, 2006). 
 
Focus group interviews are a method that can be used to collect 
information about the perceptions and attitudes of patients (Britten, 1995; 
Kitzinger, 1995; Wong, 2008) but they have been used as a method of 
data collection in only a small number of studies considering the 
perceptions of people with a chronic disease (MacNeill, 2008; Shortus et 
al., 2005; Yen et al., 2010). Most of the studies exploring perceptions or 
satisfaction of people with chronic disease (including Parkinson’s 
disease) utilise one to one interviews or questionnaires to collect data 
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from the study participants (Abu-Saad et al., 2004; Aujoulat et al., 2007; 
Buetow et al., 2010).  
 
Focus groups allow participants to talk to each other and stimulate 
discussions that may not occur when a participant is interviewed alone. 
The group may offer a participant reassurance about their own opinion 
and encourage them to disclose information that they would not disclose 
in a one to one interview (Kitzinger, 2006). MacNeill (2008) used focus 
groups to collect information about the perceptions of people with 
Parkinson’s disease about the roles of community pharmacists and 
proposed that although focus groups provide participants with 
opportunities to become involved in discussions they also allow a 
participant to rest while others speak if the symptoms of their disease 
become problematic during the focus group session (MacNeill, 2008). 
 
A focus group requires a number of participants to be together in one 
venue at the time of the interview. Moving participants to a central area 
was not achievable in this study either because the participants were 
acutely unwell or they required specialist nursing and medical care that 
could only be provided in a specific clinical area. In addition, the limited 
numbers of patients that fulfilled the study inclusion and exclusion criteria 
present in the hospital at any time meant that it was not possible to 
conduct focus groups. 
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One to one interviews may be structured, semi-structured or in-depth 
interviews. Structured interviews require the interviewee to answer a set 
of pre-determined questions which are often presented in the form of a 
questionnaire. The interviewee answers the questions whilst in contact 
with the interviewer who guides the interviewee through the questions 
(Britten, 2006). This style of interview was not appropriate for this study 
because it does not allow the interviewer to explore points that the 
interviewee raises during the interview and may limit the researcher’s 
ability to obtain a detailed understanding of the area of interest (Olson, 
2011). 
 
The interviews used in grounded theory studies are being used to collect 
data to support the generation of theory about a topic. Some researchers 
suggest that initial interviews in grounded theory studies should be in-
depth with a loose structure to explore the topic in detail and the 
interviews conducted later in the research process should be semi-
structured to explore points that have been raised by study participants 
(Bluff, 2005). Charmaz (2006) suggests that interviews can be either in-
depth or semi-structured but the interview should involve a small number 
of open ended questions which are used in conjunction with probing 
questions to develop a detailed understanding about the topic of interest. 
 
The approach to interviewing chosen for this current study was to use 
semi-structured interviews to collect data from the study participants. 
Semi-structured interviews were chosen rather than in-depth interviews 
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because answering the central research question required consideration 
of several topics rather than developing a detailed knowledge about one 
or two topics (Britten, 1995, 2006).  
 
3.4.4.2 Semi-structured interviews 
Semi-structured interviews may be conducted face to face or remotely 
(e.g. via a telephone). Participants in this current study were interviewed 
during their hospital admission therefore a face to face, semi-structured 
interview was possible with all participants and was chosen as the 
method to collect data from the participants in this current study. A face to 
face interview between a researcher and a participant allows the 
researcher to create an environment which addresses some of the 
communication difficulties that can affect people with Parkinson’s 
disease. People with Parkinson's disease can develop monotonic and 
hypophonic dysarthria during the course of their disease (Jankovic, 
2008). These secondary motor features of Parkinson's disease 
(discussed in section 1.3.1) cause the patient to have a quiet voice with 
low pitch and can lead to difficulty articulating syllables or sounds (Clarke, 
2007b; Jankovic, 2008). A face to face one to one interview in a quiet 
area may allow a participant to feel reassured that their voice will be 
audible to the researcher and allows the researcher to encourage them to 
repeat words that were inaudible. A person with Parkinson's disease can 
also have an accelerated speech rate with protracted pauses between 
words (DeLetter et al., 2006; Skodda & Schlegel, 2008). A one to one 
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interview provides an opportunity for the participant to discuss their 
opinions at a pace that helps them to feel comfortable (Britten, 2006).  
 
All interviews were conducted by the researcher whilst the participant was 
admitted to hospital. The duration of the interview was restricted to 
between 30 and 45 minutes because people with Parkinson's disease 
may experience impaired concentration (e.g. if they are experiencing 
depression related to their disease) or daytime hypersomnolence (Clarke, 
2007b; Kathawala, 2010) which could affect their ability to answer 
questions.  
 
3.4.4.2.1 Limitations of interviews 
A limitation of the use of interviews as a data collection method is that the 
quality of data obtained during an interview is influenced by the 
interviewing skills of the interviewer (Britten, 1995). The failure of the 
interviewer to ask open questions that encourage detailed responses 
from the interviewee or the limited use of probing questions during an 
interview can limit the data that is obtained (Marshall & Rossman, 1999). 
An interviewer who jumps between questions, interrupts the interviewee 
or does not allow the interviewee time to consider their response to a 
question can also impair the quality of the data that is obtained during an 
interview (Britten, 2006). Each interview was transcribed verbatim 
immediately after the interview which provided an opportunity for the 
interviewer to review their interview technique and identify aspects that 
required improvement. 
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The presence of the interviewer in a face to face interview can also affect 
the data obtained during the interview (Creswell, 2003). The data 
provided by an interviewee may be limited if they feel uncomfortable in 
the presence of the interviewer or do not believe that the interviewer will 
value the opinions that they express. Britten (2006) proposes that: 
 
"all qualitative researchers need to consider how they are 
perceived by interviewees and the effects of personal 
characteristics such as class, race, sex and social distance on the 
interview" (Britten, 2006 pp 15). 
 
An interviewer is an essential element of the face to face interviews used 
in this study therefore steps were taken to minimise the effect of the 
presence of the interviewer. These actions included the interviewer trying 
to develop a rapport with each of the interviewees (King & Horrocks, 
2010) and ensuring that their body language demonstrated to the 
interviewee that they are open to conversation. The interviewer also 
ensured that most of the talking during the interview was done by the 
interviewee and that the interviewer did not make comments or 
statements during the session which could influence the interviewee’s 
opinions. 
 
A proposed limitation of the use of interviews as a data collection method 
is that the information obtained during the interview is provided from the 
point of view of the interviewee and may not be a true representation of 
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the event that occurred (Silverman, 2009). In this study, answering the 
central research question required collection of data about patients' 
perceptions therefore obtaining information from the interviewee's point of 
view was essential. 
 
Presentation of the data obtained from one interview as reflecting the 
opinions of all of the study participants is another possible limitation of the 
use of interviews as a data collection method. In a study using grounded 
theory methodology this situation should not occur because the theory 
generated originates in the data provided by all of the study participants, 
including deviant cases, and is presented as an overall theory rather than 
a collection of quotes from individual participants. 
 
3.4.4.3 Topic guides 
A semi-structured interview allows the interviewer to ask open questions 
that explore the area of interest whilst providing the opportunity to ask 
other questions (open and closed) to clarify or probe points raised by the 
interviewee (Bowling & Ebrahim, 2005; Britten, 1995, 2006; Green & 
Thorogood, 2004; Taylor, 2005). The interviewer uses a topic guide as 
the basic structure for the interview. This document contains a small 
number of open-ended questions but the interviewer has the freedom to 
use the questions in any order and can ask follow-up questions to explore 
points that emerge during the interview (DiCicco-Bloom & Crabtree, 2006; 
Holloway & Wheeler, 2010).  
 
  - 84 - 
The core interview questions which were asked of each participant in this 
study are listed in appendix 9. These questions were intended to be non-
leading and were piloted with two participants to identify any sources of 
influence. The initial questions required the participant to discuss their 
individualised medication regimen. This is a familiar subject for the 
participant and was intended to help the participant become comfortable 
with the interviewer and the interview process (Taylor, 2005). Subsequent 
questions allowed the participant to express their opinions about specific 
topics. 
 
3.4.4.4 Transcription  
The line by line coding approach utilised during data analysis (discussed 
in chapter 4) required each interview to be transcribed verbatim. Each 
interview was recorded using two recording devices. The secondary 
motor features of Parkinson’s disease can include a quiet voice with low 
tone (discussed in section 3.4.4.2) therefore the recording devices were 
located close to the participant to ensure that the whole of the interview 
was recorded.  
 
Each interview was transcribed and analysed before the next interview 
was conducted. This simultaneous process of data collection and 
analysis is characteristic of grounded theory methodology (Glaser & 
Strauss, 1967) and allows categories emerging from the data and 
relationships between these categories to be explored in subsequent 
interviews (Charmaz, 2006; Lingard et al., 2008). Reviewing the transcript 
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of the interview also provided an opportunity to identify any factors that 
may introduce bias to the interview process and allowed the researcher’s 
practice to be amended for subsequent interviews. Actions taken to 
minimise any bias that was identified were noted in the researcher’s 
journal. 
 
3.4.5 Analysis of interviews  
Grounded theory methodology is associated with a specific approach to 
data collection and analysis. The approach to data analysis used in this 
study was largely influenced by the original work of Strauss and Corbin 
(1990) and the modified approach described by Corbin and Strauss 
(2008). These are both recognised approaches to analysing data 
collected in a study with grounded theory methodology. The criticisms of 
the Straussian approach to data analysis and theory generation 
(discussed in section 3.3.4) were recognised by the researcher and steps 
were taken to address these problems. The processes used to analyse 
the data collected during this study are detailed in chapter 4.  
 
Buetow et al. (2010) did not use grounded theory in their study which 
considered the perceptions of people with Parkinson’s disease and their 
carers about medication timing errors. The data collected by Buetow et al. 
(2010) was analysed using thematic analysis which involves analysing 
the data once all of the data has been collected. This approach was not 
appropriate for this current study because generating theory requires 
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exploration of ideas as they emerge from the data therefore data analysis 
must occur at the same time as data collection (Charmaz, 2006). 
 
3.4.6 Memo writing 
The preparation of memos during data collection, data analysis and 
theory generation is an essential element of grounded theory 
methodology (Glaser & Strauss, 1967). Strauss and Corbin (1990) state 
that “memos represent the written forms of our abstract thinking about 
data” (Strauss & Corbin, 1990 pp 198) and recommend that memos 
should be prepared throughout the data collection and analysis process 
with the first memo being started during the first interview.  
 
Memos prepared during the interviews for this study included notes about 
statements made by the participant that the researcher thought were 
poignant, notes to help aid the researcher’s memory during data analysis 
and comments about the participant’s gestures and emotions which 
would add more depth to the transcripts (Maxwell, 2005; Strauss & 
Corbin, 1990). People with Parkinson’s disease may develop reduced 
facial expression (hypomimia) during the course of their disease 
(Jankovic, 2008; Porter & Kaplan, 2010) therefore the researcher utilised 
other visual cues (e.g. hand gestures) to determine a participant’s 
response to the questions asked during the interview. The cues used 
were documented in the memos. Memos were also prepared after each 
interview which provided an opportunity for the researcher to reflect on 
their interview technique and identify aspects that could be improved for 
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future interviews (Charmaz, 2006; Maxwell, 2005; Strauss & Corbin, 
1990). 
 
Memos were prepared during the process of data analysis and theory 
generation. Many of these memos were used to record “tentative ideas 
and provisional categories, compare findings, and jot down thoughts on 
the research” (Holloway & Wheeler, 2010 pp 185) but memos were also 
used to document the thought process behind selection of names for 
codes, the identification of links between categories, the selection of the 
core category and understanding of the evolving theories. The role of 
memos during data analysis and theory generation in this study is 
discussed further in chapter 4. 
 
3.5 Research ethics approval and consent 
Qualitative researchers have recognised the ethical considerations 
associated with qualitative research in healthcare for many years. 
Richards and Schwartz (2002) propose that the risks to participants in 
health research studies using qualitative methodology include: 
 
x anxiety and distress, 
x exploitation, 
x misrepresentation of their opinions by the researchers, 
x lack of anonymity. 
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These possible risks to participants and the “ethical principles of 
autonomy, beneficence, and justice” (Orb et al., 2000 pp 93) were 
considered during the design of this study to safeguard the interests of 
the patients that agreed to participate in this study. Consideration was 
given to the potential ethical issues associated with patient selection, data 
collection, data analysis and preparation of the final report. NHS 
Permission for research was provided by Leeds Teaching Hospitals NHS 
Trust (reference: PH11/9745) and approval for the study to be conducted 
was granted by a NHS Research Ethics Committee (reference: 
11/YH/0150). 
 
Anxiety and distress associated with qualitative research can be caused 
by multiple factors e.g. participants may feel anxious discussing a 
negative opinion about a healthcare service or a hospital related 
experience if they are currently receiving healthcare interventions. Steps 
were taken during the design of this study to minimise the anxiety 
experienced by participants. These steps included giving all prospective 
participants a participant information sheet (appendix 7) which described 
the purpose of the study, the confidentiality given to a participant, the 
procedures involved with the data collection methods and explained that 
a participant could withdraw from the study at any time. The patient was 
encouraged to discuss the information sheet with their family or carers to 
ensure they had an opportunity to discuss their concerns or expectations 
with others before they agreed to become involved in the study. The 
information sheet also explained that a decision not to participate in the 
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study would not affect the medical care that the patient received whilst in 
hospital. 
 
Recalling the information that they share with the researcher could cause 
a participant to feel anxious and distressed (Hewitt, 2007). The 
participants were informed at the start of the interview that they could 
stop the interview at any time if they become distressed. Support after the 
interview was also available for any participants that experienced distress 
during the interview.  
 
Study participants may become anxious about whether the information 
that they provide will remain anonymous (Richards & Schwartz, 2002). 
The steps taken to maintain a participant's anonymity were explained to 
each of the participants in this study. These steps included: 
 
x using a numerical code in place of a name throughout the data 
analysis process,  
x all interviews being transcribed by the researcher, 
x transcripts of interviews only being reviewed by the researcher and 
an authorised independent party, 
x safe storage of audio recordings and written transcripts, and, 
x ensuring that all information presented in this thesis remained 
anonymous. 
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A participant’s privacy was respected at all times. The interviews were 
conducted in a private room within the ward that the participant was 
currently admitted to. Access to medical and nursing staff was available if 
required due to the interview room being located within the ward area.  
 
Exploitation of participants is a recognised problem that can occur when a 
researcher is recruiting participants for a qualitative study. Patients may 
chose to participate in research about healthcare “because of a sense of 
duty, or because they depend on the good will of their carers” (Richards & 
Schwartz, 2002 pp 136). Alternatively, patients may feel that if their 
doctor or nurse asked them to participate in a study they were suggesting 
the study in the patient’s best interests. The participant information sheet 
for this study explained that a decision to participate was voluntary and 
did not convey any benefits to the patient or the researcher.  
 
The importance of safeguarding vulnerable adults was considered during 
the design of this research study. A vulnerable adult is an adult that is 
unable to protect themselves against harm or exploitation (Department of 
Health, 2000), for example patients that have cognitive impairment and 
are unable to provide informed consent. People that are unwell in hospital 
may also be considered to be vulnerable people (Holloway & Wheeler, 
2010). The steps taken to safeguard vulnerable adults included ensuring 
that a patient could only become involved in this study if they had 
provided written informed consent (consent form included in appendix 8). 
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3.6 Chapter summary 
Qualitative methods were chosen for this study because answering the 
central research question required the generation of theory from data 
related to patients' perceptions. Grounded theory methodology was 
chosen to support the generation of theory about an area where there is a 
paucity of information. The methods of data collection (face to face, one 
to one, semi-structured interviews) and analysis (Straussian approach to 
grounded theory methodology) were appropriate for a study with 
grounded theory methodology. Steps were taken during the design of the 
study to safeguard study participants from the ethical issues that can be 
associated with healthcare research utilising qualitative methodology. 
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4 Data analysis 
4.1 Introduction to chapter 
The research strategy for this study was to use grounded theory 
methodology to generate a theory from data provided by study 
participants. Chapter 3 explained that grounded theory methodology 
involves the simultaneous collection and analysis of qualitative data and 
described the sampling strategy and methods of data collection used in 
this study. The purpose of this chapter is to describe the methods of data 
analysis utilised in this study and demonstrate how these methods were 
used to generate a theory that is embedded in the data. 
 
4.2 Analytical plan for this study 
The approach to data analysis used in this study was largely influenced 
by the original work of Strauss and Corbin (1990) and the modified 
approach described by Corbin and Strauss (2008). Elements of the 
approaches to data analysis proposed by Glaser (1979) and Charmaz 
(2006) were also considered by the researcher to support detailed data 
analysis and the development of a robust theory. Combining the more 
directed approach to data analysis proposed by Strauss and Corbin 
(1990) with elements of the other approaches reflects Charmaz’s opinion 
that grounded theory methods are “a set of principles and practices, not 
… prescriptions or packages” (Charmaz, 2006 pp 9) and can be applied 
in different ways to meet the needs of the study and the researcher.  
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The analytical plan for this study is detailed in Table 4.1 below. This 
combines coding of data with constant comparison analysis and involves 
identifying and developing categories and then making connections 
between the categories to generate theory that is embedded in the data 
(Charmaz, 2006; Corbin & Strauss, 2008; Glaser & Strauss, 1967; 
Strauss & Corbin, 1990).  
 
Initial coding process and generating categories: 
Utilise open coding and axial coding simultaneously 
Utilise constant comparison analysis 
(Corbin & Strauss, 2008; Strauss & Corbin, 1990) 
Making connections between categories: 
Utilise the paradigm model (Strauss & Corbin, 1990)  
Theory generation: 
Identify the core category and relate to other categories 
Generate theory and refine the theory  
Identify process within the theory 
(Corbin & Strauss, 2008) 
Table 4.1 Analytical plan for the study 
 
4.3 Coding data 
Coding in grounded theory studies involves examining the data in detail 
and identifying concepts which can then be explored during future data 
collection sessions. Ultimately the concepts are integrated to form a 
theory which is embedded in the data. 
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Coding can be conducted by hand or using computer packages. The use 
of computer packages to code data has increased during recent years 
with some researchers proposing that computer programmes increase 
the rigor of the data analysis process (Lu & Shulman, 2008; Weitzman, 
1999). Corbin and Strauss (2008) propose that computer programmes 
support the data analysis process because they allow researchers to 
identify "flaws in the logic, undeveloped categories, and insufficient 
conceptualization" (Corbin & Strauss, 2008 pp 310) which can then be 
addressed through further data collection and analysis.  
 
The analysis of data in this study involved the researcher coding interview 
transcripts by hand. This approach was chosen because it allowed the 
researcher to develop a detailed knowledge of the data and ensured that 
theoretical sensitivity (discussed in section 4.3.1.1 below) could be 
utilised during the data analysis process to support the identification of 
categories and theories emerging from the data. The dataset for this 
study was small therefore coding by hand was feasible. Theoretical 
memos were used to support the development of concepts and identify 
flaws or gaps in the theories that were emerging from the data.  
 
The process utilised in this study to code data combined the process of 
open coding data with the process of axial coding to support the 
generation of categories, develop the properties of these categories and 
start to identify relationships between these categories. The methods 
used during open coding and axial coding are discussed separately in the 
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following sections to facilitate a clear description of how they were 
conducted by the researcher but during the analysis process open coding 
and axial coding occurred simultaneously.  
 
4.3.1 Open coding - methods that can be used to label data 
The first step used to code data within the Straussian approach to 
grounded theory methodology is open coding which involves data being 
“broken down into discrete parts, closely examined, compared for 
similarities and differences, and questions ... asked about the phenomena 
as reflected in the data” (Strauss & Corbin, 1990 pp 62). 
 
A semi-structured, one to one, face to face interview was the data 
collection method chosen for this study (discussed in section 3.4.4.2). 
The process of open coding data that has been collected during an 
interview requires the interview to be transcribed verbatim (discussed in 
section 3.4.4.4) and the transcript is then coded by attaching a label to 
either: 
 
x each word (this is word by word coding), 
x each line (this is line by line coding),  
x each sentence (this is sentence by sentence coding), or,  
x each incident (this is incident by incident coding) (Charmaz, 2006; 
Glaser, 1978; Strauss & Corbin, 1990). 
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Line by line coding was utilised to open code data collected in this study. 
Glaser (1978) proposes that line by line coding encourages “a full 
theoretical coverage which is thoroughly grounded” (Glaser, 1978 pp 57). 
This detailed method of analysis encourages the researcher to consider 
the information that is contained within a line of data rather than focusing 
on the overall opinion provided by the participant (Strauss & Corbin, 
1990) and allows subtle points emerging from the data to be identified 
(Charmaz, 2006).  
 
Sentence by sentence coding and incident by incident coding are useful 
methods of open coding to employ once categories have become 
apparent within the data but use of these approaches early in the open 
coding process may prevent the identification of nuances and subtle 
points that are suggestive of the presence of a category within the data 
(Strauss & Corbin, 1990). 
  
Open coding data involves “giving each discrete incident, idea, or event, 
a name, something that stands for or represents a phenomenon” (Strauss 
& Corbin, 1990 pp 63). An open code assigned to a piece of data should 
reflect the content of that section of data. Developing an open code for 
each line of text within an interview transcript requires the researcher to 
understand the information (implicit and explicit) that was contained within 
each line and Strauss and Corbin propose that a researcher should use 
analytical tools to help them understand the data (Corbin & Strauss, 
2008; Strauss & Corbin, 1990). 
  - 97 - 
4.3.1.1 Analytical tools utilised during open coding 
The analytical tool of questioning data to identify the information that is 
being provided by the data was utilised in this study. Strauss and Corbin 
propose that questioning a piece of data “opens the data up” (Strauss & 
Corbin, 1990 pp 77) and allows the researcher to consider what that 
piece of data is telling them without being constrained by thinking about 
the total content of the interview transcript. The Glaserian approach to 
grounded theory also recommends questioning data to allow the 
researcher to understand the information that is contained within the data 
(Glaser, 1978). 
 
Questions utilised early in the coding process to interrogate data and 
generate open codes included the sensitising questions proposed by 
Strauss and Corbin (1990 and 2008) that are detailed in Table 4.2 and 
Glaser’s question “what is actually happening in the data?” (Glaser, 1978 
pp 57).  
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Sensitising questions proposed by Strauss and Corbin: 
x Who? 
x When? 
x Where? 
x What? 
x How? 
x How much? 
x Why?  
x With what consequences?  
 
(Corbin & Strauss, 2008; Strauss & Corbin, 1990) 
Table 4.2 Sensitising questions used to interrogate data 
 
Following the identification of possible categories within the data, Glaser’s 
question “What category or property of a category, of what part of the 
emerging theory, does this incident indicate?” (Glaser, 1978 pp 57) was 
frequently utilised in conjunction with Strauss and Corbin's theoretical 
questions to support the identification of relationships between 
categories. 
 
Consideration of the meanings of words that were used by a participant 
during their interview was another analytical tool utilised to interrogate 
data (Corbin & Strauss, 2008). Examining individual phrases can help the 
researcher to identify subtle meanings contained within the information 
provided by a participant. An example of the use of this approach was 
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during analysis of the transcript from the first interview when a participant 
stated that they were “right cut up” (#1) when they thought that they had 
been administered incorrect tablets by a member of staff. This choice of 
words suggested that the participant had felt distressed due to the 
perceived deviation from their usual medication regimen. Another 
participant used the phrase “right staunch at taking it” (#6) when they 
described their usual medication regimen at home. This phrase 
suggested the effort that the participant made to take their medications at 
a particular time.  
 
A researcher's ability to understand the data, including identifying subtle 
points raised by the participants, and identify relationships between the 
concepts present within the data can be influenced by a researcher's 
theoretical sensitivity. The role of theoretical sensitivity in a grounded 
theory study was highlighted by Glaser and Strauss (1967) in the original 
description of grounded theory methodology and has subsequently been 
defined by Strauss and Corbin (1990) as: 
 
 "the attribute of having insight, the ability to give meaning to data, 
the capacity to understand, and capability to separate the pertinent 
from that which isn't" (Strauss & Corbin, 1990 pp 42). 
 
A researcher's theoretical sensitivity can be derived from a range of 
sources, including personal and professional experience and awareness 
of literature relevant to the topic of interest (Glaser & Strauss, 1967; 
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Strauss & Corbin, 1990), and can be utilised during all stages of data 
analysis and theory generation. The central question of this study is 
related to an area of practice in which the lead researcher has become a 
specialist practitioner therefore their theoretical sensitivity was employed 
during data analysis to understand and interpret the information provided 
by the participants and identify relationships between the categories 
emerging from the data. 
 
4.3.2 Labelling the data provided by the participants in this study 
The open codes used to label a line of data in the interview transcripts 
were chosen to reflect the phenomenon that the data was describing. 
Most of the labels were chosen by the researcher once they understood 
the information contained within the line of data but some in-vivo codes 
(terms provided by the participants to reflect their opinions) were utilised 
during the coding process (Charmaz, 2006). An example of an in-vivo 
code is 'rely on others' which reflected a participant’s perception that 
during their hospital admission they were reliant on nursing staff to 
administer their antiparkinsonian medication.  
 
The process of simultaneous data collection and analysis in grounded 
theory studies requires that data analysis begins after the first interview is 
completed. Multiple open codes were generated following line by line 
coding of transcripts of the early interviews and many of the codes 
appeared to be describing similar phenomena. The generation of multiple 
open codes is a recognised problem but “precision and specificity” 
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(Strauss & Corbin, 1990 pp 62) can be introduced to the codes by 
questioning the data (using questions described in section 4.3.1.1) and 
making comparisons between the data.  
 
Generation of the open code 'worried about getting doses of medicines' 
provides an example of the use of questioning and comparing data to 
develop one open code that accurately describes a phenomenon that 
was being suggested by several similar open codes. The process of open 
coding the first three interviews generated many open codes that 
appeared to be related to participants feeling worried about whether they 
would receive doses of their medication during a hospital admission. The 
initial open codes that were replaced with the open code 'worried about 
getting doses of medicines' are detailed in Table 4.3. Once this open 
code had been developed it was used to code relevant pieces of data in 
subsequent interviews. Earlier interview transcripts were also reviewed to 
identify which data could be recoded with this open code.  
 
Original open codes Final open code 
 ‘worried about getting doses of medicines’ 
‘not worried about getting doses of medicines’  
‘concerned about getting doses’ 
‘lack of confidence that will get doses of medicines’ 
'frightened won't get dose of medicine' 
 
‘worried about 
getting doses of 
medicines' 
Table 4.3 The original open codes that informed the development of the 
code 'worried about getting doses of medicines' 
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Throughout data analysis open codes were refined and the thought 
processes underlying the decisions to alter open codes were recorded in 
theoretical memos.  
 
4.3.3 Generating categories - an essential element of the open 
coding process 
The codes that were attached to the data during the process of open 
coding suggested that the study participants were providing data related 
to a number of phenomena and each of the open codes appeared to be 
related to one or more of the emerging phenomena. The open codes that 
appeared to be related to a phenomenon were grouped together to form 
a category.  
 
Grouping open codes around a phenomenon is a recognised method 
used to categorise the data in a grounded theory study utilising a 
Straussian approach (Strauss & Corbin, 1990). The generation of 
categories is a fluid process because new data obtained through an 
interview could suggest a new phenomenon which would lead to the 
formation of a new category. 
 
Theoretical memos were used to document the thought processes 
underlying identification of a phenomenon within the data and the 
generation of a category by grouping open codes related to this 
phenomenon. The processes that were used to generate a category are 
demonstrated below using the category 'patient anxiety'.  
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Several open codes appeared to describe emotions that were suggestive 
of worry and concern and indicated possible causes of this worry. The 
phenomenon that these codes appeared to be related to was anxiety. A 
category is named using terms that reflect the data contained within that 
category but the name should be different to the names of the individual 
open codes (Strauss & Corbin, 1990). The label ‘anxiety' was appropriate 
because it reflected the phenomenon that the data was suggesting and 
the term was different to the open codes that had been used to label the 
data. Links between the category ‘anxiety' and some of the associated 
open codes is displayed below in Figure 4.1. 
 
 
Figure 4.1 The links between the category of ‘anxiety’ and the associated 
open codes 
 
The category of 'anxiety' became apparent early in the data process 
therefore the category could be explored during subsequent interviews. 
Worried about being 
in hospital 
Fear of the unknown 
Panic when missed 
dose of medicine 
Frightened 
Want reassurance 
Worried about getting 
doses of medicines 
Concerned about 
their care 
Reassured 
Not worried  
about hospital 
admission 
Anxiety 
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The category name was amended as more data became available to 
become 'patient anxiety' to reflect that the data was specifically related to 
anxiety felt by patients during their hospital admission. 
 
Once a phenomenon had been identified and a category had been 
conceived, subsequent interviews were utilised to explore the 
phenomenon. The data provided by participants can change the 
researcher's understanding of the phenomenon and this can lead to a 
change in the choice of name for a category. An example of such a 
change can be described through examination of the generation of the 
categories 'utilising expertise' and 'staff knowledge about Parkinson’s 
disease'. 
 
Open codes generated early in the data analysis process suggested a 
category of 'knowledge' which encompassed open codes related to 
patient knowledge and ward staff knowledge. The process of open coding 
data collected during subsequent interviews and comparing pieces of 
data using constant comparison analysis suggested that participants 
were providing data related to: 
 
x their own knowledge of the disease, 
x the perceived knowledge of ward nurses, 
x the perceived knowledge of allied healthcare professionals 
(including pharmacists), 
x the perceived knowledge of consultant neurologists, 
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x the perceived knowledge of Parkinson's disease nurse specialists, 
x the perceived difference in knowledge between ward staff and the 
perceived experts in the disease, and, 
x the desire to have access to an expert during a hospital admission 
to utilise the expert's knowledge to raise staff awareness about 
Parkinson's disease. 
 
The new data changed the researcher's view about the phenomenon 
because it appeared to be suggesting the presence of two distinct 
phenomena: 
 
a) 'staff knowledge about Parkinson’s disease' which was related 
to participants' perceptions about the knowledge of ward nurses, 
doctors and allied healthcare professionals about Parkinson's 
disease, and, 
b) 'utilising expertise' which was related to participants' beliefs that 
their anxiety about their hospital admission could be reduced if 
experts in Parkinson's disease were involved in their care.  
 
Open codes could be grouped around these two phenomena and this led 
to the replacement of the original category 'knowledge' with the two 
categories 'staff knowledge about Parkinson’s disease' and 'utilising 
expertise'. 
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The process of constant comparison analysis was utilised throughout the 
data analysis process. Comparison of categories facilitated review of both 
the data and the open codes underlying each category, however there 
were occasions where this highlighted that some of the categories 
generated early in the data analysis process were providing information 
related to a common phenomenon. An example can be demonstrated by 
considering the formation of the category 'patient involvement'. Initially 
open codes were grouped around the categories of 'patient participation' 
and 'reliance' but the researcher identified that the same set of open 
codes could be grouped with each of these categories. The phenomenon 
was reviewed and a new category of 'patient involvement' was formed 
with 'patient participation' and 'reliance' becoming subcategories of this 
category. Appendix 10 details a theoretical memo that explains the 
thought processes underlying the formation of the category 'patient 
involvement'. 
 
The process of coding data and constant comparison analysis supported 
the generation of eight categories and each category was named to 
reflect the phenomenon that it represented. These categories are:  
 
– Maintaining usual medication routine, 
– Accuracy and consistency, 
– Access to antiparkinsonian medicines, 
– Staff knowledge about Parkinson’s disease, 
– Trust in healthcare professionals, 
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– Patient anxiety, 
– Utilising expertise, and, 
– Patient involvement. 
 
4.3.4 Defining a category in terms of its properties  
The approach to data analysis used in this current study involved defining 
a category in terms of its properties and the dimensions of these 
properties where the properties of a category are the "characteristics of 
a ... category" (Strauss & Corbin, 1990 pp 70) and the dimensions of a 
property "represent locations of a property along a continuum" (Strauss & 
Corbin, 1990 pp 69). This approach is consistent with the approaches to 
data analysis described by Strauss and Corbin in 1990 and 1998 and 
allows a researcher to develop a detailed understanding of a category 
and start to identify links between categories. These links can be further 
developed during the process of axial coding (Strauss & Corbin, 1990). 
The later work by Corbin and Strauss (2008) does not discuss identifying 
the properties of categories. 
 
The properties (and dimensions of these properties) for the eight 
categories that were generated during the process of open coding are 
detailed in Table 4.4.  
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Category Properties Dimensions 
Maintaining usual 
medication routine 
Extent 
Frequency 
More---------------Less 
Often--------------Never 
Accuracy and 
consistency 
Extent 
Frequency 
Full ----------------None 
Often--------------Never 
Access to antiparkinsonian 
medicines 
Extent 
Frequency 
Full ----------------None 
Often--------------Never 
Staff knowledge about 
Parkinson’s disease 
Extent 
Depth 
Broad--------------None 
Detailed-----------None 
Trust in healthcare 
professionals 
Extent 
Frequency 
Full-----------------None 
Often--------------Never 
Patient anxiety Frequency 
Intensity 
Duration  
Often--------------Never 
High ---------------Low 
Long---------------Short 
Utilising expertise Extent 
Frequency 
More----------------Less 
Often---------------Never 
Patient involvement Extent 
Frequency 
Duration  
More----------------Less 
Often---------------Never 
Long----------------Short 
Table 4.4 Properties and dimensions for each category 
 
Properties of an emerging category were initially explored by reviewing 
the existing data to identify possible characteristics of the category e.g. 
frequency that a phenomenon occurs. This process allowed identification 
of gaps in the current knowledge about the properties of a category which 
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were addressed by introducing questions related to the category into the 
interview topic guide. Theoretical sampling was used to select potential 
participants that may be able to provide information that would allow the 
researcher to develop a more detailed understanding about the category. 
 
Describing the properties for each category was a fluid process because 
they were continuously modified in response to the collection of new data 
related to the properties of a category. The process used to understand 
the properties of a category is described below using the category 'patient 
anxiety'.  
 
4.3.4.1 Understanding properties of the category 'patient anxiety' 
The category of 'anxiety', which evolved into 'patient anxiety' (discussed 
in section 4.3.3), emerged early during data analysis but at this time there 
was limited data available to provide information about the properties of 
this category. The initial data suggested that the properties could be: 
 
a) Frequency of feeling anxious,  
b) Intensity of the anxiety, and, 
c) Duration of the anxiety. 
 
Additional information was required to confirm whether these were 
possible properties of the category 'patient anxiety' and to identify other 
properties of the category.  
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Questions related to the category 'patient anxiety' were included in the 
interview topic guide to ensure that the category was explored during 
subsequent interviews. Coding the data collected during these interviews 
and using constant comparison analysis confirmed that properties of the 
category 'patient anxiety' were frequency, intensity and duration. The 
dimensions of each of these properties (detailed in Table 4.4 above) were 
also identified. 
 
This approach was combined with theoretical sampling to explore the 
properties of the other emerging categories and identify their dimensions. 
Theoretical memos were used to record the thought processes that 
occurred when a piece of data suggested a possible property of a 
category. These memos also documented the decisions made related to 
choosing a name for the property and the use of theoretical sampling to 
collect data that would help to explore whether the proposed property 
was a property of the category. An example of a theoretical memo 
discussing these points is included in appendix 11. 
 
4.3.5 Making connections between categories 
Connections between the eight categories generated during the open 
coding process were explored using axial coding which is a recognised 
method of "relating concepts to each other" in the Straussian approach to 
grounded theory (Corbin & Strauss, 2008 pp 195).  
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In their original guidance about coding qualitative data, Strauss and 
Corbin (1990) defined axial coding as a "set of procedures whereby data 
are put back together in new ways after open coding, by making 
connections between categories" (Strauss & Corbin, 1990 pp 96) which 
suggested that axial coding should occur once categories had been 
developed through the process of open coding. In their later work, Corbin 
and Strauss (2008) explained that open and axial coding should occur 
simultaneously during data analysis and this simultaneous approach was 
utilised in this study. This ensured that once a possible connection 
between categories had been identified it could then be explored in future 
interviews to identify the nature of the relationship. 
 
Strauss and Corbin (1990) propose that before connections between 
categories can be identified the phenomenon at the centre of each 
category needs to be explained in terms of: 
 
x the context in which it occurs, 
x the conditions that can allow the phenomenon to occur,  
x strategies that can be used to manage the effects of the 
phenomenon, and, 
x the consequences of these responses. 
 
Information about each of these factors can be obtained using the original 
paradigm model proposed by Strauss and Corbin (1990) and the modified 
  - 112 -
version described in the 2008 (Corbin & Strauss, 2008). The paradigm 
model is defined by Corbin and Strauss (2008) as: 
 
"a set of questions that can be applied to data to help the analyst 
draw out the contextual factors and identify relationships between 
context and process" (Corbin & Strauss, 2008 pp 88). 
 
Using the paradigm model to explore the phenomenon at the centre of 
each category supports the development of a detailed understanding 
about the category because it involves "intense analysis done around one 
category at a time in terms of the paradigm items" (Strauss, 1987 pp 32). 
The paradigm model utilised in this study is described in appendix 12 and 
this includes an explanation of each of the components of the model. This 
model was utilised to explore each of the eight categories that emerged 
from the data provided by the study participants and appendix 13 details 
an example of a completed paradigm model for the category 'maintaining 
usual medication routine'.  
 
Utilising the model to analyse a category highlighted gaps in existing 
knowledge related to the category which were addressed by introducing 
relevant topics into the interview topic guide and using theoretical 
sampling to support the selection of potential participants who may be 
able to provide information related to the topics. Each model was updated 
as new data related to the conditions causing the phenomenon, 
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strategies to manage the phenomenon or the consequences of the 
phenomenon was provided by participants. 
 
Once the researcher had started to develop an understanding about each 
of the categories then the paradigm model was used to support 
identification of possible connections between categories. Information 
generated using the paradigm model suggested the categories that could 
be possible causes or consequences of the phenomenon associated with 
another category. An example of this was provided when the use of the 
model allowed the researcher to identify that the categories 'maintaining 
usual medication routine' and 'patient involvement' appeared to be 
connected because the participants reported that they utilised 'patient 
involvement' (action strategy) to support 'maintaining usual medication 
routine' (the phenomenon). 
 
The nature of the connections between categories were not always clear 
when they were first identified by the researcher but possible connections 
were explored during future interviews and the data obtained aided the 
researcher to begin to understand the connections.  
 
4.3.6 Integrating categories and selecting the core category 
The purpose of studies with grounded theory methodology is to develop 
theory about the topic being researched (Glaser & Strauss, 1967; Strauss 
& Corbin, 1990). Generating theory from the data in a study using a 
Straussian approach involves integrating the categories and recognising 
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a core category that emerges during the integration process (Corbin & 
Strauss, 2008). The relationships between the core category and the 
other categories are then explored to achieve theoretical integration of 
the data. 
 
The core category "represents the main theme of the research" (Corbin & 
Strauss, 2008 pp 104) and Corbin and Strauss explain that the core 
category should be "the concept that all other concepts will be related to" 
(Corbin & Strauss, 2008 pp 104). Two categories emerged as potential 
core categories for this study with both appearing frequently in the data 
and having connections with many of the other categories. These 
categories were 'patient anxiety' and 'maintaining usual medication 
routine'. A grounded theory study should only have one core category 
(Corbin & Strauss, 2008; Glaser, 1978) therefore each of the possible 
core categories had to be re-evaluated for their suitability as the core 
category for this study.  
 
Both Glaser (1978) and Corbin and Strauss (2008) have produced criteria 
that can be used to assess whether a category is the core category. The 
criteria proposed by Corbin and Strauss (2008) are detailed in Table 4.5 
below. 
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Criteria for choosing a core category: 
1. "It must be abstract; that is, all other major categories can be related 
to it and placed under it. 
2. It must appear frequently in the data. This means that within all, or 
almost all, cases there are indicators pointing to that concept. 
3. It must be logical and consistent with the data. There should be no 
forcing of data. 
4. It should be sufficiently abstract so that it can be used to do research 
in other substantive areas, leading to the development of a more 
general theory. 
5. It should grow in depth and explanatory power as each of the 
categories is related to it through statements of relationship." 
 
(Corbin & Strauss, 2008 pp 105)  
Table 4.5 Criteria for choosing a core category as proposed by Corbin 
and Strauss (2008) 
 
Although a Straussian approach has been utilised throughout data 
analysis, Glaser's criteria for identifying a core category were also 
considered because these criteria highlighted additional factors that could 
be considered to support the decision making process. A summary of the 
points that Glaser (1978) recommends a researcher should consider 
during selection of a core category is detailed in Table 4.6. 
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Factors to consider when choosing a core category include: 
x "It must be central, that is related to as many other categories and 
their properties as possible and more than any other candidate for the 
core category". 
x "It must reoccur frequently in the data". 
x "It takes more time to saturate the core category than other 
categories". 
x "It relates meaningfully and easily with other categories". 
x "Has a clear and grabbing implication for formal theory". 
x "The core category has considerable carry-through". 
x "It is completely variable". 
x "A core category is also a dimension of the problem". 
x "The core category can be any kind of theoretical code: a process, a 
condition, two dimensions, a consequence and so forth". 
 
(Glaser, 1978 pp 95-96) 
Table 4.6 A selection of the criteria proposed by Glaser (1978) that 
should be considered when choosing a core category  
 
Each of the criteria detailed in Table 4.5 and Table 4.6 were considered 
during the selection of the core category and the thought processes that 
were used to choose the core category were recorded in a theoretical 
memo.  
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The core category that emerged following consideration of the criteria and 
sorting through previous theoretical memos was 'patient anxiety'. This 
category explains "what the research is all about" (Corbin & Strauss, 
2008 pp 108). The category of 'patient anxiety' is connected with all of the 
other categories and these connections can be explained using elements 
of the paradigm model, with some of the other categories being causal 
conditions for the phenomenon of 'patient anxiety' and others being action 
strategies implemented in response to the phenomenon. The causal 
conditions for 'patient anxiety' and the action strategies implemented in 
response to the phenomenon are detailed in a theoretical memo which is 
included in appendix 14 and the connections between the core category 
and the other categories are displayed in Figure 4.2. 
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consistency
Patient 
anxiety
Staff knowledge about
Parkinson’s disease
Patient 
involvement
Decreased 
anxiety
Maintaining usual
medication routine
Utilising 
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Access to antiparkinsonian 
medicines
Consequence
Action strategies
Central phenomenon
Causal conditions
Trust in healthcare 
professionals
 
Figure 4.2 Connections between the core category 'patient anxiety' and 
the other categories 
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4.3.7 Process and context 
An essential element of a Straussian approach to grounded theory 
methodology is looking for process and context and both of these factors 
were considered during data analysis in this study.  
 
Strauss and Corbin (1990) define process as "the linking of sequences of 
action/interaction as they pertain to the management of, control over, or 
response to a phenomenon" (Strauss & Corbin, 1990 pp 143) and 
propose that it is a method to demonstrate the sequence of events that 
can lead to or occur in response to a phenomenon. Consideration of 
process during data analysis in this study involved identifying data which 
provided an explanation of the effect that any changes in the causal 
conditions could have on the central phenomenon 'patient anxiety' and 
subsequently on the action strategies that participants utilised to address 
their anxiety. Data that explained the effects of both positive and negative 
changes in the causal conditions on the action strategies used by 
participants was considered during data analysis. The possible effects on 
'patient anxiety' that may occur if a patient was unable to implement the 
action strategies were also considered. Each of these situations are 
considered in a theoretical memo that is detailed in appendix 15. Figure 
4.3 provides a visual representation of the process identified during data 
analysis: 
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Patient can be admitted to hospital via a variety of routes and for a variety of reasons
Perceives positive examples of causal conditions including:
•Medication routine maintained
•Patient has no concerns about accuracy of prescribing 
•Consistency in medications
•Medication available
•Patient has no doubts about staff knowledge 
related to Parkinson’s disease
•Patient has trust in staff
Perceives negative examples of causal conditions including:
•Medication routine not maintained
•Patient has concerns about accuracy of prescribing 
•Lack of consistency in medications
•Medication unavailable
•Patient has doubts about staff knowledge 
related to Parkinson’s disease
•Patient has lack of trust in staff
Patient anxiety
Patient involvement but
no use of expertise
Use of expertise and
patient involvement
•Routine maintained
•Increased accuracy of 
prescription
•Increased staff knowledge
Reduced anxiety
•Reliant on ward staff
Remains anxious
•Routine maintained
•Increased accuracy of 
prescription
•Increased staff knowledge
May have reduced anxiety
Patient reassured
No response required
Use of expertise but 
no patient involvement
None
•Increased staff knowledge
•Increased accuracy of
prescription
•Routine maintained
Use of action
strategies
Situation
Possible
consequences
Outcome
Leads to
Response
Leads to
 
Figure 4.3 Visual representation of the process identified during data 
analysis 
 
Corbin and Strauss (2008) define the context for a theory as the "sets of 
conditions that give rise to problems or circumstances to which 
individuals respond by means of action/interaction/emotions" (Corbin & 
Strauss, 2008 pp 229). The conditions identified that could lead to the 
central phenomenon of 'patient anxiety' included the influence of both 
local practice (e.g. practice on a ward in a teaching hospital in the UK) 
and organisational, professional and political policies. 
 
4.4 Achieving theoretical saturation 
Section 3.4.2.2 stated that the researcher intended to use theoretical 
sampling to achieve theoretical saturation. Theoretical saturation became 
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apparent after analysis of the thirteenth interview because at this point 
"no further data pertinent to the categories emerge[d] during data 
collection … [and] … all participants [were] expressing the same ideas 
relevant to the developing theory" (Bluff, 2005 pp 155). 
 
Dey (2007) proposes that it is difficult to identify when a study has 
achieved theoretical saturation and data collection should stop. Bluff also 
argues that it is "difficult to state categorically that saturation has been 
achieved" (Bluff, 2005 pp 156). Data collection for this study was 
discontinued after interview thirteen because during the analysis of the 
transcript of this interview it became evident that the criteria of Strauss 
and Corbin's (1990) definition of theoretical saturation (stated in section 
3.4.2.2) had been fully satisfied. 
 
4.5 Chapter summary 
Data collection and analysis occurred simultaneously in this study and the 
methods utilised to analyse the data reflected a Straussian approach to 
grounded theory methodology. Open coding was used in conjunction with 
axial coding and eight categories emerged from the data. These 
categories were 'maintaining usual medication routine', 'accuracy and 
consistency', 'access to antiparkinsonian medicines', 'staff knowledge 
about Parkinson’s disease', ‘trust in healthcare professionals’, 'patient 
anxiety', 'utilising expertise' and 'patient involvement'. The core category 
was 'patient anxiety' and the connections between this category and all of 
the other categories could be described using the paradigm model. 
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Process was considered during data analysis to ensure that the effects of 
changes in causal conditions on both the central phenomenon and the 
action strategies were considered. 
 
Integration of the categories and identification of both the causal 
conditions for the core category 'patient anxiety' and the action strategies 
used in response to this anxiety provided the basis of the theory related 
to patients' perceptions of the management of medication during a 
hospital admission. This theory is detailed in chapter 5. 
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5 Laying out the theory 
5.1 Introduction to chapter 
The purpose of this chapter is "laying out the theory" (Strauss & Corbin, 
1990 pp 133) that was apparent within the data and then validating this 
theory using data provided by the study participants (characteristics of 
these participants are summarised in appendix 16). Throughout this 
chapter the relationships between the core category and the other major 
categories are explored and the emerging theory is explained.  
 
5.2 Causal conditions for a patient's anxiety and the strategies 
implemented in response to this anxiety 
The central phenomenon (also known as the core category) that was 
evident within the data was 'patient anxiety' and all of the other categories 
that were identified within the data could be related to this central 
phenomenon. Figure 4.2 in the previous chapter provided a visual 
representation of the links between the core category and the other 
categories and demonstrates that the categories 'maintaining usual 
medication routine', 'accuracy and consistency', 'access to 
antiparkinsonian medicines', 'staff knowledge about Parkinson’s disease' 
and ‘trust in healthcare professionals’ are possible causal conditions for a 
patient's anxiety related to the management of their medicines during a 
hospital admission. The categories 'utilising expertise' and 'patient 
involvement' are action strategies that could be implemented by patients 
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in response to their anxiety. The consequence of implementing the action 
strategies will be decreased anxiety. 
 
The following sections explore whether these categories are causal 
conditions or action strategies for the central phenomenon of 'patient 
anxiety' and detail the theory that was apparent within the data. A 
separate section is not included for the category 'patient involvement' 
because this action strategy is discussed within each of the other 
sections. The consequences of being able (or unable) to implement the 
action strategies are discussed throughout the chapter rather than being 
discussed in a separate section. 
 
5.2.1 'Maintaining usual medication routine' - a causal condition 
5.2.1.1 Participants' individualised medication regimens 
All participants explained that prior to admission to hospital they had a 
routine related to their medicines which either involved doses of their 
antiparkinsonian medications being taken at specific times each day or 
specific time intervals elapsing between doses of antiparkinsonian 
medications.  
 
Those participants who took doses of their antiparkinsonian medicines at 
specific times were able to recall these times: 
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“I take them in the morning about nine … two o’clock in the 
afternoon and then ... ten at night” #1. 
 
"So I take them when I get up at eight o’clock. Then twelve o’clock 
I take the next one, four o’clock I take the next one and err at eight 
I take the next one. That’s me full day and I can’t have anymore 
then until eight o’clock next morning" #6. 
 
Those who had medication regimens that required specific time intervals 
to elapse between doses of medication were able to articulate their dose 
intervals: 
  
"I take a couple [of tablets] in the morning about 6 o’clock and then 
I take next one about half past seven, and then I take it … every 
five hours" #12. 
 
"Usually at four hourly intervals" #9. 
 
Each participant had a medication regimen that had been developed to 
manage their features of the disease and the complications caused by 
their medications. One explained: 
 
"Me symptoms were not controlled … Dr X looked at them 
[medicines] and changed it straight away … main thing he did was, 
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you know how they do, put pills to get you going … and that’s been 
real successful has that" #2. 
 
Another stated: 
 
"I’ve actually been trying to get me levels of tablets right, been 
chopping and changing them about quite a bit in the past three 
months … because I got really bad of shaking all over, you know, 
like this. But eventually they seem to have got the tablets right 
now, you know. I’m only shaking occasionally, you know" #9. 
 
All participants thought that it was important to try to take their medication 
at their individualised times to maintain control of their features of 
Parkinson's disease. One individual described their adherence to their 
medication regimen as: 
 
“I am right staunch at taking it. You know, I am right staunch. I 
know that it is important to me and it only works if you get your 
tablets every four hours” #6. 
 
Another stated: 
 
"I take them [medicines] religiously" #7. 
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One of the reasons that participants tried to maintain their medication 
regimen was they thought that they had previously experienced a loss of 
symptom control when they deviated from the regimen: 
 
"The thing is, I do shake to a degree but I don’t shake a right lot, so 
it doesn’t bother me too much, if you know what I mean, but if I 
don’t take them I start shaking a lot more" #6. 
 
“It affected me a lot. They did not give me the tablets on time … 
about a two hour wait … 
And how did that affect you? 
I was shaking … I felt awful” #12. 
 
One participant did not think that they experienced a loss of symptom 
control when they missed doses of their medication: 
 
"It doesn’t seem to effect me whether I take them. If I miss a dose 
or don’t miss a dose. It might do it in the long-term but certainly not 
at the moment " #3. 
 
Even though they had this opinion, they still wanted to receive their 
medication doses at the correct times during their admission. 
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Other participants took their medication at specific times because their 
consultant neurologist had advised them to take their medication at those 
times: 
 
"Dr X … says that them every four hours ... so I take ..." #6. 
 
"I take all the tablets when they say I have to take them" #7. 
 
"Dr X is the one who changes my medicine. They set three, three 
times a day until I see them again" #11. 
 
 "It is up to them to know what I was going to take" #4. 
 
5.2.1.2 Methods used by participants prior to admission to hospital 
to maintain their medication regimen  
Prior to admission to hospital some participants utilised a medication aid 
(e.g. compliance aid or reminder chart) to support them to remember to 
take their medicines at the correct time: 
 
"I have a dosette box" #12. 
 
"Well I had a system. Erm I don’t know whether it’s general or not 
but each day I have a little square box … that has been a god 
send. And I know exactly, if I haven’t taken it its there in the 
box" #7. 
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 "I get them in a box you know with the days … I was really bad at 
taking them. I felt I was forgetting them you know. So that’s why 
they decided to give me the box" #9. 
 
Others relied on a carer to administer their medications at the appropriate 
times: 
 
"Umm (..) they were becoming a bit of a (.) I won't say problem but 
(.) I did start forgetting them, umm, it became easier for my wife to 
remember them … she does tell me, she thinks for herself but 
officially I do it" #2. 
 
5.2.1.3 Participants' concerns about their ability to maintain their 
usual medication regimen during a hospital admission 
All participants, except one, articulated that they had felt anxious about 
how their antiparkinsonian medicines would be managed by hospital staff 
when they were informed that they would be admitted to hospital: 
 
 "I was worried, they [staff] would do it right, you know what I 
mean. To get the right thing at the right times" #1. 
 
"I wor worried. If they don’t do it, it's spoilt it" #6. 
 
"I did think about that, I did think about how they would organise 
that" #7. 
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Participants who were admitted to the hospital electively had considered 
this point prior to their admission and those who were admitted acutely 
had thought about this once they were aware that they were going to be 
admitted to hospital. 
 
Participants that believed that they had previously had a negative 
experience of the management of their medicines during a hospital 
admission were anxious about whether this would occur during their 
current admission: 
  
"Well I was having a fit because they made such a flaming mess of 
it last time" #6. 
 
"Ahh, I was worried. I didn’t like it … Last time I went to X and it 
was hopeless … they didn’t know what Parkinson’s was … Some 
of the nurses didn’t … it affected me a lot. They did not give me 
the tablets on time" #12. 
 
One of the causes of 'patient anxiety' was a concern that staff would not 
administer a patient's antiparkinsonian medications at the patient's 
individualised times and this would lead to loss of control of their features 
of Parkinson's disease: 
 
“Parkinson’s has to come first. It is only by doing it every four 
hours that helps me. Otherwise it does not help me” #6. 
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"Must do eight hours between each one ... you can't break the run 
of it" #8. 
 
"It is important that you don’t miss it … I would feel really bad" #1. 
 
In summary, participants were anxious about whether they would be able 
to maintain their usual antiparkinsonian medication routine during their 
hospital admission.  
 
5.2.1.4 Participants' perceptions of maintaining their usual 
medication regimen during their hospital admission 
Some of the participants perceived that they had consistently received 
the correct dose of medication at the correct time during their admission. 
They felt reassured that they had been able to maintain their usual 
medication routine: 
 
"It’s very good at the moment" #2. 
 
"No gaps in my medicines. I brought my tablets in and the hospital 
have given me them" #11. 
  
Those participants that did not believe that they had always received the 
correct doses of their antiparkinsonian medications at the correct time 
during this current hospital admission explained that they continued to 
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feel anxious because they were worried that they would miss further 
doses of their medicines: 
 
"About the day that I didn’t have any 'til teatime. The following day, 
well they’d said they’d ordered them and they’d be in the following 
day and the following day they said your tablets still haven’t come 
yet. So my son was in at the time so he said well I’m coming 
tonight do you want me to bring my dad’s other box. They said yes 
to start with and then when he was going one of the nurses said oh 
we’ve got your tablets in … so don’t bother bringing them. So that 
following day they couldn’t find them … so I went a while again 
without taking them … it seems like it’s not organised yeah … I 
was worried" #9. 
 
The participants articulated that causes of deviations from their usual 
medication routine included lack of availability of the medication on the 
ward (discussed in section 5.2.3.1 below) and doses not being 
administered due to a patient's prescription chart being misplaced. One 
participant did not receive doses of their medication on two occasions 
due to their prescription chart being misplaced: 
 
“They lost my drug chart. Lost my drug chart … It got lost! Last 
night. Not sure how but they lost it … 
And when was the last time you had your dose? 
Yesterday afternoon … 
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And how long did it take for you to get your dose? 
This morning. 
And how did you feel? 
Angry. I am angry about it. I was ill through the night” #10. 
 
The deterioration in symptoms reported by participants was not validated 
by healthcare professionals. 
 
5.2.1.5 'Maintaining usual medication routine' - Section summary 
All participants, except one, were anxious when they were informed that 
they were going to be admitted to hospital about how the hospital staff 
and medicines management processes would support them to be able to 
maintain their usual medication regimen during the admission. They all 
thought that it was important to have their correct medicine at the correct 
time to maintain their symptom control but did not believe that they would 
be able to achieve this during a hospital admission. These participants 
were worried that they would not be able to maintain symptom control 
due to hospital staff failing to administer the correct medicine at the 
correct time. During the course of their admission, some participants 
became less anxious about being able to maintain their medication 
regimen because they consistently received their correct medicines at the 
correct times. Those participants that experienced events that meant that 
their usual regimen was not consistently delivered remained anxious 
about whether they would receive the correct medicine at the correct time 
for the rest of their hospital admission. 
  - 133 -
5.2.2 'Accuracy and consistency' - a causal condition 
Most participants recognised that maintaining their usual medication 
regimen during their hospital admission required their medications to be 
prescribed at the "right" (#1) times on their hospital prescription.  
 
5.2.2.1 Accuracy of prescriptions 
Many participants were anxious about whether their hospital prescription 
would include the correct antiparkinsonian medication, formulation of the 
medication (e.g. immediate release or controlled release levodopa based 
medications), dose and times of each dose. A prescription that did not 
reflect their usual medication regimen was perceived as a "mistake" (#1) 
whereas a prescription that had the correct medicine prescribed at the 
correct time was perceived as an accurate prescription. 
 
Advising the prescriber about their usual medication regimen was 
suggested as a method that patients could use to ensure that the 
medications and dose times on their hospital prescription accurately 
reflected their usual regimen: 
 
“Did you bring your box of tablets into hospital with you? 
I showed them to the doctor … Yes. I think it is important … stops 
them making mistakes” #1. 
 
"I showed doctors my box" #12. 
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All participants, except one, tried to be involved in the process when their 
prescription chart was being prepared and most thought that their 
involvement in the prescribing process would improve the accuracy of 
prescriptions written for their antiparkinsonian medications: 
 
“I helped the doctor get the drug chart right” #10. 
 
"[My prescription] is correct because I brought the medicines in 
myself and showed the doctor" #11. 
 
One participant did not believe that the prescriber had listened to the 
information that they had provided: 
 
"Well obviously, they have not taken any notice again … I was not 
getting my stuff at the right time" #6. 
 
Information about a participant's usual medication regimen was presented 
to the prescriber in a variety of formats including lists of medicines and 
printed instructions on labels on medicine boxes. One participant 
explained the importance that they attach to their list of medicines 
because this allows them to advise prescribers about their usual 
medication regimen: 
 
"I remember the time when we, somebody, had the bright idea that 
we draw up a chart ... for Parkinson’s stuff ... I mean it didn’t take 
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much doing but he thought of doing that ... and that were lovely…. 
I won’t go in now without it, a lot of information" #2. 
 
The anxiety caused by fear that their prescription may be written 
incorrectly was reduced in some participants once they believed that the 
prescriber had written an accurate prescription: 
 
“Once its right its fine” #10.  
 
Despite involvement in the process of writing their prescription, some 
participants continued to feel anxious about whether their prescription 
accurately reflected their usual dose times. These participants wanted 
reassurance from an external source that their prescription accurately 
reflected their usual regimen and explained that they wanted a 
pharmacist to review their prescription to detect and address any possible 
errors: 
  
"A pharmacist would check I am taking the right thing at the right 
time" #1.  
 
These participants thought that pharmacists have detailed knowledge 
about medicines and suggested that a pharmacist could use this 
knowledge to help a patient ensure that their hospital prescription 
accurately reflects their usual medication regimen:  
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"Seeing a pharmacist would be a good thing because, you know, 
you can ... say to him, I’m a bit worried because I may not get me 
medication on time" #3. 
 
One participant described how a pharmacist had helped them to correct 
an error that the participant had identified related to the timings of the 
administration of their medication doses. They explained that they had 
been asking a doctor for several days to change the prescribed dose 
times so that the times reflected their usual regimen but they had been 
unsuccessful. The participant had asked the pharmacist for help with this 
matter and their prescription had subsequently been amended. The 
patient thought this was because: 
 
"They have to take notice of her; they don’t take any notice of 
me" #6. 
 
In summary, many participants were worried about the accuracy of their 
prescription and responded to this anxiety by advising the prescriber 
about their usual medication regimen. Many participants proposed that 
access to a pharmacist during a hospital admission would provide them 
with reassurance about the safety and appropriateness of any medication 
that was prescribed for them during their admission.  
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5.2.2.2 Consistency of medication 
Many participants articulated that they utilised the shape and colour of a 
medication dosage form and the number of these dose units to assess 
whether they were being administered the correct medication and correct 
dose by members of the nursing staff: 
 
"I go by the colour of them, and I know what I am takin" #6. 
 
"I remember them by the colour of the tablet" #7. 
  
"I use the colours as a way of knowing that I've taken the right  
thing" #9. 
 
These participants explained that they felt anxious when the number of 
tablets that they had been administered for a dose did not agree with the 
number of tablets that they had expected or the shape or colour of the 
dosage forms were different to what they had expected. The participants 
articulated that these situations increased their anxiety because they 
were worried that they were being administered the incorrect medicine: 
 
"Well yes. I was worried ... I was expecting three yellow tablets but 
I got different things. But then it came back that it was right. So … 
You know what I mean? I were right cut up ... I couldn’t understand 
… I was worried about my medicines" #1. 
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One participant described a situation where they had challenged the 
nurse administering their medicines because they thought that the nurse 
was giving them incorrect medication due to the number of tablets and 
colour of tablets being different from what they had expected: 
 
“They gave me half a one, half a white one and erm I says, he 
says it is a Parkinson’s thing. And I say no, I only have three 
yellow ones for the Parkinson’s” #6. 
 
One participant, who had managed their own medicines prior to this 
admission, explained that they thought that the visual appearance of the 
antiparkinsonian medicines used in the hospital were different to those 
they used at home. They believed that this had affected their ability to 
assess if they were being administered the correct dose of medication by 
nursing staff: 
 
"The pramipexole seems as though they are a different tablet, I 
don’t know, to what I’m taking at home, I suppose different 
manufacturers are different aren’t they?... I've lost track of how I’m 
getting my tablets, you know" #9. 
 
In summary, the data suggests that consistency in the number of dosage 
forms and colour and shape of dosage forms provides reassurance for 
many of the participants that they are being administered the correct 
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medications. Variations in the colour and shape or number of dose units 
were causes of anxiety for some participants. 
  
5.2.3 'Access to antiparkinsonian medicines' - a causal condition 
Participants provided data related to the availability of their 
antiparkinsonian medicines within the ward area, their ability to access 
nurses when a dose of medication was required and the perceived role of 
self-administration of medicines during a hospital admission. 
 
5.2.3.1 Availability of medications 
Most participants thought that there had always been a supply of their 
medicines available for their use during this admission. Some thought 
that there had been occasions when their medicines were unavailable 
and explained that when they had been made aware that their medicine 
was not available on the ward they had become anxious: 
 
“Has there ever been a time when your tablets were not 
available for you to have?  
Well yes. Once. 
And how did that make you feel?  
I panicked” #12. 
 
The anxiety was related to whether missing a dose of medication would 
affect their symptom control and whether their next dose would be 
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delayed or omitted due to the lack of availability of the medicine. One 
participant described an occasion during this admission where their 
tablets were not available on the ward and had not been supplied by 
pharmacy. They did not receive a dose of medication for 24 hours and 
when they challenged staff about the situation they were told that the 
medicines were not available. This caused them to feel anxious about 
when they would be able to receive a dose of medicine: 
 
"I went a full day without taking any tablets at all ... I did feel worse 
yes ... I asked them what was happening about my tablets and  
they said they didn’t have any in and were going to have to order  
them" #9. 
 
Once these participants were aware that their medicines were available 
on the ward their anxiety related to the availability of medicines was 
reduced. 
  
5.2.3.2 Access to nursing staff to administer the medication dose 
Most of the participants reported that they felt anxious throughout their 
hospital admission about whether a nurse would remember that a dose of 
their medicines needed to be administered at a specific time and be 
available to administer the dose at that time. One participant felt 
reassured that staff would always know when they needed a dose of their 
medicines and thought that a member of staff would always be available 
to administer their medication doses at these times: 
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"I don’t worry about that … They just came along with what 
medicines I required" #8. 
 
This individual was achieving symptom control with one antiparkinsonian 
medication taken three times a day and the dose times corresponded to 
the ward medication rounds. 
 
Other participants were worried about staff remembering to administer 
their medication doses and prompted staff when a dose of medication 
was due. Prompting staff was a method used by many participants to 
ensure that the nurse was available to administer the dose at the correct 
time: 
 
"I shout out come and give me a Stalevo®" #2. 
 
"I always call the nurse … I will say please can you give me a 
tablet" #4. 
 
This active participation in their own care allowed many participants to 
feel reassured that they would receive their medications at the correct 
time but some described this as a "burden" (#9) that they had to 
undertake during their hospital admission. One participant said: 
 
 “You have to keep on top of it [prompting staff]" #6. 
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They also said: 
 
"the thing is you are busy trying to get a wash and you are waiting 
for people to take you to the bathroom and you are waiting for this 
that and the other. It can be all day job just to get one lot down you 
… I am aware of the time all the time" #6. 
 
Another explained that prompting staff when medication was required 
was a continuous task: 
 
"You have to ask for the tablets, you get them and then it's time for 
the next one. You have to ask for them, so you remember the time. 
Yes, you find you have to remember the times and ask them" #12. 
 
The belief that they had to prompt staff in order to access their medicine 
at the correct time made many participants feel anxious because they 
were worried that there could be occasions when they would forget to 
prompt staff and they thought that this would cause them to miss a dose 
of their medication: 
 
"What if I forget?" #1. 
 
Most participants believed that nurses were accessible and responded 
promptly when they tried to contact a nurse to request a dose of 
medication: 
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“If I couldn’t access a nurse it would only be for twenty minutes or 
so” #2. 
 
A few participants explained that they were concerned about the 
accessibility of nursing staff: 
 
 “Nurses are not very accessible some times” #9.  
 
They deliberately contacted a nurse prior to the times that they needed 
their medication dose to ensure that they would get their medications on 
time: 
 
"What time do you change the [apomorphine] pump at home? 
Six o’clock. 
Have you been doing that here? 
About five o’clock I ask the nurse, to make sure no gaps" #10. 
 
In summary, only one of the participants thought that nurses would 
always remember to administer their medication and they felt reassured 
that they would receive their medication doses at the correct times. The 
other participants were worried about whether the nurses would 
administer their doses on time and responded by prompting staff when 
doses were required. The act of prompting staff when a dose was due 
offered many participants reassurance that doses of their medication 
would be administered at the correct time but the responsibility of 
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prompting staff caused them to feel anxious throughout their hospital 
admission. 
 
5.2.3.3 Self-administration of medicines 
One participant had expressed a desire to self-administer their 
medication during this admission but the nursing staff had declined their 
request: 
 
"I said well I prefer to self medicate when I was in hospital. They 
didn’t want me to. They said we prefer to lock it up in those 
cupboards" #3. 
  
They explained that they had wanted to self-administer their medications 
because this would allow them to have prompt access when they 
believed that they needed a dose of medication. 
 
None of the other participants had been offered the option to self-
administer their medication during this admission and many participants 
did not think that the hospital provided an opportunity for a patient to 
administer their own medications:  
 
"I would have been better looking after it myself but they don’t give 
it to yourself. When you come in here they take it off you" #6. 
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Many participants were able to articulate the benefits they perceived that 
they could obtain by self-administering their medicines: 
 
"If I have them at least I have a better chance of taking them on 
time" #9. 
 
"Well this is supposed to be making life easier for me isn’t it? 
[points to bedside locker] When you go to them, my medication is 
already there and if I know when to take it and what time it has to 
be taken for, it's no problem" #6. 
 
"You know you will get them" #12. 
  
These participants explained that despite these benefits they would not 
want to be responsible for administering their own medications during this 
hospital admission: 
 
"No, I wouldn’t want to look after them" #12. 
 
"I would not want the responsibility" #10. 
 
 "No I wouldn't because my mind isn't, I'm 91 nearly, and my mind 
 isn't 100% to that extent" #8. 
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Some participants explained that they did not feel confident to administer 
their own medications because they did not manage their own 
medications prior to admission to hospital: 
 
"I thought that I wouldn’t have anything to do with it. I don’t do it at 
home, my mum does it" #10. 
 
"My daughter deals with them … it's all done by my daughter" #6. 
 
Some participants who had utilised compliance aids prior to admission to 
administer their medication doses explained that they would feel 
confident to administer their medication doses during the admission if 
they had access to the same aid: 
 
"I would like to keep on taking the er the dosette box during 
admission ... it would have to be somewhere near me otherwise I 
am not going to get the benefit from it but I think I ought to be able 
to" #7. 
 
In summary, some participants recognised that self-administration of 
medication could reduce their anxiety related to the administration of their 
medication during a hospital admission but chose not to self-administer 
because they did not think that they would be able to safely administer 
their medications in the unfamiliar environment of a hospital ward. Others 
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would not want to self-administer their medication because they did not 
administer their own medications prior to admission to hospital. 
 
5.2.4 'Staff knowledge about Parkinson's disease' - a causal 
condition 
Most participants thought that many members of the nursing staff caring 
for them had limited knowledge about Parkinson's disease and the 
medicines used for the management of the disease: 
 
"I think there is a lack of information and understanding [about 
Parkinson's disease] and the first thing I did was tell them I have 
Parkinson’s and about my medicines" #10. 
 
"They have a lack of knowledge about the medicines" #12. 
 
"I mean some nurses are brilliant they know what to do, others just 
don’t know … I don’t think they understand them" #9. 
 
All of these participants explained that the perceived lack of staff 
knowledge about the medicines used to manage the symptoms of 
Parkinson's disease was a stressor for them during their hospital 
admission. The participants explained that they were anxious because 
they thought that many nurses did not understand the importance of 
giving antiparkinsonian medicines at specific times to manage a patient's 
symptoms:  
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"They said well you won’t be able to have them when you want 
them. You will have to have them when we give them … I thought 
hell they are making it light hearted and I can’t do with that. I got to 
... if I don’t take them I start shaking a lot more" #6. 
 
Many attributed the lack of knowledge about Parkinson's disease to a 
"lack of education" (#7) provided for nurses about the disease and its 
treatment. They believed that this education was needed because: 
 
 "You’ve got to know PD to know what to ... do, because it really, it 
affects so many different ways" #8.  
 
"If they were taught how to do it I think it would be a lot easier" #9. 
 
In summary, some participants thought that staff had an awareness of the 
medication related care needs of patients with Parkinson's disease but 
most did not think that staff had knowledge about the disease and this 
caused them to feel anxious about whether they would receive their 
correct medications at the correct time. 
 
5.2.5  'Trust in healthcare professionals' - a causal condition 
Many of the participants provided data related to patient trust in 
healthcare professionals. All of the participants trusted their neurologist 
and PDNS to manage their medicines and their Parkinson's disease: 
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 "I went to see Dr X and she is exceptional … she says what I am 
 going to do is give you these tablets … they have been marvellous 
 have them [tablets]" #6. 
 
"My medicines depend on the specialist" #10. 
 
A few of the participants trusted that the ward healthcare professionals 
would manage their Parkinson's disease appropriately during this 
admission. One participant stated: 
 
"I have every trust in the two hospitals" #7. 
 
This participant also explained that they rely on doctors to ensure that 
they receive appropriate care during their hospital admission: 
 
"I don’t worry. I rely on the doctor knowing his business" #7. 
 
Many of the participants explained that did not trust the healthcare 
professionals managing their care during this admission to manage their 
medications correctly. One explained that they did not trust staff to 
administer their medicines at the correct times: 
 
"I would really like to trust them... but if you can’t trust them then 
you can’t" #6. 
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The same participant said: 
 
"You know I can’t just trust it will come to me" #6. 
 
Other participants demonstrated their lack of trust in hospital staff through 
their choice of words when recalling a situation. One explained: 
  
"They said I could have them [medicines] the next day but I 
thought I have heard it all before” #5. 
 
Another participant displayed their lack of trust in the staff by using the 
phrase “so they said” (#9) when recalling situations related to their 
hospital admission. 
 
Section 5.2.2.1 includes data that demonstrates that some participants 
did not trust prescribers to accurately prescribe their usual medicine and 
were worried that the prescriber would make "mistakes" (#1). Many of 
these participants did trust a pharmacist to identify any errors in the 
prescription and take steps to correct these errors. 
 
5.2.6 'Utilising expertise' - an action strategy 
Participants perceived their consultant neurologist and PDNS as experts 
in the management of Parkinson's disease. Many explained that they take 
their medication at the times that their consultant has told them to take 
the doses and only adjust these times when advised to do so by the 
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consultant to achieve better symptom control (discussed in section 
5.2.1.1). 
 
Some of the participants expected to be visited by a PDNS or neurologist 
during their hospital admission: 
 
"I thought someone who knew a bit more about it would visit me. 
Someone who knew what she was doing with regard to 
Parkinson’s" #9. 
 
None of the participants were visited by a PDNS or neurologist during 
their admission but all suggested that having access to these 
professionals during their admission would be beneficial because the 
doctor or PDNS would be able to use their knowledge to ensure that the 
patient's medications were being managed correctly during their 
admission: 
 
"They would be concerned for your welfare … and … would make 
sure that you got what you needed. She knows how serious it 
is” #6.  
 
"A nurse could visit one-off and make sure everything is alright 
with medicines" #10. 
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"I am not quite sure whether they would be able to take over my 
care but most it would be good to check everything is ok with my 
medicines" #4. 
 
"They could increase awareness of Parkinson’s disease and 
medicines" #12. 
 
Many participants thought that the PDNS could advise ward staff about 
the specialist care and medicine related "needs" (#9) of a patient with 
Parkinson's disease. One participant explained that the expert would: 
 
"acknowledge that there is a problem and everybody knows it and 
everybody will be made aware of this" #2. 
 
The participant used the word "problem" to explain that they believed that 
their Parkinson's disease caused them to have specific requirements 
related to the administration of their medications which were different to 
the needs of other patients admitted to the hospital ward. 
 
In summary, many of the participants thought that having access to an 
expert in Parkinson's disease and being able to use this expertise to 
advise ward staff about the medicine related care needs of a patient with 
Parkinson's disease would reduce their anxiety related to the 
management of their medications.  
 
  - 153 -
5.3 Chapter summary 
All of the participants thought that maintaining their individualised 
medication regimen during their hospital admission was important and 
they felt anxious about whether they would be able to maintain this 
regimen in the unfamiliar environment of a hospital ward. They were 
worried that any deviations from their usual medication regimen could 
lead to a loss of symptom control.  
 
Participants were also worried about the ability of prescribers to write a 
prescription that accurately reflected their usual medication regimen and 
most responded to this anxiety by advising the prescriber about their 
usual regimen. Anxiety was also caused by a concern that they would not 
be able to access their medicines (or a nurse to administer these 
medicines) when a dose of medication was due to be taken. Participants 
addressed these concerns by prompting nursing staff when a dose of 
medication was due. 
 
Most participants felt reassured once they believed that they would be 
able to maintain their individualised medication regimen during their 
hospital admission. This reassurance was provided when the participant 
thought that their hospital prescription reflected their usual medication 
regimen and they had experience of being administered doses of the 
correct medicines at the correct time. 
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Self-administration of medication was proposed by some participants as a 
possible solution to their anxiety about their ability to access medications 
at specific times but many participants did not want to engage in this 
process during their current hospital admission. 
 
The data suggests that an experience of a deviation from an 
individualised medication regimen (e.g. due to medicines being 
unavailable or doses being administered at incorrect times) or a belief 
that staff have limited knowledge about the medications used for the 
management of Parkinson's disease can cause a patient to feel anxious 
throughout their hospital admission. Participants suggested that having 
access to an expert in Parkinson's disease and utilising this expertise to 
educate ward staff would reduce their anxiety. 
 
This theory appears to confirm that the categories 'maintaining usual 
medication routine', 'accuracy and consistency', 'access to 
antiparkinsonian medicines', 'staff knowledge about Parkinson's disease' 
and 'trust in healthcare professionals' are possible causes for a patient's 
anxiety related to the management of their medicines during a hospital 
admission. The strategies employed by participants in response to their 
anxiety were related to the categories of 'utilising expertise' and 'patient 
involvement'. The consequence of using these strategies was reduced 
patient anxiety about the management of their medicines during the 
hospital admission. 
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6 Discussion and Conclusion 
6.1 Introduction to chapter 
The purpose of this grounded theory study was to generate theory about 
patients' perceptions of the management of antiparkinsonian medications 
during an admission to LTHT. Chapter 5 details the theory generated 
from the participant data and the purpose of this chapter is to validate or 
refute this theory using existing literature and explore the implications of 
the theory for practice development. Areas for future research will also be 
highlighted throughout the chapter. 
 
The literature referred to within this chapter was identified either during 
the initial literature search that is discussed in chapter 2 or during a 
subsequent literature search that was conducted after data analysis had 
started and categories were identified.  
 
6.2 Refining and validating the theory 
The following sections consider aspects of the theory detailed in chapter 
5 and use literature from a range of professional disciplines to explore 
these findings. Information will also be provided about how the findings of 
this study develop existing knowledge about patients' perceptions of the 
management of antiparkinsonian medications during a hospital 
admission. 
 
  - 156 -
6.2.1 The central phenomenon of 'patient anxiety'  
The theory in chapter 5 suggests that patients may feel anxious early in 
their hospital admission due to concerns about the methods that would be 
used to manage their medicines during the admission. The causes of a 
patient's anxiety may change during the course of their hospital 
admission in response to their experience of the admission e.g. the 
perception that staff had a lack of knowledge about Parkinson's disease 
was developed in response to the care that the participant had received 
during the course of their admission.  
 
Anxiety associated with a hospital admission is a recognised 
phenomenon that can occur in any patient and can be caused by illness 
stressors (e.g. pain and discomfort) and hospital stressors (e.g. unfamiliar 
environment or loss of independence) (Scott, 2004). Illness stressors and 
generic hospital stressors may have contributed to the anxiety that the 
study participants experienced during their admission but they did not 
discuss examples of these stressors when they were describing the 
causes of their anxiety. The specific causes described were related to the 
management of medicines by hospital staff and perceptions of staff 
knowledge about Parkinson's disease.  
 
The anxiety experienced by some people with Parkinson's disease during 
a hospital admission may be influenced by a pre-existing anxiety 
disorder. Anxiety is a non-motor feature of Parkinson’s disease 
(discussed in section 1.3.2.1.3) that affects more that 40% of people with 
  - 157 -
the disease (Marsh, 2000; Quelhas & Costa, 2009; Walsh & Bennett, 
2001). A patient's pre-existing anxiety disorder could affect their 
perceptions of a hospital admission if their anxiety is exacerbated by 
hospital or illness stressors or concerns about the management of their 
medicines. Some people with Parkinson's disease may develop a panic 
attack when their levodopa based medicines are 'wearing off', therefore 
they could develop a panic attack during their hospital admission if doses 
of these medicines are omitted or delayed. The experience of a panic 
attack could adversely affect a patient's perception of their hospital 
admission.  
 
The effect that a pre-existing anxiety disorder could have on a 
participant's response to a situation was acknowledged by the researcher 
but it is important to note that most of the study participants highlighted 
the same causes of anxiety associated with a hospital admission. 
 
6.2.2 Patient anxiety related to their ability to maintain their usual 
medication routine during a hospital admission 
The data in section 5.2.1.1 suggests that prior to admission each of the 
study participants had a medication regimen that had been developed to 
manage their features of Parkinson’s disease. This finding reflects that 
each person with Parkinson's disease has an individualised medication 
regimen that has been developed to manage their motor and non-motor 
features of the disease (discussed in section 1.5) (The National 
Collaborating Centre for Chronic Conditions, 2006). 
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Participants were concerned prior to admission to hospital about whether 
hospital staff and procedures would be able to help them maintain their 
usual antiparkinsonian medication regimen during their admission and 
therefore maintain control of their features of Parkinson's disease. This 
finding has not previously been identified in a research study, but is 
consistent with information in publications associated with the ‘Get it on 
time’ campaign that suggest that going into hospital can cause people 
with Parkinson's disease to feel anxious about how their medicines will be 
managed during their admission (Parkinson's UK, 2006). The implication 
of this finding on local practice is that further work is required to develop 
methods to reassure patients that they will be supported to maintain their 
usual medication regimen during their hospital admission. 
 
Patient anxiety at the point of admission to hospital and throughout the 
admission due to concerns about whether medication doses will be 
administered at appropriate times reflects concerns about the accuracy of 
timings of administration of doses that have been highlighted by 
Parkinson’s UK and the equivalent European and American specialist 
interest groups for many years (American Parkinson Disease Association, 
2011; European Parkinson’s Disease Association, n.d; Parkinson's UK, 
2006).  
 
There is a paucity of published data that explores patients' perceptions 
about the accuracy of timings of administration of their doses of 
antiparkinsonian medicines and the perceived effects of deviations from 
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dosage times. The theory generated by this study that some patients 
thought that they had received doses of their medicines at times that 
differed from their usual routine and experienced deterioration in 
symptom control helps to provide rich insights about this topic. The 
finding suggests that further work is required to try to ensure that 
medicines are administered at the correct time. 
 
The concerns expressed by the participants in this grounded theory study 
that they had not been administered all of their medication doses at the 
correct times are consistent with the findings of a small number of 
quantitative studies that suggest that patients may not be administered 
their antiparkinsonian medications at the correct time. A national survey 
conducted by Parkinson's UK of over 13,000 people with Parkinson's 
disease highlighted that 40% of patients admitted to hospital in the five 
years prior to 2007 did not get every dose of their antiparkinsonian 
medicines on time during their hospital admission (Parkinson’s Disease 
Society, 2008b). Mappilakkandy et al. (2011) and Derry et al. (2010) also 
highlighted that some patients received doses of antiparkinsonian 
medications at inappropriate times. Mappilakkandy et al. (2011) identified 
that 73% of the patients considered in their study did not get every dose 
of their antiparkinsonian medicines on time during their hospital 
admission whereas Derry et al. (2010) reported that doses of 
antiparkinsonian medicines were administered at incorrect times in only 
26% of the patients considered in their study. Neither study reported the 
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reasons for administration of medicines at times that differed from a 
patient's usual regimen. 
 
The administration of doses of antiparkinsonian medication at times that 
do not correspond with a patient's usual routine is an internationally 
recognised problem. Hou et al. (2012) considered medication 
administration in patients with idiopathic Parkinson’s disease that were 
admitted to a hospital in America during a two year period. The results 
suggest that out of a total of 3873 doses of antiparkinsonian medications, 
322 doses were omitted, 300 doses were given thirty minutes or more 
after the dose of medication was due and 53 doses were given more than 
thirty minutes before the dose of medication was due. The reasons for 
these deviations from usual routine were not reported by the researchers.  
 
Administration of medication by hospital staff at times that do not 
correlate with a patient's usual routine can also occur for patients with 
other chronic diseases. For example, the administration of doses of 
insulin at inappropriate times has been reported by insulin controlled 
diabetic patients admitted to hospital. The National Diabetes Inpatient 
Audit (NHS Diabetes, 2010) highlighted that some diabetic patients 
admitted to hospital were receiving insulin doses at times that did not 
correlate with their meals. The audit results suggested that this had led to 
complications for some diabetic patients admitted to hospital. Currently 
there are no studies that explore the perceptions of patients with other 
chronic diseases about the accuracy of times of administration of 
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medication doses during a hospital admission. Although this is outside 
the scope of this study, it is possible that patients with other chronic 
diseases that have a strictly controlled medication regimen may feel 
anxious about whether their medicines will be administered at the correct 
time during a hospital admission which suggests implications for further 
research. 
 
The theory discussed in chapter 5 suggests that those participants that 
prompted staff when a dose of medication was due thought that this 
action had allowed then to receive most of their medication doses at the 
correct times. The use of prompts to make a nurse aware when a dose of 
medication is required is consistent with suggestions made by 
Parkinson’s UK that audible prompts for nurses (e.g. pill timers) may 
support patients to receive doses of their medications at the correct times 
(Parkinson's UK, 2006).  
 
Some people with Parkinson's disease (e.g. those that are cognitively 
impaired, confused or sedated) will be unable to prompt staff when a 
dose of medication is due. These patients are reliant on members of the 
nursing staff to administer their medications at the correct time. The 
insight provided by the study participants that they were concerned that 
members of the nursing staff may not remember to administer their 
medicines at the correct time without being prompted suggest that further 
work is required to explore methods that can be used to support nurses to 
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administer medicines at times that are different to the normal ward 
medication rounds. 
 
The act of prompting staff when a dose of medication was due allowed 
many participants to believe that they were controlling when they 
received doses of their medicines. The feeling of a loss of control is 
experienced by many people when they are admitted to hospital and is a 
recognised stressor associated with a hospital admission (Alder et al., 
2004; Bowman et al., 1992). There are many factors that can cause a 
patient admitted to hospital to perceive that they are no longer in control 
of a situation including not knowing what to expect during the admission 
or the unfamiliar nature of any medical and surgical procedures that the 
patient might experience (Alder et al., 2004; Powell & Johnston, 2007; 
Vogele, 2007). Patients with Parkinson's disease may also feel that they 
have lost control of the times that doses of their medications will be 
administered if they have to rely on others to administer their medications 
(Parkinson's UK, 2010; Sadler, 2007). The act of prompting staff allows 
the patient to feel that they have regained control and believe that their 
medications will be administered at the correct times. 
 
6.2.3 Patient anxiety related to the accuracy of prescriptions 
There is currently limited information available about whether patients 
with Parkinson's disease think that the prescriptions written for their 
antiparkinsonian medicines by hospital prescribers accurately reflect their 
usual regimen. The available information is provided by Buetow et al. 
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(2010) (study discussed in section 2.7.1) who suggested that one 
participant in their study believed that a patient's hospital prescription did 
not accurately reflect their usual medication regimen. The findings of this 
current grounded theory study that patients with Parkinson's disease may 
become anxious prior to or on admission to hospital due to concerns 
about whether their prescription would reflect their usual regimen 
develops existing knowledge about this topic and highlights that further 
work is required to identify methods to address these concerns.  
 
The anxiety experienced by patients with Parkinson's disease due to 
concerns about the accuracy of their hospital prescription may also be felt 
by patients with other chronic diseases that believe that they need to 
have their medicines administered at specific times to maintain symptom 
control but there is a paucity of information about this topic. Although 
outside the scope of this study, this area may require further exploration 
to determine if patients with other chronic diseases that are admitted to 
hospital experience anxiety about the accuracy of prescriptions for their 
medicines. 
 
A small number of quantitative studies have considered the accuracy of 
prescribing of antiparkinsonian medications when a person with 
Parkinson's disease is admitted to hospital. These studies considered 
whether all of a patient's usual antiparkinsonian medications were 
prescribed when they were admitted to hospital and for those medicines 
that were prescribed, the researchers collected data about whether the 
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prescribed doses and dose times reflected the routine that the patient had 
prior to admission to hospital. 
 
Magdalinou et al. (2007) (study discussed in section 2.7.1) identified that 
74% of patients with Parkinson's disease admitted to a district general 
hospital in the UK during a twelve month period had their 
antiparkinsonian medications inappropriately prescribed or omitted during 
their hospital admission. The proportion of these patients that had 
medications prescribed inappropriately is unknown. The term 
inappropriately prescribed included incorrectly stopping the medication 
when the patient was admitted to hospital. 
 
Mappilakkandy et al. (2011) conducted a retrospective case note audit for 
patients with Parkinson's disease admitted to a large teaching hospital in 
the UK during a three month period. The authors do not report the 
reasons why patients were admitted to the hospital. The researchers 
identified 41 patients that met the study inclusion criteria and although 
89% of these patients had their usual antiparkinsonian medications 
prescribed when they were admitted to hospital only 48% had the correct 
times prescribed for their doses of antiparkinsonian medications. The 
causes of these discrepancies were not reported.  
 
The findings of these quantitative studies suggest that some patients are 
not prescribed their antiparkinsonian medications when they are admitted 
to hospital and those prescriptions that are written may not reflect a 
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patient's usual medication regimen. These findings demonstrate that the 
concerns expressed by the participants in this current qualitative study 
about whether the prescriptions for their antiparkinsonian medications 
would accurately reflect their usual regimen, are consistent with issues 
that have been previously highlighted in quantitative studies. 
 
The studies conducted by Magdalinou et al. (2007) and Mappilakkandy et 
al. (2011) were small scale studies considering patients with one disease 
admitted to one hospital. A literature search for this study has identified 
that there is currently a lack of national data about the incidence of 
prescribing errors associated with antiparkinsonian medications when a 
patient is admitted to hospital. Parkinson's UK has facilitated national 
audits that consider whether patients are administered their medications 
on time but these do not specifically discuss if the medications were 
prescribed correctly (Parkinson's UK, 2010).  
 
National audits that consider prescribing errors associated with medicines 
used in the management of other chronic diseases have highlighted that 
patients may experience inadvertent deviations in their medication 
regimen when they are admitted to hospital. For example, the National 
Diabetes Inpatient Audit in 2010 considered the prescription charts of 
over 12,000 inpatients with diabetes and identified that a quarter of the 
charts had prescription errors (NHS Diabetes, 2010) which included 
patients' usual medications being prescribed at the incorrect dose or dose 
frequency. The incidence of inadvertent deviations from a patient's usual 
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medication regimen has also been considered for adult patients with any 
disease state admitted to hospital and it is estimated that nationally 
between 30% and 70% of all hospital prescriptions contain at least one 
unintentional deviation from the patient's medication regimen that they 
used prior to admission to hospital (National Institute for Health and 
Clinical Excellence and National Patient Safety Agency, 2007). 
 
6.2.3.1 What are the sources of the patients' anxiety related to their 
prescriptions? 
Participants who felt anxious about whether their prescriptions would 
reflect their usual medication regimen included those who were being 
admitted to hospital for the first time since their diagnosis with Parkinson's 
disease as well as those with a previous experience of a hospital 
admission since diagnosis with the disease. Patients with Parkinson's 
disease can be admitted to hospital many times during the course of their 
disease and common causes of admission for these patients include 
medication adjustment to manage the motor and non-motor features of 
Parkinson's disease, falls, infection (typically urinary tract or pneumonia), 
cardiac conditions, gastrointestinal disorders and psychiatric conditions 
(Hou et al., 2012; Temlett & Thompson, 2006; Woodford & Walker, 2005). 
 
Those participants who thought that during a previous hospital admission 
they had not been prescribed their usual medications or believed that 
their doses had been prescribed at times that did not match their usual 
regimen were anxious because they were concerned that the same 
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problems could occur during this current admission. Many of these 
participants suggested that previous deviations from their usual routine 
had caused them to lose symptomatic control of the motor features of 
their disease (e.g. developed tremor or increased frequency of 'on/off' 
fluctuations) and were worried that this could happen again. 
 
Participants without experience of a hospital admission since diagnosis 
with Parkinson's disease were unable to explain the causes of their 
doubts related to whether their medication regimen would be prescribed 
correctly by hospital prescribers. A possible explanation could be related 
to information about prescribing errors that they had seen in the media. 
Another possible cause of their concern could be reading publications by 
Parkinson's UK (Parkinson’s Disease Society, 2008a) which include 
information about patients' experiences of antiparkinsonian medications 
being inadvertently stopped or prescribed incorrectly when they were 
admitted to hospital. 
 
The national media have issued many reports about problems with 
patient care in NHS organisations. Some of these have included 
information about errors in medication prescribing and could undermine 
public confidence in NHS prescribers. An example of a study related to 
prescribing errors which was reported in the national media is the EQUIP 
study (Dornan et al., 2009). This study explored the causes of prescribing 
errors made by foundation doctor trainees working in NHS hospitals. The 
study found that out of 124,260 medication prescriptions there were 
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11,077 errors (error rate of 8.9%) with less than 2% of these errors being 
potentially lethal for a patient. The findings of the PRACtICe study (Avery 
et al., 2012) which considered GP prescribing were also published in the 
national media. This study examined 6,048 medication prescriptions and 
researchers found that 5% of prescriptions had either a prescribing or 
monitoring error. The reporting of studies like these in the media could 
lead to people being uncertain about whether their medicines will be 
prescribed correctly during a hospital admission and this may lead to 
anxiety. For people with Parkinson's disease who are already anxious 
about how their medicines will be managed during a hospital admission 
this could further increase their anxiety. 
 
The specialist interest group Parkinson’s UK has issued publications 
(Parkinson’s Disease Society, 2008a) for patients that are going to be 
admitted to hospital which acknowledge that going into hospital can be a 
stressful time for a patient with Parkinson's disease and include guidance 
about activities that the patient (or carer) can undertake to ensure that the 
patient's medicines are prescribed correctly when they are admitted to 
hospital and administered at the correct times. These publications aim to 
prepare people with Parkinson's disease for the experience of going into 
hospital; however the 'Get it on time' campaign includes examples of 
negative experiences of hospital admissions reported by people with 
Parkinson's disease and this information may cause a person with the 
disease to feel anxious about how their antiparkinsonian medicines will 
be managed during their hospital admission. Also, people who attend 
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local group meetings hosted by Parkinson’s UK may become anxious 
about what to expect when they are admitted to hospital because they 
have heard accounts of negative experiences of hospital admissions from 
other group members. 
 
6.2.3.2 What action strategies are utilised in response to this cause 
of a patient's anxiety? 
Many participants were concerned about an error occurring whilst their 
prescription chart was being written and responded by becoming actively 
involved in the prescribing process. They informed the prescriber about 
their usual medication regimen (medication, formulation, dose and dose 
times) and ensured that this was prescribed. Becoming involved in the 
prescribing process is a problem focused coping strategy (Lazarus & 
Follkman, 1984) that was utilised by participants to minimise anxiety 
associated with the prescribing process. The participants had recognised 
that there was a risk that their medications may not be prescribed 
accurately, considered the problems that could occur during the 
prescribing process and developed solutions to address these problems. 
These solutions included advising prescribers about their medication 
regimen and ensuring that the prescription was written correctly.  
 
Participants thought that informing the prescriber of their usual regimen 
increased the likelihood that their prescription would accurately reflect this 
regimen and this allowed them to feel less anxious about the situation. 
Their expectation that being involved in the prescribing process would 
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reduce the number of errors in their prescription is consistent with the 
opinion of the Medicines Partnership Centre and NICE who proposed that 
patient involvement in both the prescribing process and the process of 
medicines reconciliation can prevent errors occurring and detect any 
errors that do occur (Levenson, 2003; National Institute for Health and 
Clinical Excellence and National Patient Safety Agency, 2007). 
 
Preparing a prescription that accurately reflects a patient's usual 
medication regimen requires the prescriber to have access to information 
about this regimen. Patients and their carers are often best placed to 
provide this information due to their knowledge about the patient's usual 
medication regimen. When the study participants were admitted to 
hospital they all had information about their medication regimen with them 
but this information was presented in a variety of formats including a copy 
of a repeat prescription slip, a list of medication written by the patient (or 
their carer) or labelled medication boxes. This is consistent with 
Parkinson's UK's recommendation that people with Parkinson's disease 
should take information about their medication regimen with them when 
they are going into hospital (Parkinson’s Disease Society, 2008a). Many 
PDNSs and GPs also advise their patients to document their current 
medication regimen and share this information with hospital staff.  
 
In summary, participants were concerned about the ability of hospital 
prescribers to prepare a prescription which accurately reflected their 
usual medication regimen. The participants reported that their doubts 
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about whether their prescription would reflect their existing medication 
regimen caused then to feel anxious and explained that assisting the 
prescriber to write an accurate prescription helped to reduce their anxiety. 
These findings have not previously been identified in a research study 
and help to develop existing knowledge about patients' perceptions of the 
prescribing of antiparkinsonian medication when a patient is admitted to 
hospital. 
 
Some patients with Parkinson's disease may not be able to inform 
prescribers about their usual medication regimen when they are admitted 
to hospital due to cognitive impairment or the nature of the condition that 
has caused their admission. The insight that patients may be concerned 
regarding the information that a prescriber could obtain about their 
medication regimen if they cannot advise the prescriber suggests that this 
area could be explored further to improve the accuracy of information 
available from other sources about a patient's medication regimen. 
 
6.2.3.3  Medicines reconciliation  
The insight that a patient's anxiety related to whether their prescription 
accurately reflect their usual medication regimen may be reduced if they 
knew that a healthcare professional had conducted a "second check" (#1) 
on their prescription has not previously been identified in research 
studies. This finding suggests that the process of medicines reconciliation 
(discussed in section 2.7.2) may offer a method to provide reassurance 
for patients because it involves healthcare professionals verifying that the 
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patient's hospital prescription matches their usual medication regimen. 
The process involves assessing whether the hospital prescription 
matches a patient's usual medication, formulation, dose and timings of 
these doses. Since the introduction of medicines reconciliation it has 
been demonstrated that this process allows the identification of 
unintentional deviations between the medicines prescribed when a 
patient is admitted to hospital and those taken by the patient prior to 
admission (Dutton et al., 2003; Gray et al., 2007; Terry et al., 2010).  
 
The findings of this study suggest that participants were unaware of the 
process of medicines reconciliation. Raising the awareness of people with 
Parkinson's disease that medicines reconciliation can support them to 
maintain their usual medication regimen during a hospital admission may 
offer reassurance for some patients. 
 
6.2.4  Patient anxiety related to their ability to access their 
medications  
For a patient to receive a dose of their medication they need to have 
access to their medicines. This requires a supply of each medicine to be 
available on the ward and when a patient relies on a nurse to administer 
their medication the patient also requires access to a nurse at the time 
that a dose of medication is due. The following sections explore the 
reported causes of participants' concerns related to 'access to 
antiparkinsonian medicines'. 
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6.2.4.1 Availability of antiparkinsonian medicines in a ward area 
The theory discussed in chapter 5 suggests that patients may feel 
anxious due to concerns about the availability of their antiparkinsonian 
medications during their hospital admission. Participants were worried 
that there could be an interruption to their supply of medication during 
their admission. This anxiety was experienced both by participants that 
had previous experience of their antiparkinsonian medicines not being 
available during a hospital admission and those who had not previously 
been admitted to hospital since their diagnosis with Parkinson's disease. 
Participants with previous experience of missing doses of their 
antiparkinsonian medicines during a hospital admission due to a lack of 
availability of the medicines were anxious that this may occur again. 
Other participants were concerned about whether their specialist 
medications would be available within a ward area that did not specialise 
in the care of patients with Parkinson's disease. 
 
Some participants reported that they had missed doses of their 
antiparkinsonian medication during the current hospital admission due to 
a lack of availability of these medications on the ward and thought that 
their symptoms had deteriorated due to the omitted doses. These 
changes in symptom control were not validated by a healthcare 
professional. 
 
There are currently no published studies that provide a detailed insight 
into the perceptions of patients with Parkinson’s disease about the 
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availability of their medications during a hospital admission. Elphick, 
Bolam, et al. (2006) reported in an abstract for a conference that the 
results of their study which issued questionnaires to members of a 
specific branch of Parkinson's UK showed that patients had "anxiety 
regarding medication provision and potential or actual worsening of 
function consequent upon sub-optimal medication provision" (Elphick, 
Bolam, et al., 2006). There is no further information provided about the 
causes of these anxieties. The rich insight provided by the participants in 
this current grounded theory study develops the limited existing 
knowledge that people with Parkinson's disease may be anxious about 
the availability of their medications during a hospital admission. 
 
Quantitative studies have shown that some patients have missed doses 
of their antiparkinsonian medications or had administration of their doses 
delayed due to a lack of availability of the appropriate antiparkinsonian 
medication when a dose was required (Derry et al., 2010; Elphick, 
Madan, et al., 2006; Magdalinou et al., 2007; Mappilakkandy et al., 2011). 
Mappilakkandy et al. (2011) reviewed the case notes of 41 patients with 
Parkinson's disease and identified that 48% of patients had a delay in 
receiving their first dose of medication. This delay was mainly caused by 
a lack of availability of the medicine. Lack of availability was also 
identified as a cause of omission or delayed administration of doses by 
Derry et al. (2010) (study discussed in section 2.7.3). They considered 
the total number of prescribed doses of antiparkinsonian medications that 
should have been administered to 59 patients and reported that 12% of 
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doses were omitted or delayed due to a lack of availability of the 
medicine. These quantitative studies suggest that patients can 
experience missed or delayed doses of antiparkinsonian medications due 
to lack of availability of medications which is consistent with the concerns 
expressed by participants in this grounded theory study. 
 
The omission or delayed administration of doses of medication due to the 
medicine not being available at the time that the patient requires the dose 
has been identified by the NPSA as a potential cause of harm to a 
patient. The NPSA issued a Rapid Response Alert (National Patient 
Safety Agency, 2010) directed at healthcare organisations to ensure that 
these organisations developed action plans to reduce the incidence of 
omitted and delayed doses and to raise the awareness of healthcare 
professionals about the possible effects of missed and delayed doses of 
medicines. This alert highlighted that medicines may not be available 
when a patient is admitted to hospital, following initiation of a new 
treatment or when existing supplies run out during a patient's admission. 
The alert stated that NHS organisations must develop a “list of critical 
medicines where timeliness of administration is crucial. This list should 
include … medicines for Parkinson’s disease” (National Patient Safety 
Agency, 2010). Organisations were also advised to “review and, where 
necessary, make changes to systems for the supply of critical medicines 
within and out-of-hours to minimise risks” (National Patient Safety 
Agency, 2010).  
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The critical list developed for use within LTHT included antiparkinsonian 
medications. The contents of this list were briefed to all staff within LTHT 
and staff were advised about the steps that should be taken to avoid 
missing or delaying doses of these medicines. The theory detailed in 
chapter 5 suggests that despite these actions being taken, some of the 
study participants thought that they had missed doses of their 
medications during this admission due to the medicines not being 
available. These findings suggest that further research could be 
conducted to explore the reasons why patients do not receive doses of 
their medications during a hospital admission. 
 
Participants utilised problem focused coping strategies in response to 
their anxiety about the availability of antiparkinsonian medicines during 
their hospital admission. They brought a supply of their own medicines 
into the hospital on admission and expected hospital staff to administer 
their medicine doses from this supply. This is reflective of the advice 
given by the specialist interest group Parkinson's UK that people with 
Parkinson's disease should take their own medicines with them into 
hospital to maintain a supply of these medicines and avoid delays in 
receiving the first dose of medication after admission to hospital 
(Parkinson’s Disease Society, 2008a). Despite expecting to use their own 
medicines during the admission, most participants explained that their 
own supply of medicines had not been used by ward staff. 
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6.2.4.2 Self-administration of medicines during a hospital admission 
The small number of participants in this study who would choose to use 
self-administration of medicines schemes during their hospital admission 
is consistent with the findings of the study conducted by Elphick, Madan, 
et al. (2006) who highlighted that only 5.8% of their study participants 
self-administered medication at any point during their hospital admission. 
Elphick, Madan, et al. (2006) did not report the reasons for the low 
number of patients who self-administered their medication. 
Mappilakkandy et al. (2011) considered the subset of their study 
participants who were able to self-administer medication and found that 
only 25% of these patients self-administered their medication. It is unclear 
if this low uptake is due to patient choice, lack of understanding about 
how the scheme would benefit the patient or a lack of awareness of the 
possibility to self-administer their medications. 
 
The low uptake of self-administration of medication by participants in this 
study is not consistent with the opinion suggested by Parkinson's UK 
(2006) that many people with Parkinson's disease would choose to self-
administer their medication during a hospital admission. The findings of 
this study suggest that the low use of the self-administration of 
medication scheme may be due to many participants being unaware of 
the availability of the scheme within LTHT. The implications of this finding 
is that further work is required to raise the awareness of patients about 
these schemes within LTHT and to promote the associated benefits of 
these schemes for patients with Parkinson's disease. 
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The patient insights discussed in chapter 5 suggest that some 
participants did not want to self-administer their medication due to the 
nature of the illness which had caused them to be admitted to hospital or 
because they would not feel confident to administer dose of their 
medications without their usual support tools (e.g. compliance aid or 
reminder chart). These insights have not previously been identified for 
patients with Parkinson's disease and suggest that this area requires 
further investigation to support the identification of any perceived barriers 
preventing patients from self-administering medicines and methods that 
healthcare professionals could use to address these barriers. 
 
The perceived benefits of self-administration for people with Parkinson's 
disease described by the participants (discussed in section 5.2.3.3) are 
consistent with those proposed by Parkinson's UK and some healthcare 
professionals that manage the care of patient with Parkinson's disease 
(Derry et al., 2010; Elphick, Madan, et al., 2006; Mappilakkandy et al., 
2011; Parkinson's UK, 2006; Sadler, 2007). The insights from the study 
participants add to the knowledge base about the role of self-
administration of medication in supporting patients with Parkinson's 
disease to maintain their medication regimen during a hospital admission. 
 
A large proportion of people with Parkinson's disease admitted to hospital 
may not be considered suitable to self-administer their medications either 
because the non-motor features of their Parkinson's disease have 
impaired their cognitive function or the reason for their hospital admission 
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leads to a mental or physical incapacity that prevents the patient being 
able to safely administer their own medications (Sadler, 2007). These 
patients are reliant on nursing staff to administer their medications at the 
correct time. As discussed above, further work is required to explore 
methods that can be used to support nurses to administer these patients' 
medicines at times that are different to the normal ward medication 
rounds.  
 
6.2.5 Patient anxiety related to the knowledge of ward staff about 
Parkinson's disease 
The theory discussed in chapter 5 explains that participants thought that 
ward staff (nurses, doctors and some allied healthcare professionals) did 
not have knowledge about the role of medicines in managing the 
symptoms of Parkinson's disease and the importance of administering 
medication at specific times. It is important to note that only one of the 
participants had been admitted to a ward where the clinical speciality was 
managing the care of patients with neurological conditions. All of the 
other participants were providing information about their perceptions of 
the knowledge about Parkinson's disease of staff that do not specialise in 
managing the care of patients with this condition.  
 
The participants' perception that some healthcare staff are unaware of the 
importance of administering the correct dose of antiparkinsonian 
medication at the correct time is consistent with the perceptions of the 
patients and carers that participated in a qualitative study conducted by 
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Buetow et al. (2010) which explored the perceptions of patients with 
Parkinson's disease (and their carers) about medication timing errors in 
hospital and community settings in New Zealand. The study design is 
discussed in section 2.7.1. Buetow et al. (2010) reported that some of the 
participants were concerned about staff knowledge related to Parkinson's 
disease medicines and the importance of administering them at the 
correct time. One participant reported that staff "were not aware, I think, 
of the need for Parkinson people to have their medication at a given time" 
(Buetow et al., 2010 pp 3). 
 
Concerns about the knowledge of ward staff about the medicines 
prescribed for patients with Parkinson's disease have also been raised by 
PDNSs. The results of a national survey of PDNSs highlighted that 70% 
of the respondents thought that patients would not receive their 
medication at the correct time during a hospital stay and they suggested 
that the main reason that these doses would not be administered on time 
was "a lack of understanding about Parkinson's medication among ward 
staff" (Agnew, 2006 pp 8). 
 
The concerns expressed by participants in this current grounded theory 
study about some healthcare professionals having a lack of knowledge 
about the medicines used to manage the symptoms of Parkinson's 
disease and the importance of administering these medicines at specific 
times are consistent with the concerns expressed by patients with 
Parkinson's disease who participated in a survey conducted by The 
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National Council for Palliative Care (2009). This survey considered the 
opinions of patients with motor neurone disease (MND), multiple sclerosis 
(MS) or Parkinson's disease about their experience of a hospital 
admission. The purpose of this survey was to collect information about 
the experience of a hospital admission for patients in the palliative stage 
of one of these chronic neurological conditions. The validity of the data 
from this survey cannot be rigorously assessed because there is limited 
information provided about the method of recruitment of participants, 
questions, response rate and the methods used to analyse the data.  
 
The survey questions were designed to collect information about each 
participant's experience of a hospital admission and included questions 
about "how staff handled their medicine" and "whether the participant was 
visited by a specialist nurse or neurologist during their stay" (The National 
Council for Palliative Care, 2009). The respondents included 90 patients 
with Parkinson's disease, 186 patients with MS and 170 patients with 
MND. The replies from patients with Parkinson's disease and MS were 
presented together and 52 respondents reported that they believed that 
staff had a "poor understanding of the condition" (The National Council 
for Palliative Care, 2009). The authors report that for patients with 
Parkinson's disease these concerns were related to a lack of staff 
awareness of the importance of a patient receiving the correct medication 
at the correct dose at the correct time. The data suggested that some 
respondents were concerned about the awareness that NHS staff had 
about the management of patients with chronic neurological conditions. 
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A recent National Audit Office (2011) report that reviewed the health and 
social care services for adults with neurological conditions (resulting from 
disease rather than head injuries) highlighted that staff working in areas 
that do not specialise in the management of neurological conditions have 
a limited knowledge about Parkinson's disease. During the preparation of 
the report the National Audit Office conducted research into the 
experiences of patients with neurological conditions of accessing and 
using health services (both community and hospital setting). The 
researchers conducted focus groups with people with Parkinson's 
disease and MS and semi-structured interviews with people with MND. 
The information collected during these focus groups and interviews is not 
available for review at this time.  
 
The authors of the report highlighted areas of good practice within the 
NHS as well as areas that require development and the report states that 
patients with neurological conditions admitted to hospitals are "usually 
cared for by health professionals without neurological knowledge and 
experience" and concludes that "this increased the risk of poor patient 
outcomes" (National Audit Office, 2011). The report highlighted an 
association between a lack of knowledge about Parkinson's disease and 
failure to prescribe antiparkinsonian medication at the correct times or 
administer doses at the appropriate times which reflects the perceptions 
of the participants in this current study.  
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Participants in this current grounded theory study were concerned that 
they may not receive their medications at their individualised times 
because ward staff may not understand why they need their medicines at 
specific times. The theory detailed in chapter 5 suggests that patients 
wanted reassurance that the staff members managing their care were 
aware of the symptoms of Parkinson's disease, the types of medications 
used to manage the disease, the importance of administering medicines 
at individualised times and the complications that can occur when doses 
of medications are omitted or delayed. The implications of these findings 
is that work needs to be undertaken to improve staff awareness of the 
medicines related needs of patients with Parkinson's disease.  
 
The insight gained from this study that patients with Parkinson's disease 
may feel anxious when they think that the people caring for them are not 
knowledgeable about their condition could possibly be translated to 
people with other chronic diseases that require the use of specialist 
medication to manage their symptoms (e.g. myasthenia gravis). Further 
research is required to identify if this is a perception that is shared by 
people with other chronic diseases when they are admitted to hospital. 
 
6.2.5.1 The generalist versus the specialist practitioner 
The participants expected that all ward staff caring for them would have a 
basic understanding about the medicine related needs of a patient with 
Parkinson's disease, including the requirement to administer the correct 
dose of antiparkinsonian medication at the correct time. They also 
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expected that a PDNS should have a detailed knowledge about the 
disease and be able to use this knowledge to advise and support ward 
staff caring for patients with Parkinson's disease. 
 
The distinction made by the participants between the knowledge about 
Parkinson's disease that they expected a general ward nurse to have 
compared to a PDNS was reflective of the differences in knowledge and 
skills that the Royal College of Nursing (RCN) expects from a hospital 
ward nurse and a PDNS. The RCN expects that hospital ward nurses 
have a broad range of skills to support the care of a patient during their 
hospital admission. These nurses would not be expected to have a 
detailed knowledge about the care needs of all patients with chronic 
diseases. The RCN expects nurse specialists to be advanced 
practitioners and have a detailed knowledge about the management of 
patients with the disease or condition in which they are an expert (The 
Parkinson’s Disease Nurse Specialist Association et al., 2008). 
 
Most ward nurses will develop a fundamental knowledge about the 
management of conditions that they commonly encounter within the 
clinical areas in which they work, therefore it could be assumed that 
nurses working in areas where patients with Parkinson's disease are 
frequently admitted may have knowledge about the management of the 
disease. Patients with Parkinson's disease may frequently be 
encountered by nurses working in: 
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x medical admissions units - this is the route by which most patients 
with medical complaints are admitted to the hospital, 
x care of the older person units, and, 
x neurology wards. 
 
Nurses working in areas where patients with Parkinson's disease are 
rarely admitted may have limited knowledge about the medicine related 
needs of patients with this disease. This opinion was expressed by 
Cotton and Heister (2012) in an article that discusses the possible care 
needs of patients with Parkinson's disease during a hospital admission. 
The article highlighted to nurses the role of individualised medication 
regimens in this patient group and the importance of administering 
medications at specific times (Cotton & Heister, 2012).  
 
The perceptions of ward nurses about their knowledge of the care and 
medicine related needs of patients with Parkinson's disease were not 
explored in this current study. This is an area for future research which 
could explore the perceptions of ward staff about their ability to care for 
patients with diseases that they are unfamiliar with. 
 
6.2.6 Patient trust in healthcare professionals 
The insight that the participants trusted their neurologist and PDNS but 
did not have trust in the ward staff managing their care during the hospital 
admission has not previously been identified. The data also suggested 
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that participants trusted a pharmacist to ensure that they were receiving 
the correct medications during their hospital admission.  
 
Trust is an essential component of a relationship between a patient and a 
healthcare professional (Bell & Duffy, 2009; Rowe & Calnan, 2006). The 
participants' trust in their neurologists and PDNSs and ward pharmacists 
appeared to be related to their confidence in the knowledge and skills of 
these professionals and a belief that the professional will act in their best 
interest. These factors affecting a patient's trust in healthcare 
professionals are consistent with those articulated by other patients with 
chronic diseases and factors identified by healthcare professionals and 
social scientists that may influence a patient's trust (Bell & Duffy, 2009; 
Burkitt-Wright et al., 2004; Elst et al., 2012; McKinstry et al., 2006; Rowe 
& Calnan, 2006).  
 
Some of the participants appeared to have what Rowe and Calnan (2006) 
describe as "blind trust in a doctor 'who knows best'" in relation to their 
neurologist and PDNS because they took their medication as they had 
been advised to by their neurologist and did not participate in the decision 
making processes related to developing a treatment plan to manage the 
features of their Parkinson's disease. This type of trust reflects the 
historical approach to healthcare in the UK where patients complied with 
the requests of their doctor because their doctor was considered to be an 
expert in the management of medical and surgical conditions. Other 
participants suggested that they had contributed to the decision making 
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process about their medication management plan, which is known as 
concordance (Cushing & Metcalfe, 2007; Horne et al., 2005; Weiss & 
Britten, 2003) and is part of the patient-centred model of healthcare that 
NHS organisations are striving to achieve (Department of Health, 2008, 
2010). 
 
The theory in chapter 5 details behaviours and attitudes that suggest that 
some participants did not trust the ward staff managing their care during 
their hospital admission. The participants demonstrated behaviours which 
Calnan and Rowe (2005) described as behaviours which suggest that 
people have "low trust" in a person or situation including "constant 
monitoring … [and]… request for a second opinion or alternative source 
of treatment". The participants also provided evidence of characteristics 
that Calnan and Rowe (2005) describe as a "low trust" attitude which 
include "high levels of anxiety, suspicion and scepticism [and belief that] 
limits to [staff] knowledge are not appropriate". 
 
The lack of patient trust in ward staff appeared to be related to patients 
doubting the knowledge and skills of the healthcare professionals related 
to Parkinson's disease and concerns about the reliability of the staff to 
administer a patient's antiparkinsonian medications at the correct times. 
These are consistent with factors that would adversely affect a patient's 
trust in healthcare professionals (Rowe & Calnan, 2006). Patient concern 
about errors, including prescribing errors, can affect a patient's trust in 
healthcare professionals. This may be a cause of reduced trust for those 
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participants in this study who were worried about prescribers failing to 
correctly prescribe their usual medication regimen. 
 
The implications of these findings suggest that further research could be 
undertaken to consider the factors that support and reduce the trust of 
patients with Parkinson's disease for their neurologist and PDNS and the 
ward staff (doctors, nurses and allied healthcare professionals) that 
manage their care during a hospital admission.  
 
6.2.7 Utilising expertise 
One of the strategies that participants suggested they would use to 
reduce their anxiety related to the management of their medicines by 
hospital staff was to involve a PDNS in their care during the hospital 
admission. The participants considered a PDNS to be an expert in 
Parkinson's disease and hoped to use the PDNS's expertise to support 
ward staff.  
 
The recognised activities of a PDNS (The Parkinson’s Disease Nurse 
Specialist Association et al., 2008) who is working in a hospital include: 
 
a) inform ward staff about the features of Parkinson's disease and the 
restrictions in activities that a patient may experience during an 'off' 
period, 
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b) inform ward staff about the specific antiparkinsonian medication 
that a patient uses to manage their symptoms and the medications 
that could be used to help that patient if they enter an 'off' period, 
c) raise ward staff awareness of the importance of administering a 
patient's medications at specific times which may not coincide with 
the ward medication rounds, 
d) advise ward staff about administration techniques for medications 
they may not be familiar with (e.g. apomorphine infusion), 
e) advise ward staff about methods that could be used to manage the 
patient's symptoms in the event that the patient becomes unable to 
take medications orally. 
 
Undertaking these activities could help a patient ensure that their 
Parkinson's disease is managed appropriately during a hospital 
admission. 
 
The participants did not think that they had been visited by a PDNS 
during their admission and believed that the hospital PDNS was not 
aware that they had been admitted to the hospital. This lack of contact 
with a PDNS was due to the PDNS position at LTHT being vacant during 
the data collection period of this study. The PDNS at LTHT would usually 
only be aware of a patient if they had been informed about them by the 
ward staff caring for the patient and historically the PDNS was 
infrequently informed about the presence of patients with Parkinson's 
disease on hospital wards. A low incidence of ward staff informing the 
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PDNS that a patient with Parkinson's disease had been admitted to 
hospital was also evident in the study conducted by Derry et al. (2010) 
who reported that a PDNS had only been informed about one of the fifty 
four patients with Parkinson's disease that they considered during their 
study. This finding suggests that further work is required to identify the 
types of patients that should be referred to the PDNS at LTHT and 
develop methods to ensure that the PDNS is made aware of the 
presence of these patients within the hospital. 
 
6.3 Evaluation of the research process 
Patton proposes that "there are no perfect research designs. There are 
always trade-offs" (Patton, 2001 pp 221). The following sections discuss 
the strengths and limitations of the research process for this study. 
 
6.3.1 Strengths of the research process 
The theory that has been generated in this study provides a rich insight 
into the perceptions of patients with Parkinson’s disease about the 
management of their medicines during a hospital admission. The theory 
generated answers the central research question for this study and adds 
to the existing knowledge about this under-researched area. 
 
The study design is clearly detailed within chapter 3 of this thesis with the 
research strategy for the study and methods of data collection and 
analysis being explained to allow the reader to assess whether the choice 
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of methods were appropriate to answer the research question for this 
study (Mays & Pope, 2000; Stacy & Spencer, 2000). The ethical issues 
that can be associated with a qualitative healthcare research study were 
also considered during the design of this study and steps were taken to 
ensure that patients were safeguarded during the process of patient 
recruitment and data collection and analysis (discussed in section 3.5).  
 
The purpose of this study was to generate theory about patients' 
perceptions of the management of their medicines during a hospital 
admission and grounded theory methodology was chosen to support the 
generation of this theory. The iterative process of data collection and data 
analysis used in this study was consistent with a grounded theory 
approach (Corbin & Strauss, 2008) and the combination of this process 
with theoretical sampling ensured that the categories emerging from the 
data were richly developed. Theoretical sampling allowed recruitment of 
participants that may provide information that was required to allow the 
researcher to develop a detailed understanding about each category and 
explore relationships between categories. Deviant cases were also 
included in the data analysis process to ensure that the ideas emerging 
from the data were challenged and considered from different 
perspectives. This supported the development of a robust detailed theory 
which reflected the information provided by all of the study participants 
(Maxwell, 2005; Mays & Pope, 2000; Silverman, 2000; Strauss & Corbin, 
1990).  
 
  - 192 -
The thought processes underlying the use of theoretical sampling were 
recorded in a series of theoretical memos (Elliott & Lazenbatt, 2005) to 
allow the decisions made related to participant selection to be assessed 
by external parties in order to ensure that researcher bias was not 
influencing the choice of participants for the study. Researcher bias was 
also reduced by: 
 
x the study design being developed by a group composed of clinical 
pharmacists and academics to minimise the influence of the 
researcher’s opinions, values and experiences on the study 
design, 
x all of the interviews being transcribed verbatim, including pauses 
and overlaps of conversation, which allowed detailed analysis of 
both what was said by the participant and the context in which the 
statements were made (Silverman, 2000), 
x interview transcripts being reviewed by an authorised independent 
party to identify any sources of bias during the interview process 
(Malterud, 2001), and, 
x peer review of the coding system developed by the researcher to 
ensure that the coding process had not been biased by the 
researcher’s opinions. 
 
During each interview a memo was prepared to capture information that 
would support the generation of rich data (Charmaz, 2006; Maxwell, 
2005). These memos were particularly valuable because patients with 
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Parkinson's disease may have monotonic and hypophonic dysarthria 
(Jankovic, 2008) which may limit the researcher's ability during the 
process of interview transcription to identify when a patient is trying to 
emphasise a particular point or express emotion. The motor feature of 
hypomimia meant that many participants were unable to express their 
emotions through their facial expressions therefore the memos included 
information about any gestures that the participant had used to 
emphasise the point that they were making.  
 
The Straussian approach to grounded theory methodology used in this 
study allowed detailed exploration of each category that emerged from 
the data and the relationships between these categories. Using line by 
line coding of interview transcripts ensured that the researcher was able 
to focus on the data contained within each line rather than being 
distracted by the overall message that was being provided by the 
participant. The researcher was also able to use their theoretical 
sensitivity to detect subtle nuances within the line of data which added to 
a detailed analysis of the study data. 
 
Considering the properties and dimensions of each category and 
exploring relationships between categories at these levels also allowed 
the researcher to develop a detailed insight into the data and supported 
the generation of a robust theory. 
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To summarise, the choice of methodology has supported the generation 
of a detailed theory that is embedded within the data provided by the 
study participants and provides a rich insight into patients’ perceptions 
about the management of their medicines during a hospital admission. 
The theory is robust and credible and has added to the existing 
knowledge about patients’ perceptions about the management of their 
antiparkinsonian medicines.  
 
6.3.2 Limitations of the study 
Although steps were taken to design a study that would allow the 
generation of a robust theory that was embedded in the data provided by 
study participants there are limitations associated with the study and 
these are discussed below. 
 
6.3.2.1 Sample size 
Section 4.4 explained that after thirteen interviews the criteria for 
theoretical saturation defined by Strauss and Corbin (1990) had been 
satisfied. The difficulties in knowing when theoretical saturation has been 
achieved are acknowledged by qualitative researchers (Bluff, 2005; Dey, 
2007) and Charmaz (2006) argues that "a novice may mistake good, but 
limited, data for an adequate study" (Charmaz, 2006 pp 18) and 
prematurely declare that saturation has been achieved. It could be 
suggested that inappropriate declaration of achieving theoretical 
saturation occurred in this study due to the small number of participants 
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that were recruited to the study but the data analysis process suggested 
that after 13 interviews all of the participants were providing the same 
information about the categories and no new information was emerging 
during interviews. 
 
The thirteen participants were recruited over a nine month period. During 
this time there had been a total of 50 patients with Parkinson's disease 
admitted to LTHT but the other people with Parkinson's disease admitted 
to the hospital were excluded because they satisfied the exclusion criteria 
for this study. 
 
The limited number of people with Parkinson's disease admitted to the 
hospital that satisfied the inclusion and exclusion criteria meant that one 
group of patients that may have been able to provide data to further 
develop the categories could not be recruited to the study. These were 
patients who were electively admitted to the hospital for medical 
procedures. There were no patients admitted for this reason during the 
nine month period of data collection. These patients may have offered 
information about whether patients admitted for elective medical 
procedures share the same causes of anxiety as the other participants in 
this study and should be included in any future research related to this 
topic. 
 
The restricted ability to employ theoretical sampling is a limitation of this 
study because theoretical sampling is an essential element of a grounded 
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theory study (Glaser & Strauss, 1967; Strauss & Corbin, 1990). A larger 
study population could have been achieved if more sites recruited 
patients for the study or if the study was conducted over a longer period 
of time. A single site was utilised because the purpose of the study was to 
generate theory about patient perceptions of the management of 
antiparkinsonian medicines during an admission to LTHT.  
 
6.3.2.2 Lack of generalisability of findings 
There are many opinions about whether the findings of qualitative 
research studies should be generalisable (Charmaz, 2006; Glaser, 2007; 
Silverman, 2009; Stake, 1994). The theory generated in this study was 
not intended to be generalised to other settings because it specifically 
reflects the opinion of a small group of patients in a specific setting. The 
implications for practice highlighted by the theory are only directly 
applicable for practice within LTHT but elements may be transferred to 
other organisations with similar patient populations. Healthcare 
professionals within other organisations are encouraged to reflect on the 
findings of this study and review the medicines management processes 
used within their hospitals to identify possible areas that could be 
changed to improve the management of medicines for patients with 
Parkinson's disease. 
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6.3.2.3 Identification of potential participants 
Potential participants for the study were identified by the pharmacist that 
was part of the patient's clinical team. This pharmacist obtained written 
informed consent from the patient for the researcher to contact them. 
Asking a member of a patient's clinical team to introduce a study to a 
patient is a recognised method of identifying potential participants for 
healthcare research studies (UK Medicines Information, 2006) and this 
approach was approved by the NHS Research Ethics Committee that 
reviewed the ethics application for this study. The researcher approached 
the patient once they had provided informed consent for the researcher to 
contact them.  
 
Asking clinical pharmacists to identify potential participants for this study 
meant that participant recruitment was reliant on these professionals to 
remember that the study was on-going, identify possible participants, 
explain to the patient that this study was on-going and obtain written 
consent for the researcher to approach the patient. Reliance on others to 
undertake these processes removed control of patient recruitment from 
the researcher. This could have led to some people with Parkinson's 
disease that would have satisfied the inclusion and exclusion criteria for 
this study not being considered if the ward pharmacist decided not to 
approach the patient. 
 
To maintain the awareness of clinical pharmacists about this study, the 
researcher regularly reminded pharmacists that the study was on-going 
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and encouraged them to continue to support the identification of 
participants. It was hoped that this would help ensure that all eligible 
patients were identified during the period of data collection. 
 
6.3.2.4 Point in the patient's hospital admission when the interview 
was conducted 
Olson (2011) advises that researchers should consider "how much time is 
required for a person to acquire "enough" experience to provide data of 
good quality?" (Olson, 2011 pp 26) when they are deciding when to 
conduct an interview. The inclusion criteria for this study required patients 
to have been admitted to hospital for at least 48 hours to ensure that they 
had experienced the medicines management processes within LTHT. 
 
Most patients were interviewed within 72 - 96 hours of their admission to 
hospital. The point of data collection was chosen to ensure that the study 
population included patients admitted to hospital for short stays as well as 
those admitted for longer stays. 
 
6.3.2.5 Single method of data collection 
A single method of data collection was used in this study. This could be 
considered to be a limitation of this study because many checklists that 
are used to critically appraise a qualitative research study (Green & 
Thorogood, 2004; Kuper, Lingard, et al., 2008; Kuper, Reeves, et al., 
2008; Mays & Pope, 1995) suggest that a study should use multiple 
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methods of data collection to allow the researcher to consider the topic of 
interest “in different ways or from different perspectives" (Holloway & 
Wheeler, 2010 pp 309). Utilising different methods of data collection is 
known as methodological triangulation which is one of four methods of 
triangulation (the others being data, investigator and theory triangulation). 
Triangulation is used in many qualitative studies to demonstrate to others 
the reliability of the data collected during the study and the robustness of 
the theory generated from the data (Brookes, 2007; Holloway & Wheeler, 
2010; Kairuz et al., 2007; Long & Johnson, 2000; Mathison, 1988; Mays 
& Pope, 2000; Russell & Gregory, 2003). It has also been suggested that 
analysis of data collected from a number of sources may allow the 
researcher to develop a comprehensive and consistent understanding of 
the topic of interest (Mathison, 1988).  
 
Data, investigator and theory triangulation could not be utilised in this 
study due to restrictions imposed by the study design and only one 
researcher collecting data from the participants. Methodological 
triangulation could not be used in this study because only a single 
method of data collection was suitable to collect the information required 
to answer the central question of this study (discussed further in section 
3.4.4).  
 
The validity of this study has not been adversely affected by the absence 
of methodological triangulation because other methods have been used 
during study design, data collection and data analysis to ensure that the 
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theory generated from the data is valid and the study is trustworthy. Many 
of these methods are discussed in section 6.3.1 above. 
 
6.3.2.6 Decision not to use respondent validation 
Respondent validation, also known as member checking, is a recognised 
method of demonstrating the validity of a qualitative study (Cho & Trent, 
2006; Holloway & Wheeler, 2010). The process involves a researcher 
presenting their analysis of an interview with a specific participant to that 
participant and asking them their opinion about the researcher's 
interpretation of the data (Mays & Pope, 1995). Many researchers 
propose that this process avoids the researcher misunderstanding a 
statement made by a participant. 
 
Although the decision not to used respondent validation in this study 
could be considered to be a limitation, this decision was made because 
the purpose of this study is to explore patients’ perceptions about a 
situation that they are experiencing at a specific time. The information 
that the participant provides during the interview provides insight into how 
they are feeling at that time, in the context of being unwell and admitted 
to hospital. Respondent validation requires the data to be presented back 
to the participant at a point after the initial interaction and by that time the 
participant’s perception of the original situation may have changed 
(McKinney, 2005).  
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It is acknowledged that the researcher may have misinterpreted a 
participant's opinion during the process of data analysis but Elliott and 
Lazenbatt (2005) suggest that the combination of constant comparative 
analysis with theoretical sampling used in this current study allows the 
identification of any misunderstandings and prevents them adversely 
affecting the theories generated from the data. 
 
6.3.2.7 Researcher subjectivity and bias 
Researcher subjectivity and bias can reduce the credibility of any 
qualitative study. Section 6.3.1 above discusses some of the steps that 
were taken during the design of this study and during the processes of 
data collection and analysis to minimise the effect of researcher bias on 
the research process. 
 
6.3.3 Summary of the evaluation of the research process 
Many steps were taken to support the generation of a credible theory. 
Although there are limitations associated with this study these have been 
recognised by the author and are presented to the reader to allow them to 
make an informed decision about the validity of the methods that were 
used during study design and data collection and analysis to generate 
this theory.  
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6.4 Conclusion 
The grounded theory methodology used in this study has supported the 
generation of a theory that provides rich insight into the perceptions of 
patients with Parkinson's disease about the management of their 
medicines during a hospital admission. The theory suggests that people 
with Parkinson's disease admitted to LTHT may experience anxiety, both 
prior to and during their admission, due to concerns about the ability of 
hospital staff and the medicines management processes within LTHT to 
support them to maintain their usual medication regimen during the 
hospital admission and maintain control of their features of Parkinson's 
disease. 
 
Patients may become anxious due to concerns about whether their 
hospital prescription will accurately reflect their usual medication regimen 
(including medication, formulation, dose and timing of the doses) and 
whether doses of their medicines will be consistently administered at the 
times that match their usual regimen. Actively participating in their care 
was a method proposed by many participants that could be used to 
reduce their anxiety related to the prescribing and administration of their 
medications.  
 
Patients had trust in neurologists and Parkinson's disease nurse 
specialists but many did not appear to trust that ward staff would manage 
their medicines appropriately. A perception that ward staff had a lack of 
knowledge about the medicines used to manage the features of 
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Parkinson's disease caused anxiety for some patients because they were 
concerned that this could prevent them receiving their correct medicines 
at the correct times. The involvement of an expert in Parkinson's disease 
in a patient's care during the hospital admission was suggested as a 
method to offer patients reassurance that their medication would be 
managed appropriately throughout their admission. 
 
Some elements of the theory generated are consistent with findings 
demonstrated in other studies (both qualitative and quantitative) but the 
detailed insights provided by participants add to the existing knowledge 
about this under-researched area. The findings suggest areas for practice 
development that may reduce the anxiety that patients with Parkinson's 
disease experience during their hospital admission and highlight areas for 
further research. 
 
6.5 Implications of findings for local practice 
Discussion of the theory that was generated from the data has highlighted 
several findings that have implications for practice within LTHT. Some of 
these findings may also have implications for the GP surgeries that 
manage the care of patients with Parkinson's disease that could be 
admitted to LTHT. The findings suggest that areas for practice 
development may include: 
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a) Improving the comprehensiveness and accuracy of information 
available for hospital prescribers preparing a prescription for a 
patient with Parkinson's disease 
Patients and carers are useful sources of information about a patient's 
medication regimen but when they are unable to advise the prescriber 
alternative sources of information will need to be utilised. These sources 
may include the patient's GP record or Summary Care Record (SCR), 
boxes of the patient's medicines or a list of medicines that the patient has 
previously written. The information provided by these sources may be of 
variable quality therefore further work could be undertaken to improve the 
accuracy and comprehensiveness of the information contained in these 
sources. 
 
b) Reducing patient anxiety about the methods that will be used to 
manage their medicines during a hospital admission 
Participants in this study who were admitted to the hospital for planned 
surgery suggested that they had been worried from the point that they 
had been informed that they would be admitted to hospital about how 
their medicines would be managed during their admission. This anxiety 
could last for several weeks if there is a long waiting list for the 
procedure. Further work could be undertaken to identify methods to 
provide reassurance to members of this patient group that healthcare 
professionals recognise that they have Parkinson’s disease and 
understand that their medicines must be prescribed at the correct times 
and administered at these times whilst they are admitted to hospital. 
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Patients that are admitted to the hospital acutely also require reassurance 
that they will be able to maintain their own medication regimen during the 
admission. Methods to provide this reassurance could also be explored. 
 
c) Raising patient awareness of the process of medicines 
reconciliation 
The theory suggests that raising patient awareness of the process of 
medicines reconciliation may provide a method to reassure patients that 
steps are being taken to ensure that their usual antiparkinsonian 
medication regimen is accurately prescribed when they are admitted to 
hospital. Further work could be undertaken to raise patient awareness of 
the process and the benefits that it may provide for patients with 
Parkinson's disease. 
 
d) Maintaining the availability of antiparkinsonian medicines and 
medicines used for the management of non-motor features of 
Parkinson's disease 
The theory suggests that participants experienced problems with the 
availability of medicines on admission to hospital, following transfer 
between wards and when medication supplies were used up during the 
their admission. 
Further work could be undertaken to assess the ability of existing 
procedures and infrastructure to support staff to maintain availability of 
medicines and identify steps that need to be taken to ensure that patients 
have access to a supply of medicines when they are admitted to the 
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hospital and throughout their hospital stay. This work could also consider 
the role of patient’s own drugs when they are admitted to hospital. 
 
e) Supporting nurses to administer medications at patient specific 
times 
The participants' concern about whether ward staff were aware when they 
required a dose of their medicine suggests that further work could be 
undertaken to identify methods to improve the awareness of nursing staff 
about the times that medication doses are required by patients under 
their care. Methods to prompt staff when a dose of medication is due 
could also be explored to assist staff to administer medications at patient 
specific times. 
 
f) Raising patient awareness of the availability of a scheme for self-
administration of medicines with the hospital 
The theory suggests that participants recognised that self-administration 
of medicines may support them to receive the correct medication at the 
correct time; however many participants were unaware of the availability 
of a self-administration of medicines scheme at LTHT. Further work could 
be undertaken to raise patient awareness of the scheme and the benefits 
that it may provide for patients with Parkinson's disease. 
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g) Identify the patient groups that should be referred to a PDNS 
during their hospital admission and develop methods to ensure that 
the PDNS is made aware of the presence of these patients within the 
hospital 
Although all participants wanted to be visited by a PDNS or a neurologist 
during their hospital admission, in practice this may not always be 
possible due to limited resources. A method could be developed to 
ensure that the activities of the PDNS are prioritised towards those 
patients with complex needs (e.g. poor disease control or nil by mouth). 
Alternative methods could be developed to ensure that other people with 
Parkinson's disease admitted to hospital also receive appropriate 
management of their medicines during their hospital stay. 
 
6.6 Implications of findings for national practice 
The findings of this study were not intended to be generalisable but they 
could help to inform areas of national practice including: 
 
a) Considering whether information about hospital only medicines, 
medicines provided by home care companies and medication dose 
times and dose intervals could be included on patient GP records 
and SCRs 
This would improve the comprehensiveness of information available to 
hospital prescribers when any patient is admitted to hospital.  
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b) Reviewing at a national level the effect of the rapid response alert 
that considers reduction of harm from omitted and delayed doses of 
medicines in hospital 
This could help to identify causes of omitted or delayed medicines that 
have not been resolved following the issue of the original alert and 
support the development of a national approach to address these causes. 
 
6.7 Implications for future research 
Using existing literature to validate the theory that was generated from 
the data has suggested a number of areas that could be further 
researched. These areas are highlighted below. 
 
a) The factors that could prevent a patient receiving all of their 
prescribed medication doses during a hospital admission 
The findings of this current study suggested that some participants did 
not receive all of their prescribed doses of medication during their hospital 
admission and this was a source of anxiety for these participants. These 
findings imply that further research may be required to identify the 
reasons why doses of medication are not administered to patients and 
methods that can be used to address the issues that are identified. 
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b) The factors that may influence the decisions of patients with 
Parkinson's disease to self-administer their medication during a 
hospital admission 
There is currently a lack of information available about the factors that 
may influence whether a patient with Parkinson's disease chooses to self-
administer their medicines whilst in hospital. This area could be explored 
further to identify if there are barriers that can be addressed by healthcare 
professionals to enable patients with Parkinson's disease to self-
administer their medications during a hospital admission. 
 
c) The opinions of ward nurses about their knowledge of the 
management of patients with Parkinson's disease 
The findings of this study suggested that participants believed that ward 
nurses had a lack of knowledge about the medicines used to manage the 
features of Parkinson's disease and the importance of administering 
these medicines at specific times. The opinions of ward nurses about 
their knowledge of these topics were not explored during this study but 
these could be explored in a future research study to identify if nurses 
think that they have learning needs related to this topic and possible 
methods that could be used to address any needs that are highlighted. 
 
d) The perceptions of carers about the management of 
antiparkinsonian medications during a patient's hospital admission 
Many carers of people with Parkinson's disease have a detailed 
knowledge about the patient's medication regimen and the effects that a 
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deviation from this routine can have on their symptom control. Carers 
may also experience anxiety about the management of a patient's 
medicines during a hospital admission but there is currently a lack of 
information related to this topic. The perceptions of carers about the 
management of antiparkinsonian medications during a patient's hospital 
admission could be explored in a future research study. 
 
e) The factors that affect the trust of a patient with Parkinson's 
disease in their neurologist, PDNS, GP and ward staff managing 
their care during a hospital admission 
Further research could explore the factors that increase or reduce a 
patient's trust in the healthcare professionals managing their care in a 
range of clinical settings and identify factors that could be addressed to 
increase their trust, where appropriate. 
 
f) The perceptions of patients with other chronic diseases about the 
management of their medicines during a hospital admission 
The anxiety that patients with Parkinson's disease may feel due to 
concerns about whether their prescription will reflect their usual 
medication regimen or doses of their medicines will be administered at 
correct times, may also be felt by patients with other chronic diseases 
that believe that they need to have their medicines administered at 
specific times to maintain symptom control. There is a paucity of 
information about the perceptions of patients with other diseases about 
the management of their medication during their hospital admission and 
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this may require further exploration to determine whether patients with 
other chronic diseases experience anxiety about the management of their 
medicines when they are admitted to hospital. 
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Appendix 1 – Hospital Pharmacy Europe article 
 
Parkinson's disease - Medicines management issues associated 
with the admission of patients with Parkinson's disease to hospital 
 
L C Dunsmure, MPharm, DipClinPharm, MRPharmS(PIP), Advanced 
Clinical Pharmacist for Neurosciences, Leeds Teaching Hospitals NHS 
Trust 
B J Lucas, PhD, FHEA, BSc (Hons), RNT, Diploma in Nursing, RMN, 
Senior Lecturer, School of Pharmacy, University of Bradford 
C Acomb, BSc, MPharm, MRPharmS, Clinical Pharmacy Manager, Leeds 
Teaching Hospitals NHS Trust 
 
Summary: 
The purpose of this article is to explore the medicines management 
issues associated with the admission of patients with Parkinson's disease 
to hospital. We report some early findings from our research that was 
undertaken to explore patients' perceptions of the prescribing and 
administration of their antiparkinsonian medications during a hospital 
admission. 
 
Introduction:  
Parkinson’s disease is a progressive neurological condition that affects 
more than one million people in Europe and this number is expected to 
double by 2030 due to many countries having an ageing population [1]. 
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The estimated total annual cost of managing the care of patients with 
Parkinson’s disease in Europe is €13.9 billion [2].  
 
Patients with Parkinson’s disease have characteristic changes within their 
brain which include loss of dopaminergic neurons containing 
neuromelanin from the substantia nigra pars compacta and the presence 
of intraneuronal inclusions (including Lewy bodies) [3]. The motor 
features of the disease include the cardinal features of tremor at rest, 
bradykinesia, rigidity and postural instability. Patients can also develop 
non-motor features of the disease including cognitive impairment, 
affective disorders and psychosis. 
 
Individualised medication regimens: 
Most patients with Parkinson’s disease will have an individualised 
medication plan that has been designed to manage the features of their 
disease. The aim of treatment for ‘early’ Parkinson’s disease is to 
manage the motor features whereas in patients with 'later' disease the 
treatment aim is to manage both the motor features and the 
complications caused by the levodopa based medicines. 
 
A patient’s treatment plan should be developed through discussions 
between the patient and their specialist healthcare professional. 
Pharmacological treatments should be chosen after consideration of the 
patient’s previous experience with antiparkinsonian medications, the 
patient’s lifestyle and their ability to manage a complicated medication 
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regimen. Preference about route of administration of medications, the 
known efficacy of a medication and its adverse effect profile should be 
factored into the treatment plan [4]. 
 
Maintaining a patient's usual medication regimen when the patient is 
admitted to hospital: 
On admission to hospital a patient's usual medication regimen should be 
maintained throughout the admission (where it is clinically appropriate to 
do so). Omitted or delayed doses frequently lead to significant adverse 
consequences for the patient e.g. increased ‘off effects’ and dysphagia. 
Administration of excessive doses can lead to dyskinesias or psychosis. 
 
Obtaining information about a patient's antiparkinsonian medication 
regimen, including dose timings, often presents a challenge to hospital 
prescribers. Patients (or their carers) are often best placed to provide this 
information but when a patient is unable to advise the prescriber (patient 
has cognitive impairment or unconscious on admission to hospital) 
alternative resources must be utilised. The information that can be 
obtained from a GP record is variable because maintaining an accurate 
record of a patient's medication regimen is a challenge for many GPs due 
to neurologists frequently adjusting the medication regimen in response 
to the patient's changing symptoms.  
 
The importance of making accurate and current information about a 
patient’s medication regimen available to healthcare professionals when 
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a patient is transferred between care providers was a central theme in the 
document 'Keeping patients safe when they transfer between care 
providers - getting the medicines right' [5]. The aim of this document is to 
improve the transfer of information about a patient's medicines when 
patients are transferred between care providers (e.g. admitted to hospital 
from care home) and reduce the medicine related errors that can occur 
following transfer.  
 
In response to this document, members of the pharmacy, medical and 
nursing teams at Leeds Teaching Hospitals have reviewed the processes 
used to transfer information about medicines when a patient with 
Parkinson's disease is admitted to and discharged from hospital. The 
group have developed a scheme to include information about the specific 
times of doses of antiparkinsonian medications on GP records. Patients 
are also being encouraged to carry a medication card to record their 
current regimen and share this information with all healthcare 
professionals. Work is currently ongoing to evaluate whether these 
changes have improved the accuracy of the medication regimen 
prescribed on a hospital prescription. 
 
For a number of years concerns have been expressed about the effects 
that accidental changes from a usual antiparkinsonian medication routine 
can have on symptom control and length of hospital stay [6, 7]. The 
correlation between the medication prescribed and a patient's usual 
routine has been explored in studies using both quantitative methods and 
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mixed methods. These studies highlighted that some patients were not 
prescribed their usual medicines on admission to hospital, had doses 
prescribed at incorrect times or did not consistently receive their doses of 
antiparkinsonian medications at the times prescribed [8-11].  
 
Parkinson’s UK and its international equivalents have recognised 
problems with prescribing and administering the correct antiparkinsonian 
medication at the correct times when a patient is admitted to hospital and 
these concerns were initially highlighted to healthcare professionals 
through the Parkinson's UK ‘Get it on time’ campaign in 2006. This 
campaign is still on-going and provides advice for patients and healthcare 
professionals about the management of a patient's medications during a 
hospital admission. In 2007, Parkinson's UK conducted a national survey 
of over 13,000 people with Parkinson's disease and their carers and the 
results highlighted that 40% of patients admitted to hospital did not get 
every dose of their medicines on time during their admission [12].  
 
Whilst many practitioners recognise that changes to medication regimens 
can have detrimental effects on symptom control, there is a paucity of 
research about patients’ perceptions of the management of their 
medicines during a hospital admission. The literature suggests that some 
patients and their carers have expressed concerns that patients' 
medicines were inappropriately stopped when they were admitted to 
hospital and believed that the patients had experienced deterioration in 
symptom control during their hospital admission [13]. Some of these 
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patients and their carers also expressed concerns about medicines being 
administered at times that differed from their usual routine. Other 
participants in this study articulated that they had doubts about the 
knowledge that nursing and medical staff had about the management of 
their condition. 
 
Patients’ perceptions about medicines management issues: 
We undertook a qualitative study to generate theory about patients’ 
perceptions of the management of antiparkinsonian medications during 
an admission to Leeds Teaching Hospitals. A grounded theory approach 
[14] was adopted to facilitate detailed exploration of patient perceptions of 
this under-researched area. Semi-structured individual face-to-face 
interviews were conducted with participants, fully transcribed and 
analysed using the constant comparative approach. The study population 
included patients with Parkinson's disease admitted to the hospital either 
electively or acutely for surgical or medical indications. None of the 
participants were admitted to hospital for adjustment of their 
antiparkinsonian medications. 
 
Early results from the study suggest that the central phenomenon in the 
data provided by the participants is 'patient anxiety'. Most participants 
articulated that they felt anxious both prior to and during their hospital 
admission due to concerns about the risk associated with not continuing 
their usual medication regimen. Participants were anxious about whether 
the hospital prescription charts would accurately reflect their usual 
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medication regimen and expressed concerns about the availability of their 
antiparkinsonian medications during a hospital admission. The coping 
strategies utilised by the participants in response to these stressors 
involved the patient advising prescribers about their usual medication 
regimen and bringing a supply of their medicines into the hospital to 
ensure that the medicines were available throughout their stay.  
 
Most participants had concerns about whether their medications would be 
administered at the correct times and these participants responded to this 
stressor by actively prompting nursing staff prior to the time when a dose 
of medication was due. However most chose not to self-administer their 
medication during the admission because they did not feel competent to 
self-administer their medications in the unfamiliar setting of a hospital 
ward. 
 
All participants expressed concerns regarding the lack of knowledge that 
the healthcare professionals managing their care had about Parkinson's 
disease. Participants perceived that many staff were unaware about the 
role of medication in managing the symptoms of the disease. Participants 
believed that if they had access to a person that they perceived to be an 
expert in Parkinson's disease (either a neurologist or Parkinson's disease 
nurse specialist) this would provide them with reassurance. 
 
Data analysis is ongoing but the early findings of the study suggest that 
the patients' concerns are related to the processes and behaviours 
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associated with the prescribing and administration of antiparkinsonian 
medications. These findings are not intended to be generalisable 
because they reflect the perceptions of a specific group of patients 
admitted to one hospital in the UK but they do suggest that many of the 
causes of this anxiety could have implications for practice e.g. raising 
awareness of prescribers about the importance of ensuring that all of a 
patient's antiparkinsonian medications are prescribed at the correct time 
and making nurses aware of the importance of administering these 
medications at specific times. 
 
The early findings of this study and the findings from previous qualitative 
studies [13, 15] suggest that the causes of anxiety for some patients with 
Parkinson's disease admitted to hospital are related to concerns over the 
accuracy of prescribing and administration of their antiparkinsonian 
medication. These stressors are reflective of the concerns that have been 
highlighted by healthcare professionals and members of the Parkinson's 
UK specialist interest group for many years.  
 
Conclusion: 
Accurate prescribing and timely administration of antiparkinsonian 
medications may present a challenge for healthcare professionals but 
concerns about their ability to receive the correct medication at the 
correct time is causing some patients with Parkinson's disease to feel 
anxious during their hospital admission. Work is on-going within Leeds 
with patients and GPs to identify a robust method to ensure the effective 
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transfer of information about a patient's medication when admitted to 
hospital and support the timely administration of antiparkinsonian 
medication during a hospital admission.  
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Appendix 2 – Inclusion criteria for literature review 
 
The documents included in the review process were: 
 
x studies with qualitative methodology published in peer reviewed 
journals or discussed in grey literature, 
x studies with quantitative methodology published in peer reviewed 
journals or discussed in grey literature, 
x mixed methods studies published in peer reviewed journals or 
discussed in grey literature, 
x descriptive studies, 
x narrative review documents, 
x editorials, 
x government publications related to healthcare, and, 
x publications issued by Parkinson’s disease special interest groups. 
 
Documents published from 1960 onwards that considered humans only 
were included in the search and articles could be in any language. 
Parkinson’s disease affects people throughout the world and the 
condition is being researched by practitioners in many countries. 
Inclusion of documents in languages other than English ensured that the 
search considered information related to practices undertaken in other 
countries which could provide insight into topics that may be a concern 
for people with Parkinson's disease in the UK. 
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Appendix 3 – Search strategies 
Medline (1960 onwards) 
MESH terms were used where they were available.  
Search terms used: 
1. Parkinson Disease (MESH term) 
2. Attitude to Health (MESH term) 
3. Patient Satisfaction (MESH term) 
4. Health Knowledge, Attitudes, Practice (MESH term) 
5. Patient Acceptance of Health Care (MESH term) 
6. Patient Participation (MESH term) 
7. Chronic Disease (MESH term) 
8. Sick role (not a MESH term) 
9. Inpatients (MESH term) 
10. Nervous System Disease (MESH term) 
11. Hospital admission (not a MESH term) 
12. Perception (MESH term) 
13. Patient perceptions (not a MESH term) 
14. Medication Errors (MESH term) 
15. Hospitals, Chronic Disease (MESH term) 
16. Self Medication (MESH term) 
17. Self Administration (MESH term) 
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Search term Results 
1 42467 
2 135449 
1 and 2 99 
3 51347 
1 and 3 76 
4 52259 
1 and 4 19 
5 24443 
1 and 5 11 
6 14952 
1 and 6 12 
7 204696 
7 and 2 2723 
7 and 3 207 
7 and 4 729 
7 and 5 544 
7 and 6 485 
8 10981 
1 and 8 71 
7 and 8 980 
7 and 8 in humans 739 
9 10122 
1 and 9 18 
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7 and 9 194 
10 32063 
10 and 2 43 
10 and 3 67 
10 and 4 23 
10 and 5 19 
10 and 6 21 
10 and 8 30 
10 and 9 106 
11 7961 
1 and 11 29 
7 and 11 45 
10 and 11 47 
12 214762 
1 and 12 875 
7 and 12 1700 
10 and 12 302 
13 907 
1 and 13 5 
7 and 13 6 
10 and 13 1 
14 8865 
1 and 14 12 
7 and 14 86 
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10 and 14 17 
15 368 
15 and 12 4 
16 3602 
1 and 16 6 
7 and 16 115 
10 and 16 3 
15 and 16 0 
17 7899 
1 and 17 9 
7 and 17 107 
10 and 17 3 
15 and 17 0 
 
Embase (1980 onwards) 
Search terms used: 
1. Parkinson and disease 
2. Attitude 
3. Satisfaction 
4. Participation 
5. Chronic and disease 
6. Sick and role 
7. Inpatients 
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8. Nervous and system and disease 
9. Hospital and admission 
10. Perception 
11. Medication and errors 
12. Self and medication 
Search term Results 
1 8560 
2 32145 
1 and 2 3 
3 74056 
1 and 3 22 
4 87687 
1 and 4 63 
5 257317 
6 1935 
1 and 6 2 
5 and 6 79 
7 26311 
1 and 7 20 
5 and 7 628 
8 37839 
9 13 
1 and 9 0 
5 and 9  0 
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8 and 9 0 
10 92169 
1 and 10 62 
5 and 10 1386 
8 and 10 185 
11 4595 
1 and 11 5 
5 and 11 52 
8 and 11 No search results 
12 12890 
1 and 12 23 
5 and 12 630 
8 and 12 23 
5 and 2 515 
5 and 3 1196 
5 and 4 1573 
8 and 2 28 
8 and 3 26 
8 and 4 167 
8 and 6 No search results 
8 and 7 67 
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CINAHL (Cumulative Index to Nursing and Allied Health Literature) 
(1960 onwards) 
Keywords were used where they were available.  
Search terms used: 
1. Parkinson Disease  (standard keyword in database) 
2. Chronic Disease  (standard keyword in database) 
3. Diagnosis, Neurologic (standard keyword in database) 
4. Attitude to Health  (standard keyword in database) 
5. Attitude to Illness  (standard keyword in database) 
6. Sick Role   (standard keyword in database) 
7. Patient Centered Care (standard keyword in database) 
8. Health behaviour  (not a standard keyword in database) 
9. Self Medication  (standard keyword in database) 
10. Patient Satisfaction  (standard keyword in database) 
11. Patient participation  (not a standard keyword in database) 
12. Self Administration  (standard keyword in database) 
13. Patient perceptions  (not a standard keyword in database) 
14. Hospital admissions  (not a standard keyword in database) 
15. Expectations   (not a standard keyword in database) 
The search was not restricted to full text publications only. 
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Search term Results 
1 7350 
2 25165 
3 1122 
4 16659 
1 and 4 17 
2 and 4 554 
3 and 4 2 
5 4195 
1 and 5 30 
2 and 5 313 
3 and 5 0 
6 922 
1 and 6 10 
2 and 6 111 
3 and 6 0 
7 7636 
1 and 7 12 
2 and 7 235 
3 and 7 0 
8 1734 
1 and 8 1 
2 and 8 36 
3 and 8 0 
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9 996 
1 and 9 2 
2 and 9 22 
3 and 9 0 
10 24681 
1 and 10 45 
2 and 10 49 
3 and 10 3 
11 536 
1 and 11 0 
2 and 11 12 
3 and 11 0 
12 1764 
1 and 12 3 
2 and 12 35 
3 and 12 0 
13 487 
1 and 13 1 
2 and 13 7 
3 and 13 0 
14 2057 
1 and 14 7 
2 and 14 62 
3 and 14 0 
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15 11322 
1 and 15 20 
2 and 15 138 
3 and 15 0 
 
ASSIA (Applied Social Sciences Index and Abstracts) (1960 
onwards) 
Search terms used: 
1. Parkinson’s disease 
2. Parkinson*  
3. Neurological conditions  
4. Chronic disease 
5. Satisfaction 
6. Attitude 
7. Patient participation  
8. Medication 
9. Medication administration 
10. Self administration of medication  
11. Patient perception  
12. Medication error 
13. Errors in medication 
14. Expectations 
15. Hospital admission 
16. Sick role 
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Search term Results 
1 606 
2 809 
3 289 
4 4229 
5 13456 
2 and 5 7 
3 and 5 5 
4 and 5 138 
6 27700 
2 and 6 16 
3 and 6 10 
4 and 6 123 
7 2285 
2 and 7 11 
3 and 7 8 
4 and 7 97 
8 6815 
2 and 8 58 
3 and 8 10 
4 and 8 253 
9 467 
2 and 9 3 
3 and 9 0 
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4 and 9 8 
10 79 
2 and 10 0 
3 and 10 0 
4 and 10 1 
11 4130 
2 and 11 15 
3 and 11 5 
4 and 11 146 
12 224 
2 and 12 0 
3 and 12 0 
4 and 12 4 
13 214 
2 and 13 0 
3 and 13 0 
4 and 13 23 
14 9255 
2 and 14 8 
3 and 14 6 
4 and 14 80 
15 3254 
2 and 15 6 
3 and 15 4 
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4 and 15 129 
16 342 
2 and 16 0 
3 and 16 1 
4 and 16 16 
 
Profession specific journals 
Profession specific journals were considered during the literature search 
to identify articles, editorials and letters which had not been identified 
during the search of the databases discussed above. The journals 
searched were: 
x Pharmaceutical Journal 
x Clinical Pharmacist (from 2009) 
x Hospital Pharmacist (predecessor of Clinical Pharmacist) 
x British Journal of Clinical Pharmacy 
x Hospital Pharmacy Europe 
x Pharmacy World & Science 
x The Lancet Neurology 
x British Medical Journal 
x British Journal of Nursing 
x British Journal of Neuroscience Nursing 
x Nursing Standard 
x Nursing Times 
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Search terms used: 
1. Parkinson disease 
2. Parkinson’s disease 
3. Chronic disease 
4. Attitude to health 
5. Health knowledge, attitudes and practice 
6. Patient acceptance of health care 
7. Hospital admission 
8. Inpatient 
9. Medications 
10. Medication administration 
11. Nursing care 
12. Patient satisfaction  
13. Patient participation 
14. Sick role 
 
These journals are medical, nursing and pharmacy journals to reflect the 
multidisciplinary approach to managing the care of people with 
Parkinson's disease. 
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Grey literature: 
x Parkinson’s UK website accessed at www.parkinsons.org.uk 
x Department of Health website accessed at www.dh.gov.uk 
Search terms:  
1. Chronic disease 
2. Long-term conditions 
3. Patient centred care 
4. Patient participation 
5. Self medication 
x NICE website accessed at www.nice.org.uk 
Search term = Parkinson’s disease 
x NPSA website accessed at www.npsa.nhs.uk 
Search terms = Omitted or missed doses 
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Appendix 4 – Methods used to critically appraise studies identified 
during the literature search 
 
a) Studies utilising qualitative methodology 
There are many checklists available to support healthcare professionals 
to critically appraise studies utilising qualitative methodology 
(Greenhalgh, 2006; Kuper, Lingard, et al., 2008; Malterud, 2001; Mays & 
Pope, 1995). The criteria used to appraise the studies with qualitative 
methodology identified during the literature search for this study were 
derived from guidance issued by Mays and Pope (1995), Kuper, Lingard, 
et al. (2008) and Greenhalgh (2006). The appraisal process involved 
consideration of whether: 
 
a) the purpose of the study was clearly described, 
b) reflexivity was addressed, 
c) the data collection and analysis methods chosen were appropriate 
for the research question and were clearly documented, 
d) the sampling method used was appropriate, 
e) the design of the study ensured the validity and rigour of the study 
and minimised bias, 
f) an appropriate link had been drawn between the data and the 
conclusion, and, 
g) the limitations of the study had been discussed. 
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b) Studies utilising quantitative methodology 
At the start of the literature review process it was intended that 
quantitative studies that were identified during the literature search for 
this study would be appraised using the criteria set out by Greenhalgh 
(2006) to appraise studies with quantitative methodology. During the 
literature search only case note reviews and audit reports were identified, 
therefore a simplified critical appraisal was conducted which involved: 
 
a) assessing the suitability of the methods of data collection and 
analysis (including statistical analysis), 
b) assessing if the sample was appropriate, 
c) assessing if an appropriate link had been drawn between the data 
and the conclusion, and, 
d) assessing if the limitations of the study had been discussed. 
 
c) Studies utilising mixed methods 
A combination of the approaches discussed above was used to appraise 
studies using mixed methods. 
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Appendix 5 – Inclusion and exclusion criteria for the study 
 
The inclusion criteria for this study are: 
x aged over 18 years, 
x confirmed diagnosis of Parkinson’s disease, 
x prescribed one or more medicines for the management of motor or 
non-motor features of Parkinson’s disease,  
x received pharmacological treatment for the symptomatic management 
of Parkinson’s disease for at least six months, 
x able to provide informed consent. 
 
The exclusion criteria for this study are: 
x patient has parkinsonism caused by a condition other than 
Parkinson’s disease, 
x duration of admission to hospital will be less than 48 hours, 
x patient was admitted to hospital via an intensive care unit, 
x patient was admitted to a haematology or oncology ward, 
x patient was admitted to a care of the older person ward, 
x patient has a previous diagnosis of dementia,  
x patient has a previous diagnosis of a psychiatric disorder which will 
prevent the patient providing informed consent,  
x patient has been diagnosed with psychosis or delirium during current 
hospital admission. 
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Appendix 6 – Consent for researcher to approach potential 
participants for the study 
 
Consent form 
 
Patients with Parkinson’s disease perceptions of the management 
of antiparkinsonian medications during an in-patient stay at Leeds 
Teaching Hospitals NHS Trust 
    
There is an ongoing study within the hospital which is considering the 
opinions of patients with Parkinson’s disease about the management of 
the medicines for their Parkinson’s disease during an admission to 
hospital. The researcher for the study would like to make contact with you 
during your hospital admission to discuss the study, show you the 
information sheet for the study and assess whether you could be included 
in the study. 
 
Initial each box 
 
1. I understand that my agreement to speak to the researcher is  
    voluntary and that I can withdraw my agreement to meet with them 
    at any time and without giving any reason, without my medical care  
    or legal rights being affected. 
 
2. I understand that to assess whether or not I will be suitable for the 
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    study the researcher will need to access relevant sections of my  
    medical notes. I give permission for the researcher to have access 
    to my medical notes. 
 
3. I agree for the researcher to contact me. 
     
______________________      
Name of patient                                Date   Signature         
 
______________________      
Name of clinical pharmacist                   Date                Signature 
 
Researcher: Louise Dunsmure 
Contact details: tel: 01133922455  
email: louise.dunsmure@leedsth.nhs.uk 
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Appendix 7 – Participant information sheet 
 
Participant information sheet 
 
Patients with Parkinson’s disease perceptions of the management 
of antiparkinsonian medications during an in-patient stay at Leeds 
Teaching Hospitals NHS Trust 
 
You are being invited to take part in a research study. Before you decide, 
it is important for you to understand why the research is being done and 
what it will involve. Please take time to read the following information 
carefully and discuss it with others if you wish. Ask if there is anything 
that is not clear or if you would like more information. Take time to decide 
whether or not you wish to take part.  
 
Name of Researcher: Louise Dunsmure  
Contact details:  telephone 0113 3922455  
                             e-mail louise.dunsmure@leedsth.nhs.uk 
 
1) What is the purpose of the study? 
This study is a student research project. The purpose of this study is to 
identify the opinions of patients with Parkinson’s disease about the 
management of their medicines during an in-patient stay within specific 
clinical areas of Leeds Teaching Hospitals NHS Trust.  
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2) Why have I been asked to take part in the study? 
You have been asked to take part in this study because you have been 
admitted to Leeds Teaching Hospitals NHS Trust and you took 
medication for your Parkinson’s disease before admission to hospital. 
You will be able to provide useful information about the experience of 
patients with Parkinson’s disease admitted to Leeds Teaching Hospitals 
NHS Trust.  
 
Other patients with Parkinson’s disease who are admitted to Leeds 
Teaching Hospitals NHS Trust will be assessed for suitability to 
participate in the study if they received treatment for their Parkinson’s 
disease before admission to hospital.  
 
3) Do I have to take part? 
You do not have to take part in this study. It is up to you to decide 
whether or not to take part. If you do take part, you will be given this 
information sheet to keep and be asked to sign a consent form. You are 
still free to withdraw at any time and without giving a reason. A decision 
to withdraw at any time, or a decision not to take part, will not affect the 
standard of care you receive. 
 
4) What will happen to me if I take part? What will I be asked to do? 
You will be asked to participate in an interview where questions will be 
asked to obtain information about your opinions related to your hospital 
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admission. The interview will take between 30 minutes and 45 minutes 
depending on the information that you provide.  
 
The interview will be conducted in a confidential area on the ward that 
you are staying on. Only the interviewer and you will be present for the 
interview but medical and nursing staff will be accessible if you require 
medical or nursing support during the interview. 
 
The interview will be recorded using a dictaphone. Following the interview 
the researcher will prepare a written copy of the interview to allow the 
information to be looked at further to find points that are also raised by 
other participants in the study. 
 
5) Will my taking part in this study be kept confidential? 
The procedures for handling, processing, storing and destroying 
information collected during your interview are compliant with the Data 
Protection Act 1998. 
 
The data collected will be kept anonymous at all times. Your interview will 
be assigned a numerical code and only the researcher will know that the 
code is associated with your data. Only the researcher and an 
independent reviewer will have access to the anonymous original 
information that you provided and they have a duty of confidentiality to 
you as a research participant. 
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The audio-recording of the interview and the written copy prepared by the 
researcher will be stored in a locked area and kept secure at all times. 
The audio-recordings and documents will be safely destroyed one year 
after this study has finished.  
 
Information presented in the final report for this study will be kept strictly 
confidential and no information will be given which would allow you to be 
identified. 
 
6) What are the benefits of the study? 
You will not get any personal medical benefits from agreeing to take part 
in this study. The study is intended to identify opportunities to improve the 
current practices used within Leeds Teaching Hospitals NHS Trust to 
manage the medicines of patients with Parkinson’s disease. This could 
help patients in the future. 
 
7) What are the disadvantages and risks of taking part? 
There are no personal disadvantages to taking part in the study. You are 
free to withdraw at any time and without giving a reason. A decision to 
withdraw at any time will not affect the standard of care you receive. 
 
8) What if there is a problem or something goes wrong? 
During the interview you will be asked to provide your opinion about 
specific issues. In the event that this causes you to feel emotional 
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distress Leeds Teaching Hospitals NHS Trust will provide support to help 
you manage your concerns. 
 
In the event that you have concern about any aspect of this study you 
should ask to speak to the researcher who will do their best to answer 
your questions (Louise Dunsmure via telephone on 0113 3922455). If you 
remain unhappy and wish to complain formally, you can do this through 
the NHS Complaints Procedure. Details can be obtained from the 
hospital. 
 
9) What will happen to the results of the research study? 
This study forms part of the researcher’s university programme therefore 
the report will be read by a small number of university examiners and an 
external examiner. The results of the study will also be shared with 
colleagues within the pharmacy profession through publishing the study 
in pharmacy journals. Any personal details will be kept strictly confidential 
and no information will be included which would allow you to be identified. 
At the end of the study you will be able to receive a copy of the report by 
contacting the researcher on the number below. 
 
10) Who is organising and funding the research? 
This is an independent piece of research for a pharmacy further 
education qualification. The research is not being funded by commercial 
or professional bodies. No members of the research team are being paid 
for asking you to participate in this study. 
  - 272 -
11) Who has reviewed the research? 
The research proposal was reviewed by NHS Research Ethics 
Committee to ensure that participants will be managed safely and 
equitably.   
 
Research governance approval has been gained from the Leeds 
Teaching Hospitals NHS Trust research and development office. 
 
12) What if I want further information? 
If you have any problems, concerns or other questions about this study, 
you should contact the researcher Louise Dunsmure via telephone on 
0113 3922455 or email louise.dunsmure@leedsth.nhs.uk. 
 
Thank you for taking the time to read this information sheet and for 
considering taking part in this study. 
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Appendix 8 – Consent form for patient to participate in the study 
 
Consent form 
 
Patients with Parkinson’s disease perceptions of the management 
of antiparkinsonian medications during an in-patient stay at Leeds 
Teaching Hospitals NHS Trust 
Researcher: Louise Dunsmure 
Contact details:  telephone 0113 3922455 or  
email louise.dunsmure@leedsth.nhs.uk      
   Initial each box 
1. I confirm that I have read and understand the information  
    sheet for the above study. I have had the opportunity to consider 
    the information, ask questions and have had these answered  
    satisfactorily. 
 
2. I understand my participation is voluntary and that I am  
    free to withdraw from the study at any time, without giving 
    any reason, without my medical care or legal rights being affected. 
 
3. I understand that the discussion will be audio-recorded and  
    parts of the conversation may be quoted in research publications 
    but I will not be identified.   
 
 
 
 
 
  - 274 -
 
4. I understand that data collected during the study may be looked  
    at by responsible individuals from Bradford University pharmacy  
    department tor from the NHS trust where it is relevant to my 
     taking part in this research.  
 
5. I agree to take part in this study 
                                                                                                                            
 
____________________   ____________ __________ 
Name of participant                            Date                        Signature 
                                                                                                                       
____________________   ____________ __________ 
Name of researcher                             Date                  Signature 
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Appendix 9 – Interview schedule for interviews with participants 
 
The following is a set of questions to provide an initial structure to the 
interview. The order of questions may change between interviewees and 
the interviewer can ask additional questions to explore areas or clarify 
issues raised during the interview. The phrasing of the questions may be 
adjusted to match the participant’s vocabulary.  
 
Written consent will be obtained to record the session and issues of 
anonymity and confidentiality will be readdressed when recording begins. 
 
Background:  
x When were you diagnosed with Parkinson’s disease? 
 
x What treatments are you currently using to manage your Parkinson’s 
disease? 
 
x Prior to your admission to hospital, how did you remember when to 
take your medications for Parkinson’s disease? 
 
x Do you find it helpful to take your medications at specific times?  
 
x Prior to your admission to hospital, what were your experiences of 
not taking you medicines for Parkinson’s disease at your usual 
times? 
  - 276 -
x Prior to this admission to hospital, what beliefs did you have about 
how your Parkinson’s disease medicines would be managed when 
you were admitted to hospital? 
 
Questions related to hospital admission: 
x What is your opinion about your contribution to the process of 
prescribing your regular medications on a hospital prescription 
chart? 
 
x Did a pharmacist approach you to confirm the medicines that you 
take at home and when you take each medicine?  
 
x Whilst you have been on the ward, what has been your experience 
of the availability of your medicines for Parkinson’s disease?  
 
x Whilst you have been on the ward, what has been your experience 
of the timings of doses of your medicines for Parkinson’s disease?  
 
x Do you think that you have experienced any changes in your 
symptom control during your admission to hospital?  
 
x What are your opinions about the way that your medicines are 
stored whilst you are admitted to hospital? 
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x What are your opinions about being able to give yourself your own 
medications whilst you are admitted to hospital? 
 
x What is your opinion about ward doctors and nurses managing your 
Parkinson’s disease medication whilst you are admitted to hospital? 
 
x What is your opinion about whether a member of the Parkinson’s 
disease specialist team should contribute to your treatment whilst you 
are admitted to hospital? 
 
x What other information about your Parkinson’s disease or your 
medicines would you have liked to have received during your 
admission? 
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Appendix 10 – Theoretical memo showing formation of the category 
'patient involvement' 
 
Early open coding has generated several codes that appear to be related 
to 'patient reliance' and suggest that 'patient reliance' could be a category 
within the data.  
 
The open codes include 'reliant', 'rely on others', 'reliance on carers', 
'reliance on ward staff', 'rely on doctors to advise about medicine 
regimen', 'need support aids to administer medicines' and 'rely on family 
members to organise medicines'. 
 
The open codes suggest that the patient's perceived reliance is on other 
people and on medicine support tools to ensure that their needs related 
to their medicines are satisfied. 
 
The data suggests that those participants who did not usually manage 
their own medicines prior to admission believed that they were 'reliant' 
(in-vivo code) on their carers to ensure that they received the correct 
medicines at the correct time. These participants also suggested that they 
felt 'reliant' on ward staff to administer their medicines during the hospital 
admission. This data suggests that the category of 'patient reliance' could 
be related to patient reliance on others for their care needs, including 
administration of medicines. 
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It is also evident from the data that some participants believe that they 
actively participate in their care, both prior to and during the hospital 
admission. The open codes 'advising doctors about usual medicines', 
'told him what I take' (in-vivo code), 'prompt staff when medicines due' 
and 'advise staff about what medicines should be given at each 
administration time' suggest that the participants are participating in their 
care. These codes are suggestive of a phenomenon of 'patient 
participation'. 
 
I am unclear if these two emerging categories are distinct categories or 
are linked. The data suggests that the properties of the category 'patient 
reliance' (and dimensions of these properties) could be: 
 
Properties Dimensions 
Frequency 
Extent 
Duration  
Often---------------Never 
More ----------------Less 
Long----------------Short 
Table A10.1 Properties and dimensions of these properties for the 
category 'patient reliance' 
 
The data suggests that the properties of the category 'patient 
participation' (and dimensions of these properties) could be: 
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Properties Dimensions 
Frequency 
Duration  
Extent 
Often---------------Never 
Long----------------Short 
More----------------Less 
Table A10.2 Properties and dimensions of these properties for the 
category 'patient participation' 
 
There appears to be overlap between these properties.  
 
The paradigm models for these two categories suggest that their 
conditions and strategies are similar items but opposite views of each 
point e.g. cause of reliance may be an inability to remember the times 
that medicines are due but participation requires a patient to have the 
ability to control their own medication regimen. 
 
The two categories seem to be linked and my thoughts are that the 
category 'patient involvement’ would explain the data associated with 
both of these categories. 'Patient involvement' could be the category with 
the subcategories being 'patient reliance' and 'patient participation'. 
 
The concept of 'patient involvement' should be explored in future 
interviews and existing data should be reviewed in light of this potential 
category.  
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Appendix 11 – Theoretical memo related to exploring the properties 
and dimensions of these properties for the category 'patient 
anxiety' 
 
Question: 
The category of 'patient anxiety' became evident in the data early in the 
data analysis process but what are the properties of the category and 
dimensions of these properties? 
 
Initial thoughts (after interview 6): 
The transcripts of the early interviews contained data that suggested the 
category of 'patient anxiety' and this data also suggested possible 
properties of the category. 
 
Some of the participants reported that they felt anxious at particular 
points during their hospital admission (e.g. when their prescription was 
being written, when medication doses were being administered). Does 
this suggest that a property could be 'frequency' of feeling anxious? This 
requires further exploration which may involve considering whether 
participants have frequent episodes of anxiety or their anxiety is related to 
specific events. 
 
The available data seems to suggest that participants were able to 
articulate when their anxiety was first apparent and how long the anxiety 
lasted for. Some participants suggested that their anxiety resolved once 
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they had taken steps to address the cause of their anxiety whereas other 
participants remained anxious throughout their hospital admission. This 
data could be suggestive of a property of 'duration' of anxiety. The data 
also suggests that the dimensions of this property could be: 
 
    long periods       short periods  
 
Each patient's 'duration' of anxiety could be situated on this continuum. 
This possible property requires exploration during future interviews. 
 
The available data also suggests that some participants were highly 
anxious about all aspects of their care and were concerned about all 
activities that their nurses undertook whereas others were anxious but the 
intensity of their anxiety was reduced compared to that experienced by 
other participants. Could this be suggestive of a property of 'intensity' of 
anxiety or is it 'magnitude'? For some patients the anxiety preoccupied 
their daily activities ("I find that I have to be on top of the situation. You 
know I can’t just trust it will come to be. You know what I meant. You 
have to keep on top of it, especially when it is a life line to me" #6) 
whereas for others the anxiety was present but they could engage in 
other activities. This possible property requires further exploration. 
 
Subsequent thoughts: 
The data collected during later interviews suggested that whilst some 
participants stated that they had felt anxious during their admission others 
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explained that they had not been anxious at any point during their 
admission ("No. I don’t worry" #8). The data suggests that a property of 
the category 'patient anxiety' is 'frequency' of anxiety and the dimensions 
are 'often to never'. 
 
The data also suggests that 'intensity' is a property of the category with 
the dimensions being 'high to low'. 
 
Some participants articulated that they had become anxious due to 
concerns about a specific event and once that event had been addressed 
their anxiety was reduced (e.g. the prescriber writing the participant's 
prescription chart) whereas other participants remained anxious for 
prolonged periods of time. The data was suggestive that a property of the 
category 'patient anxiety' is 'duration' of anxiety and the dimensions are 
'long to short'. 
 
The properties of 'patient anxiety' suggested by the data and the 
dimensions of these properties are summarised in Table A11.1 below. 
 
Category Properties Dimensions 
Patient anxiety Frequency 
Intensity 
Duration  
Often---------------Never 
High ---------------Low 
Long---------------Short 
Table A11.1 Properties and dimensions of these properties for the 
category 'patient anxiety' 
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Appendix 12 – The components of the paradigm model utilised 
during the data analysis process in this study 
 
The paradigm model proposed by Strauss and Corbin (1990) was utilised 
in this study to provide a framework to explore categories and 
connections between the categories. The model was modified in 2008 to 
have a procedural emphasis (Corbin & Strauss, 2008) but the approach 
utilised in this study focuses on the original paradigm model. 
 
The elements of the model are: 
 
x phenomenon, 
x causal conditions, 
x context, 
x intervening conditions, 
x action/interactional strategies, and, 
x consequences. 
 
Strauss and Corbin (1990) provide a description of each element of the 
model and these are detailed below. 
 
Phenomenon. This is the "central idea, event, happening, about which a 
set of actions/interactions is directed at managing or handling, or to which 
the set is related" (Strauss & Corbin, 1990 pp 100). 
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Causal conditions. These are "the events or incidents that lead to the 
occurrence or development of a phenomenon" (Strauss & Corbin, 1990 
pp 100).  
 
Context. This "represents the specific set of properties that pertain to a 
phenomenon" (Strauss & Corbin, 1990 pp 101) and is "the particular set 
of conditions within which the action/interaction strategies are taken to 
manage, handle, carry out, and respond to a specific phenomenon" 
(Strauss & Corbin, 1990 pp 101). 
 
Intervening conditions. "These conditions act to either facilitate or 
constrain the action/interactional strategies taken within a specific 
context" (Strauss & Corbin, 1990 pp 103). 
 
Action/Interactional strategies. These are "action/interaction, which is 
directed at managing, handling, carrying out, responding to a 
phenomenon as it exists in context or under a specific set of perceived 
conditions" (Strauss & Corbin, 1990 pp 104). 
 
Consequences. These are the "outcomes or consequences" (Strauss & 
Corbin, 1990 pp 106) that occur in response to an action or interaction. 
 
A paradigm model was used to explore each category, including the core 
category. These descriptions informed the development of each paradigm 
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model utilised in this study. An example of a paradigm model prepared for 
one of the categories generated in this study is detailed in appendix 13. 
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The paradigm model for 'maintaining usual medication routine' highlighted 
possible relationship between the properties and dimensions of the 
category 'maintaining usual medication routine' and the properties and 
dimensions of several other categories. The possible relationships are 
summarised in Figure A13.1. 
 
 
Accuracy and 
consistency
Maintaining usual 
medication routine
Patient 
involvement
Maintain usual medication 
routine or not
Staff knowledge about
Parkinson’s disease
Access to antiparkinsonian 
medicines
Consequence
Action strategies
Phenomenon
Causal conditions
 
Figure A13.1 Connections between the category of 'maintaining usual 
medication routine’ and the other categories 
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Appendix 14 – Using the paradigm model for the core category 
'patient anxiety' to identify causes of this anxiety and methods 
that can be used to manage the anxiety 
 
The elements of the paradigm model are detailed in appendix 12 but brief 
definitions of each element are described throughout this appendix to aid 
the reader to understand how the paradigm was utilised to explore the 
core category 'patient anxiety' and its relationships with the other 
categories identified within the data. 
 
Phenomenon. The "central idea" (Strauss & Corbin, 1990 pp 100) in this 
study is 'patient anxiety'.  
 
Causal conditions. These are the "events or incidents that lead to the 
occurrence or development of a phenomenon" (Strauss & Corbin, 1990 
pp 100). The data suggests that the causal conditions for 'patient anxiety' 
are related to the categories: 
 
x maintaining usual medication routine, 
x accuracy and consistency, 
x access to antiparkinsonian medicines, 
x staff knowledge about Parkinson's disease, and, 
x trust in healthcare professionals. 
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Context. This is "the specific set of properties that pertain to a 
phenomenon" (Strauss & Corbin, 1990 pp 101) and "the particular set of 
conditions within which the action/interaction strategies" are implemented 
(Strauss & Corbin, 1990 pp 101). 
 
The properties for the category 'patient anxiety' and the dimensions of 
these properties are detailed in Table A14.1 below. The thought 
processes related to the naming of these properties and dimensions is 
discussed in appendix 11. 
 
Properties Dimensions 
Frequency 
Intensity 
Duration 
Often--------------Never 
High ---------------Low 
Long----------------Short 
Table A14.1. Properties and dimensions of these properties for the 
category of 'patient anxiety' 
 
Under conditions where a participant is often anxious or the intensity of 
their anxiety is high or the patient was anxious for a long period of time, 
the patient may implement the action strategies discussed below.  
 
Under conditions where the participant is not anxious they do not 
implement the action strategies. 
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Action/Interactional strategies. These are "action/interaction, which is 
directed at managing ... [or] ... responding to a phenomenon" (Strauss & 
Corbin, 1990 pp 104). 
 
The action strategies in this study are related to the categories 'patient 
involvement' and 'utilising expertise'. The strategies include: 
 
x the patient participating in the prescribing process, 
x the patient providing a supply of medicines to maintain access 
to medicines, 
x the patient prompting staff when a medication dose is due, 
x self-administration of medication, 
x access to experts in Parkinson's disease. 
 
When a patient is anxious due to a belief that they need to maintain their 
usual medication routine then the patient may utilise the following 
strategies:  
 
x participating in the prescribing process and advising doctors about 
their usual medication routine,  
x providing a supply of medicines, 
x prompting staff when a medication dose is due,  
x self-administering medication. 
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When a patient is anxious due to concerns about 'accuracy' of a 
prescription then the patient may: 
 
x participate in the prescribing process, 
x utilise expert knowledge. 
 
When a patient is anxious due to concerns about 'access to 
antiparkinsonian medicines' then the patient may: 
 
x provide a supply of medicines. 
 
When a patient is anxious due to a perceived lack of 'staff knowledge 
about Parkinson's disease' then the patient can: 
 
x use their own knowledge to educate staff, 
x ask experts in Parkinson's disease to educate staff. 
 
When a patient is anxious due to a lack of trust in the healthcare 
professionals managing their medicines they may: 
 
x participate in the prescribing process, 
x provide medicines to maintain access to medicines, 
x prompt staff when a medication dose is due, 
x self-administer medication, 
x ask experts in Parkinson's disease to educate staff. 
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Intervening conditions. "These conditions act to either facilitate or 
constrain the action/interactional strategies taken within a specific 
context" (Strauss & Corbin, 1990 pp 103). 
 
Conditions that facilitate action strategies 
a) conditions that facilitate the action strategy 'participate in the 
prescribing process' include: 
 
x patient knowledge about medication routine, 
x good patient-doctor relationship, 
x patient being able to communicate. 
 
b) conditions that facilitate the action strategy 'providing medicines to 
maintain access to medicines' include: 
 
x the patient brought a supply of their medicines with them to the 
hospital. 
 
c) conditions that facilitate the action strategy 'prompt staff when 
medication dose is due' include:  
 
x the patient has access to a timing device, 
x the patient has an awareness of the concept of time, 
x the patient is able to contact staff, 
x the patient is able to access staff. 
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d) conditions that facilitate the action strategy 'self-administration of 
medication' include: 
 
x the availability of a self-administration of medication scheme 
within the hospital, 
x the patient is competent to self-administer their medications, 
x the patient has access to their compliance aid or reminder 
chart, 
x the patient has access to a supply of their medication, 
 
e) conditions that facilitate the action strategy 'access to experts in 
Parkinson's disease' include: 
 
x the presence of a PDNS within the hospital, 
x an agreement from the consultant neurologists or PDNS to be 
contacted when a patient with Parkinson's disease is admitted 
to hospital, 
x ward staff referring a patient to the PDNS or consultant 
neurologist when the patient is admitted to hospital. 
 
Conditions that constrain action strategies 
a) conditions that constrain the action strategy 'participate in the 
prescribing process' include: 
 
x unconscious/impaired patients, 
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x lack of patient knowledge about their usual routine, 
x doctor ignores information provided by patient.                 
 
b) conditions that constrain the action strategy 'providing medicines to 
maintain access to medicines' include: 
 
x the patient is admitted to hospital acutely without their own 
medicines. 
 
c) conditions that constrain the action strategy 'prompt staff when 
medication dose is due' include:  
 
x the patient does not have access to timing device, 
x the patient is unaware of the concept of time, 
x the patient is unable to contact staff, 
x the patient is unable to access staff. 
 
d) conditions that constrain the action strategy 'self-administration of 
medication' include:      
 
x a lack of availability of a self-administration of medication 
scheme within the hospital, 
x the patient is unable to administer their own medications due to 
mental or physical disability, 
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x the patient does not have access to their usual medication 
support tools, 
x the patient's medications are unavailable in the ward area, 
 
e) conditions that constrain the action strategy 'access to experts in 
Parkinson's disease' include: 
 
x the hospital trust does not employ a PDNS, 
x a lack of agreement from consultant neurologists or PDNS to 
be contacted when a patient with Parkinson's disease is 
admitted to hospital, 
x ward staff do not refer the patient to the PDNS or consultant. 
 
Consequence:  
When action strategies that are intended to reduce 'patient anxiety' are 
utilised then a patient's anxiety may be reduced. 
 
When these strategies can not be utilised a patient's anxiety may persist. 
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Appendix 15 – "Bringing process into the analysis" 
Quote from Strauss and Corbin (1990 pp 143) 
 
Theoretical memo: Process is an essential element of the theory 
generated in a grounded theory study but what is the process 
evident within the theory for this study? 
 
As process is the "linking of sequences of action/interaction as they 
pertain to the management of, control over, or response to a 
phenomenon" (Strauss & Corbin, 1990 pp 143) how does this definition 
transfer into practice? Process seems to be articulated by explaining how 
the action strategies chosen will change as the causes of the 'patient 
anxiety' change. 
 
In the event that there is a change in the causal conditions (maintaining 
usual medication routine, accuracy and consistency, access to 
antiparkinsonian medicines, staff knowledge about Parkinson's disease 
and trust in healthcare professionals) then the use of the action strategies 
'patient involvement' and 'utilising expertise' will change. 
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How can the causal conditions change? 
The conditions could change if:   
 
a) a patient's usual medication routine is not maintained, 
b) a patient perceives a lack of staff knowledge about Parkinson's 
disease, 
c) a patient is unable to access their antiparkinsonian medication due to 
lack of availability of the medication, 
d) the patient's routine is maintained, 
e) consistency is achieved, 
f) the patient perceives an improvement in staff knowledge, 
g) the patient develops trust in the healthcare professionals managing 
their care. 
 
What would the action/interactional responses be to those 
changes? 
a) if a patient's usual medication routine is not maintained then patients 
can: 
 
x prompt staff when dose is due ('patient involvement'), 
x use their knowledge to educate staff about why the routine is 
important ('patient involvement'),  
x self-administer medication ('patient involvement'), 
x contact PDNS and request their support to maintain routine 
('utilising expertise'). 
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b) if a patient perceives a lack of staff knowledge about Parkinson's 
disease then they may: 
 
x use their knowledge to educate staff ('patient involvement'),   
x request access to expert staff to educate staff ('utilising expertise'). 
 
c) if a patient is unable to access their antiparkinsonian medication due to 
lack of availability of the medication then they may: 
 
x prompt staff to order a supply of the medication ('patient 
involvement'), 
x ask someone to bring a supply of the patient's own medication into 
the hospital ('patient involvement'). 
 
d-g) - the patient may believe that there is less need to participate in their 
care or rely on the PDNS to educate the ward staff. 
 
What are the consequences of these responses? 
Situation a - the patient's routine may be maintained, 
Situation b - staff awareness about Parkinson's disease and its 
management may be increased, 
Situation c - the medications may become available,  
Situations d, e, f and g - the patient may be able to reduce their 
participation in their care. 
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All of these consequences may lead to the outcome of reduced 'patient 
anxiety' but if the strategies are not effective then the sequence of events 
will be repeated. 
 
The time that elapses between the change in causal conditions and the 
response through the strategies is variable. 
 
 
Summary: 
Process is evident within the theory generated from the data because the 
theory provides information about how action strategies would change if 
the causal conditions change. 
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Appendix 16 - Characteristics of the study participants 
Some relevant characteristics of the study population are presented 
below: 
 
Gender 
7 (54%) participants were male 
6 (46%) participants were female 
 
Age 
4 (31%) participants were under 60 years of age 
9 (69%) participants were over 60 years of age 
 
Reason for admission 
The reason for admission was: 
An acute medical indication for 8 (62%) participants  
An acute surgical indication for 3 (23%) participants 
An elective surgical procedure for 2 (15%) participants 
 
Experience of a previous hospital admission since diagnosis with 
Parkinson’s disease 
8 (62%) participants had been admitted to hospital since their diagnosis 
4 (31%) participants had not been admitted to hospital since their 
diagnosis 
No relevant information was available for 1 participant 
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Self-administration of medication 
No participants self-administered their medicines during this hospital 
admission.  
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in
es
 f
or
 r
ev
ie
w
 a
t 
LT
H
Ts
 
dr
ug
 
an
d 
th
er
ap
eu
tic
 
co
m
m
itt
ee
 
m
ee
tin
gs
. 
Th
e 
co
m
m
itt
ee
 is
 c
om
po
se
d 
of
 a
 la
rg
e 
gr
ou
p 
of
 c
lin
ic
ia
ns
, 
ph
ar
m
ac
is
ts
 
an
d 
nu
rs
es
. 
So
m
e 
of
 
th
e 
ap
pl
ic
at
io
ns
 m
ay
 
co
nt
ai
n 
po
in
ts
 
th
at
 a
re
 c
on
te
nt
io
us
.  
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I 
cr
iti
ca
lly
 
re
vi
ew
 
cl
in
ic
al
 
tr
ia
ls
 
re
la
te
d 
to
 
ne
ur
os
ci
en
ce
s 
an
d 
pr
es
en
t 
m
y 
fin
di
ng
s 
at
 
cl
in
ic
al
 
tr
ia
ls
 
au
th
or
is
at
io
n 
gr
ou
p 
m
ee
tin
gs
.  
 In
 m
y 
ro
le
 I
 a
m
 r
es
po
ns
ib
le
 f
or
 
id
en
tif
yi
ng
 
po
ss
ib
le
 
co
st
 
sa
vi
ng
 
in
iti
at
iv
es
 
w
ith
in
 
th
e 
ne
ur
os
ci
en
ce
s 
di
re
ct
or
at
e 
an
d 
im
pl
em
en
tin
g 
th
es
e 
su
gg
es
tio
ns
. I
 
m
an
ag
e 
an
y 
re
si
st
an
ce
 to
 c
ha
ng
e.
 
 Pi
ec
e 
of
 e
vi
de
nc
e 
fr
om
 D
Ph
ar
m
 
pr
og
ra
m
m
e 
1/
C
/2
. 
2 
Te
am
w
or
k 
an
d 
C
on
su
lta
tio
n 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 w
or
k 
as
 a
 m
em
be
r o
f t
he
 p
ha
rm
ac
y 
te
am
 
 R
ec
og
ni
se
s 
pe
rs
on
al
 
lim
ita
tio
ns
 a
nd
 is
 a
bl
e 
to
 r
ef
er
 
to
 m
or
e 
ap
pr
op
ria
te
 c
ol
le
ag
ue
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 w
or
k 
as
 
an
 
ac
kn
ow
le
dg
ed
 
m
em
be
r 
of
 
a 
m
ul
tid
is
ci
pl
in
ar
y 
te
am
 
 Ac
ce
pt
s 
co
ns
ul
ta
tio
n 
fo
r 
sp
ec
ia
lis
t 
ad
vi
ce
 f
ro
m
 w
ith
in
 t
he
 
or
ga
ni
sa
tio
n 
W
or
ks
 
ac
ro
ss
 
bo
un
da
rie
s 
to
 
bu
ild
 
re
la
tio
ns
hi
ps
 
an
d 
sh
ar
e 
in
fo
rm
at
io
n,
 
pl
an
s 
an
d 
re
so
ur
ce
s  
 So
ug
ht
 a
s 
an
 o
pi
ni
on
 l
ea
de
r 
bo
th
 
w
ith
in
 t
he
 o
rg
an
is
at
io
n 
an
d 
in
 t
he
 
ex
te
rn
al
 e
nv
iro
nm
en
t 
Ev
id
en
ce
 
 
 
Pi
ec
es
 o
f 
ev
id
en
ce
 2
B
1,
 3
C
2 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
 As
 
a 
m
em
be
r 
of
 
th
e 
U
K
C
PA
 
ne
ur
os
ci
en
ce
s 
co
m
m
itt
ee
 
I 
am
 
fr
eq
ue
nt
ly
 
in
vi
te
d 
to
 
pr
ov
id
e 
op
in
io
n 
ab
ou
t N
IC
E 
gu
id
an
ce
.  
 I w
as
 in
vi
te
d 
to
 b
ec
om
e 
pa
rt
 o
f t
he
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11
 - 
     
  N
o.
 
3.
 L
ea
de
rs
hi
p 
In
sp
ire
s  
in
di
vi
du
al
s 
an
d 
te
am
s 
to
 a
ch
ie
ve
 h
ig
h 
st
an
da
rd
s 
of
 p
er
fo
rm
an
ce
 a
nd
 p
er
so
na
l d
ev
el
op
m
en
t 
 C
om
pe
te
nc
y 
C
om
pe
te
nc
y 
Le
ve
l D
es
cr
ip
to
rs
 
Fo
un
da
tio
n 
Ex
ce
lle
nc
e 
 
 
M
as
te
ry
 
 
1 
 S
tr
at
eg
ic
 C
on
te
xt
 
 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 t
he
 n
ee
ds
 o
f 
st
ak
eh
ol
de
rs
 
an
d 
pr
ac
tic
e 
re
fle
ct
s 
bo
th
 lo
ca
l 
an
d 
na
tio
na
l h
ea
lth
 c
ar
e 
po
lic
y 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
in
co
rp
or
at
e 
na
tio
na
l 
he
al
th
ca
re
 
po
lic
y 
to
 in
flu
en
ce
 lo
ca
l s
tra
te
gy
. 
 
D
em
on
st
ra
te
s 
ac
tiv
e 
pa
rti
ci
pa
tio
n 
in
 
cr
ea
tin
g 
na
tio
na
l h
ea
lth
 c
ar
e 
po
lic
ie
s 
 
Ev
id
en
ce
 
    
 
M
y 
co
nt
rib
ut
io
n 
to
 
th
e 
ge
ne
ric
 
an
tie
pi
le
pt
ic
 
w
or
ki
ng
 
gr
ou
p 
w
ill
 
he
lp
 
to
 
sh
ap
e 
na
tio
na
l 
po
lic
y 
ab
ou
t 
us
in
g 
ge
ne
ric
 a
nt
ie
pi
le
pt
ic
s 
w
ith
in
 th
e 
N
H
S.
 
 Th
e 
im
pl
ic
at
io
ns
 
fo
r 
pr
ac
tic
e 
id
en
tif
ie
d 
du
rin
g 
th
e 
pr
oj
ec
t 
un
de
rt
ak
en
 a
s 
pa
rt
 o
f 
th
e 
G
Ph
C
 
ea
rly
 a
do
pt
er
 i
ni
tia
tiv
e 
ar
e 
be
in
g 
co
ns
id
er
ed
 b
y 
Pa
rk
in
so
n’
s 
U
K
 a
s 
pa
rt
 o
f t
he
ir 
na
tio
na
l w
or
k.
 
 na
tio
na
l 
w
or
ki
ng
 
pa
rt
y 
co
ns
id
er
in
g 
th
e 
us
e 
of
 
ge
ne
ric
 
an
tie
pi
le
pt
ic
 
m
ed
ic
in
es
 
in
 
th
e 
m
an
ag
em
en
t o
f e
pi
le
ps
y 
pa
tie
nt
s 
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2 
C
lin
ic
al
 G
ov
er
na
nc
e 
 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 th
e  
ph
ar
m
ac
y 
ro
le
 
in
 
cl
in
ic
al
 
go
ve
rn
an
ce
.  
Im
pl
em
en
ts
 t
hi
s 
ap
pr
op
ria
te
ly
 
w
ith
in
 th
e  
or
ga
ni
sa
tio
n 
In
flu
en
ce
s 
th
e 
cl
in
ic
al
 
go
ve
rn
an
ce
 
ag
en
da
 
fo
r 
th
e 
te
am
.  
  
 S
ha
pe
s 
an
d 
co
nt
rib
ut
es
 
to
 
th
e 
cl
in
ic
al
 
go
ve
rn
an
ce
 
ag
en
da
 
at
 
a 
hi
gh
er
 le
ve
l.  
  
Ev
id
en
ce
 
 
 
Pi
ec
es
 o
f 
ev
id
en
ce
 2
B
1 
an
d 
3C
2 
fr
om
 D
Ph
ar
m
 p
ro
gr
am
m
e.
 
3 
Vi
si
on
 
   
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
, a
nd
 
co
nt
rib
ut
es
 to
, t
he
 d
ep
ar
tm
en
t 
an
d  
co
rp
or
at
e 
vi
si
on
. 
C
re
at
es
 
vi
si
on
 
of
 
fu
tu
re
 
an
d 
tra
ns
la
te
s 
th
is
 
in
to
 
cl
ea
r 
di
re
ct
io
ns
 
fo
r 
st
af
f 
an
d 
su
pe
rv
is
or
s  
C
on
vi
nc
es
 o
th
er
s 
to
 s
ha
re
 th
e 
vi
si
on
 
at
 a
 h
ig
he
r l
ev
el
.  
Ev
id
en
ce
 
 
Pi
ec
e 
of
 e
vi
de
nc
e 
3B
2.
 
 
4 
In
no
va
tio
n 
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
im
pr
ov
e 
qu
al
ity
 
w
ith
in
 li
m
ita
tio
ns
 o
f s
er
vi
ce
. 
R
eq
ui
re
s 
lim
ite
d 
su
pe
rv
is
io
n 
R
ec
og
ni
se
s 
an
d 
im
pl
em
en
ts
 
in
no
va
tio
n 
fro
m
 
th
e 
ex
te
rn
al
 
en
vi
ro
nm
en
t. 
 
D
oe
s 
no
t r
eq
ui
re
 s
up
er
vi
si
on
 
Ta
ke
s 
th
e 
le
ad
 t
o 
en
su
re
 in
no
va
tio
n 
pr
od
uc
es
 
de
m
on
st
ra
bl
e 
im
pr
ov
em
en
t 
in
 
se
rv
ic
e 
de
liv
er
y.
 
Ev
id
en
ce
 
    
 
Th
is
 
w
as
 
de
m
on
st
ra
te
d 
th
ro
ug
h 
m
y 
ro
le
 a
s 
pr
oj
ec
t m
an
ag
er
 fo
r t
he
 
pr
oj
ec
t 
re
la
te
d 
to
 t
he
 G
Ph
C
 e
ar
ly
 
ad
op
te
r i
ni
tia
tiv
e.
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5 
Se
rv
ic
e 
D
ev
el
op
m
en
t  
 
R
ev
ie
w
s 
la
st
 y
ea
r’s
 p
ro
gr
es
s 
an
d  
de
ve
lo
ps
 
cl
ea
r 
pl
an
s 
to
 
ac
hi
ev
e 
re
su
lts
 
w
ith
in
 p
rio
rit
ie
s 
se
t b
y 
ot
he
rs
. 
D
ev
el
op
s 
cl
ea
r 
un
de
rs
ta
nd
in
g 
of
 
pr
io
rit
ie
s 
an
d 
fo
rm
ul
at
es
 
pr
ac
tic
al
 s
ho
rt -
te
rm
 p
la
ns
 in
 li
ne
 
w
ith
 d
ep
ar
tm
en
t s
tra
te
gy
.  
R
el
at
es
 
go
al
s 
an
d 
ac
tio
ns
 
to
 
st
ra
te
gi
c 
ai
m
s 
of
 
or
ga
ni
sa
tio
n 
an
d 
pr
of
es
si
on
. 
 
Ev
id
en
ce
 
 
 
Pi
ec
e 
of
 
ev
id
en
ce
 
3B
2 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
6 
M
ot
iv
at
io
na
l 
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
m
ot
iv
at
e 
se
lf 
to
 
ac
hi
ev
e 
go
al
s 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 m
ot
iv
at
e 
in
di
vi
du
al
s 
in
 th
e 
te
am
.  
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
m
ot
iv
at
e 
in
di
vi
du
al
s 
at
 a
 h
ig
he
r l
ev
el
.  
Ev
id
en
ce
 
    
D
em
on
st
ra
te
d 
in
 a
n 
es
sa
y 
fo
r 
le
ad
er
sh
ip
 
m
od
ul
e 
w
hi
ch
 
re
fle
ct
ed
 
on
 
in
fo
rm
at
io
n 
pr
ov
id
ed
 b
y 
ot
he
rs
 a
bo
ut
 m
y 
le
ad
er
sh
ip
 s
ty
le
. 
 
 N
o.
 
4.
 M
an
ag
em
en
t 
 
 
 
 
 
 
 
O
rg
an
is
es
 a
nd
 d
el
iv
er
s 
se
rv
ic
e 
ob
je
ct
iv
es
 in
 a
 ti
m
el
y 
fa
sh
io
n  
C
om
pe
te
nc
y 
C
om
pe
te
nc
y 
Le
ve
l D
es
cr
ip
to
rs
 
Fo
un
da
tio
n 
Ex
ce
lle
nc
e 
 
 
M
as
te
ry
  
 
 
 
1 
Im
pl
em
en
tin
g 
N
at
io
na
l 
Pr
io
rit
ie
s  
 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 t
he
 im
pl
ic
at
io
ns
 o
f 
na
tio
na
l 
pr
io
rit
ie
s 
fo
r t
he
 
te
am
 
Sh
ap
es
 
th
e 
re
sp
on
se
 
of
 
th
e 
te
am
 to
 n
at
io
na
l p
rio
rit
ie
s.
 
 
Ac
co
un
ta
bl
e 
fo
r 
th
e 
di
re
ct
 d
el
iv
er
y 
of
 
na
tio
na
l p
rio
rit
ie
s 
at
 a
 h
ig
he
r l
ev
el
. 
 
Ev
id
en
ce
 
 
 
I a
m
 r
es
po
ns
ib
le
 f
or
 w
or
ki
ng
 w
ith
 
th
e 
re
le
va
nt
 c
lin
ic
ia
ns
 t
o 
pr
ov
id
e 
LT
H
T’
s 
re
sp
on
se
 
to
 
N
PS
A 
an
d 
N
IC
E 
gu
id
an
ce
 
re
la
te
d 
to
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ne
ur
os
ci
en
ce
s.
 
2 
R
es
ou
rc
e 
U
til
is
at
io
n 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 th
e  
pr
oc
es
s 
fo
r 
ef
fe
ct
iv
e 
re
so
ur
ce
 
ut
ilis
at
io
n 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
ef
fe
ct
iv
el
y 
m
an
ag
e 
re
so
ur
ce
s.
 
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 r
ec
on
fig
ur
e 
th
e 
us
e 
of
 
av
ai
la
bl
e 
re
so
ur
ce
s.
 
Ev
id
en
ce
 
  
 
Pi
ec
es
 o
f e
vi
de
nc
e 
3/
B
/2
 a
nd
 3
/B
/3
 
fr
om
 D
Ph
ar
m
 p
ro
gr
am
m
e.
 
3 
St
an
da
rd
s 
of
 p
ra
ct
ic
e 
 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
, 
an
d 
co
nf
or
m
s 
to
, 
re
le
va
nt
 
st
an
da
rd
s 
of
 p
ra
ct
ic
e 
Ac
co
un
ta
bl
e 
fo
r 
th
e 
se
tti
ng
 a
nd
 
m
on
ito
rin
g 
of
 
st
an
da
rd
s 
of
 
pr
ac
tic
e 
at
 te
am
 le
ve
l 
Ac
co
un
ta
bl
e 
fo
r 
th
e 
se
tti
ng
 
an
d 
m
on
ito
rin
g 
of
 s
ta
nd
ar
ds
 a
t 
a 
hi
gh
er
 
le
ve
l 
Ev
id
en
ce
 
      
 
D
ev
el
op
in
g 
na
tio
na
lly
 
ac
ce
pt
ed
 
co
m
pe
te
nc
ie
s 
fo
r 
ne
ur
os
ci
en
ce
s 
ph
ar
m
ac
is
ts
 
al
lo
w
ed
 
m
e 
to
 
co
nt
rib
ut
e 
to
 
th
e 
se
tti
ng
 
of
 
na
tio
na
l 
st
an
da
rd
s.
 W
or
k 
is
 o
n-
go
in
g 
to
 
de
ve
lo
p 
m
et
ho
ds
 
to
 
as
se
ss
 w
he
th
er
 p
ha
rm
ac
is
ts
 a
re
 
ac
hi
ev
in
g 
th
es
e 
st
an
da
rd
s.
 
4 
M
an
ag
in
g 
R
is
k 
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
id
en
tif
y 
an
d  
re
so
lv
e 
ris
k 
m
an
ag
em
en
t 
is
su
es
 
ac
co
rd
in
g 
to
 
po
lic
y/
pr
ot
oc
ol
 
 
Is
 
ac
co
un
ta
bl
e 
fo
r 
de
ve
lo
pi
ng
 
ris
k 
m
an
ag
em
en
t 
po
lic
ie
s/
pr
ot
oc
ol
s 
fo
r 
th
e 
te
am
, 
in
cl
ud
in
g 
id
en
tif
yi
ng
 a
nd
 
re
so
lv
in
g 
ne
w
 r
is
k 
m
an
ag
em
en
t 
is
su
es
 
Is
 
ac
co
un
ta
bl
e 
fo
r 
de
ve
lo
pi
ng
 
ris
k 
m
an
ag
em
en
t 
po
lic
ie
s/
pr
oc
ed
ur
es
 a
t 
a 
hi
gh
er
 l
ev
el
, 
in
cl
ud
in
g 
id
en
tif
yi
ng
 
an
d 
re
so
lv
in
g 
ne
w
 r
is
k 
m
an
ag
em
en
t 
is
su
es
 
Ev
id
en
ce
 
   
Pi
ec
es
 o
f 
ev
id
en
ce
 2
/B
/1
 a
nd
 
2/
C
/1
 
fr
om
 
D
Ph
ar
m
 
pr
og
ra
m
m
e.
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5 
M
an
ag
in
g 
Pe
rf
or
m
an
ce
 
 
Fo
llo
w
s 
pr
of
es
si
on
al
 
an
d 
or
ga
ni
sa
tio
na
l  
po
lic
ie
s/
pr
oc
ed
ur
es
 re
la
tin
g 
to
 
pe
rfo
rm
an
ce
 
m
an
ag
em
en
t. 
 
R
ef
er
s  
ap
pr
op
ria
te
ly
 to
 c
ol
le
ag
ue
s 
fo
r 
gu
id
an
ce
. 
Is
 a
cc
ou
nt
ab
le
 f
or
 p
er
fo
rm
an
ce
 
m
an
ag
em
en
t f
or
 th
e 
te
am
 
  
Is
 
ac
co
un
ta
bl
e 
fo
r 
pe
rfo
rm
an
ce
 
m
an
ag
em
en
t a
t a
 h
ig
he
r l
ev
el
.  
   
Ev
id
en
ce
 
 
Pi
ec
e 
of
 
ev
id
en
ce
 
3e
 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
 
6 
Pr
oj
ec
t M
an
ag
em
en
t 
 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 th
e  
pr
in
ci
pl
es
 
of
 
pr
oj
ec
t 
m
an
ag
em
en
t. 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
su
cc
es
sf
ul
ly
 m
an
ag
e 
a 
pr
oj
ec
t a
t 
te
am
 le
ve
l.  
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 s
uc
ce
ss
fu
lly
 
m
an
ag
e 
a  
pr
oj
ec
t a
t a
 h
ig
he
r l
ev
el
 
 
Ev
id
en
ce
 
  
Pi
ec
e 
of
 e
vi
de
nc
e 
3B
2 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
 
7 
M
an
ag
in
g 
C
ha
ng
e 
 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 th
e  
pr
in
ci
pl
es
 
of
 
ch
an
ge
 
m
an
ag
em
en
t 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 m
an
ag
e 
a 
pr
oc
es
s 
of
 
ch
an
ge
 
fo
r 
th
e 
te
am
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
m
an
ag
e 
a 
pr
oc
es
s 
of
 
ch
an
ge
 a
t a
 h
ig
he
r l
ev
el
. 
Ev
id
en
ce
 
  
Pi
ec
e 
of
 e
vi
de
nc
e 
3B
2 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
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8 
St
ra
te
gi
c 
Pl
an
ni
ng
 
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 t
hi
nk
 
4-
12
 m
on
th
s 
ah
ea
d 
w
ith
in
 a
 
de
fin
ed
 a
re
a.
 P
la
ns
 t
he
 w
or
k 
pr
og
ra
m
m
e 
to
 
al
ig
n 
w
ith
 
st
ra
te
gy
.  
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 fo
rm
al
 
st
ru
ct
ur
es
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
th
in
k 
ov
er
 
a 
ye
ar
 
ah
ea
d 
w
ith
in
 
a 
de
fin
ed
 
ar
ea
. 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 
cu
ltu
re
 
an
d 
cl
im
at
e 
an
d 
ab
ilit
y 
to
 p
la
n 
w
ith
 
th
e 
w
ho
le
 o
f 
th
e 
or
ga
ni
sa
tio
n 
in
 
m
in
d.
 
 
Th
in
ks
 lo
ng
 te
rm
 a
nd
 s
ec
to
r w
id
e.
  
Ta
ke
s 
th
e 
lo
ng
-te
rm
 p
er
sp
ec
tiv
e.
 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 
or
ga
ni
sa
tio
na
l  
po
lit
ic
s 
ch
an
ge
s 
in
 
th
e 
ex
te
rn
al
 
en
vi
ro
nm
en
t.  
  
Ev
id
en
ce
 
 
I 
an
nu
al
ly
 
pe
rf
or
m
 
ho
riz
on
 
sc
an
ni
ng
 fo
r n
eu
ro
sc
ie
nc
es
. 
 Pi
ec
e 
of
 e
vi
de
nc
e 
3/
B
/3
 f
ro
m
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
 
9 
W
or
ki
ng
 A
cr
os
s 
B
ou
nd
ar
ie
s  
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 e
xt
en
d 
 
bo
un
da
rie
s 
of
 s
er
vi
ce
 d
el
iv
er
y 
w
ith
in
 th
e 
te
am
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 e
xt
en
d 
th
e 
bo
un
da
rie
s 
of
 
th
e 
se
rv
ic
e 
ac
ro
ss
 m
or
e 
th
an
 o
ne
 te
am
 
D
em
on
st
ra
te
s 
th
e 
va
lu
e 
of
 e
xt
en
di
ng
 
bo
un
da
rie
s 
ac
ro
ss
 p
ro
fe
ss
io
ns
/in
 th
e 
ex
te
rn
al
 e
nv
iro
nm
en
t. 
Ev
id
en
ce
 
      
 
I r
ec
og
ni
se
d 
th
at
 th
e 
pr
oj
ec
t t
ha
t I
 
w
as
 l
ea
di
ng
 r
el
at
ed
 t
o 
ex
pl
or
in
g 
in
fo
rm
at
io
n 
tr
an
sf
er
 
w
he
n 
a 
pa
tie
nt
 w
ith
 P
ar
ki
ns
on
’s
 d
is
ea
se
 
re
qu
ire
d 
ex
pe
rt
is
e 
fr
om
 a
 r
an
ge
 o
f 
he
al
th
ca
re
 p
ro
fe
ss
io
na
ls
 th
er
ef
or
e 
I a
ss
em
bl
ed
 a
 w
or
ki
ng
 p
ar
ty
 w
hi
ch
 
w
as
 
co
m
po
se
d 
of
 
ho
sp
ita
l 
ph
ar
m
ac
is
ts
, 
co
m
m
un
ity
 
ph
ar
m
ac
is
ts
, 
G
Ps
, 
co
m
m
un
ity
 
nu
rs
es
 
as
 
w
el
l 
as
 
co
ns
ul
ta
nt
 
ne
ur
ol
og
is
ts
 
an
d 
Pa
rk
in
so
n’
s 
di
se
as
e 
nu
rs
e 
sp
ec
ia
lis
ts
. 
Th
is
 
al
lo
w
ed
 t
he
 r
es
ea
rc
h 
qu
es
tio
n 
to
 
be
 c
on
si
de
re
d 
fr
om
 a
 n
um
be
r 
of
 
pe
rs
pe
ct
iv
es
 a
nd
 e
ns
ur
ed
 th
at
 th
e 
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re
sp
on
se
 w
as
 c
om
pr
eh
en
si
ve
 a
nd
 
re
fle
ct
ed
 
th
e 
M
D
T 
ap
pr
oa
ch
 
to
 
m
an
ag
in
g 
th
e 
ca
re
 o
f p
at
ie
nt
s 
w
ith
 
Pa
rk
in
so
n’
s 
di
se
as
e 
  
 N
o.
 
5.
 E
du
ca
tio
n,
 T
ra
in
in
g 
&
 D
ev
el
op
m
en
t 
 
Su
pp
or
ts
 th
e 
ed
uc
at
io
n,
 tr
ai
ni
ng
 &
 d
ev
el
op
m
en
t o
f o
th
er
s .
 P
ro
m
ot
es
 a
 le
ar
ni
ng
 c
ul
tu
re
 w
ith
in
 th
e 
or
ga
ni
sa
tio
n.
 
C
om
pe
te
nc
y 
C
om
pe
te
nc
y 
Le
ve
l D
es
cr
ip
to
rs
 
Fo
un
da
tio
n 
Ex
ce
lle
nc
e 
 
 
M
as
te
ry
 
 
 
1 
R
ol
e 
M
od
el
 
  
U
nd
er
st
an
ds
 
an
d 
de
m
on
st
ra
te
s 
th
e  
ch
ar
ac
te
ris
tic
s 
of
 a
 ro
le
 m
od
el
 
to
 m
em
be
rs
 o
f t
he
 te
am
 
D
em
on
st
ra
te
s 
th
e 
ch
ar
ac
te
ris
tic
s 
of
 
an
 
ef
fe
ct
iv
e 
ro
le
 m
od
el
 a
t a
 h
ig
he
r l
ev
el
 
 
Is
 
ab
le
 
to
 
de
ve
lo
p 
ef
fe
ct
iv
e 
ro
le
 
m
od
el
 b
eh
av
io
ur
 in
 o
th
er
s  
  
Ev
id
en
ce
 
    
Pi
ec
e 
of
 e
vi
de
nc
e 
is
 p
ro
vi
de
d 
by
 a
 s
ta
te
m
en
t t
ha
t I
 p
re
pa
re
d 
as
 p
ar
t 
of
 l
ea
de
rs
hi
p 
m
od
ul
e 
of
 
th
e 
D
Ph
ar
m
 
pr
og
ra
m
m
e 
w
hi
ch
 
re
fle
ct
ed
 
on
 
m
y 
le
ad
er
sh
ip
 
st
yl
e 
an
d 
ho
w
 
ot
he
rs
 
pe
rc
ei
ve
 
m
e 
as
 
a 
le
ad
er
. 
Th
is
 
pi
ec
e 
of
 
w
or
k 
in
vo
lv
ed
 th
e 
co
lle
ct
io
n 
of
 d
at
a 
fr
om
 o
th
er
 p
ha
rm
ac
is
ts
 a
bo
ut
 
m
y 
le
ad
er
sh
ip
 
st
yl
e 
an
d 
de
m
on
st
ra
te
d 
th
at
 
ot
he
r 
ph
ar
m
ac
is
ts
 p
er
ce
iv
ed
 m
e 
as
 
a 
ro
le
 m
od
el
.  
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2 
M
en
to
rs
hi
p 
 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 th
e  
m
en
to
rs
hi
p 
pr
oc
es
s 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
ef
fe
ct
iv
el
y 
m
en
to
r 
ot
he
rs
 w
ith
in
 
th
e 
te
am
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
ef
fe
ct
iv
el
y 
m
en
to
r o
ut
si
de
 th
e 
te
am
.  
Ev
id
en
ce
 
    
 
Pi
ec
e 
of
 
ev
id
en
ce
 
2B
3 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
 I 
re
gu
la
rly
 
m
en
to
r 
ju
ni
or
 
ph
ar
m
ac
is
ts
.  
  I 
al
so
 
m
en
to
r 
te
ch
ni
ci
an
s 
un
de
rt
ak
in
g 
a 
de
gr
ee
 p
ro
gr
am
m
e.
 
3 
C
on
du
ct
in
g 
Ed
uc
at
io
n 
&
 T
ra
in
in
g  
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
co
nd
uc
t t
ea
ch
in
g  
ef
fic
ie
nt
ly
 
ac
co
rd
in
g 
to
 
a 
le
ss
on
 p
la
n 
w
ith
 
su
pe
rv
is
io
n 
fro
m
 
a 
m
or
e 
ex
pe
rie
nc
ed
 
co
lle
ag
ue
 
Is
 
ab
le
 
to
 
as
se
ss
 
th
e 
pe
rfo
rm
an
ce
 a
nd
 le
ar
ni
ng
 n
ee
ds
 
of
 o
th
er
s.
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 p
la
n 
a 
se
rie
s 
of
 
ef
fe
ct
iv
e 
le
ar
ni
ng
 
ex
pe
rie
nc
es
 fo
r o
th
er
s.
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 d
es
ig
n 
an
d 
m
an
ag
e 
a 
co
ur
se
 
of
 
st
ud
y,
 
w
ith
 
ap
pr
op
ria
te
 
us
e 
of
 
te
ac
hi
ng
, 
as
se
ss
m
en
t a
nd
 s
tu
dy
 m
et
ho
ds
 
 
Ev
id
en
ce
 
    
 P
ie
ce
 o
f e
vi
de
nc
e 
fr
om
 C
H
EP
 
po
rt
fo
lio
 s
ec
tio
n 
7.
 
 Pi
ec
e 
of
 e
vi
de
nc
e 
3C
5 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
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4 
C
on
tin
ui
ng
 
Pr
of
es
si
on
al
 
D
ev
el
op
m
en
t 
 
D
em
on
st
ra
te
s 
se
lf-
de
ve
lo
pm
en
t t
hr
ou
gh
 
ro
ut
in
e 
C
on
tin
ui
ng
 
Pr
of
es
si
on
al
 
D
ev
el
op
m
en
t 
ac
tiv
ity
 
w
ith
 
fa
ci
lit
at
io
n 
Ac
ts
 
as
 
a 
C
on
tin
ui
ng
 
Pr
of
es
si
on
al
 
D
ev
el
op
m
en
t 
fa
ci
lit
at
or
 
  
Sh
ap
es
 
an
d 
co
nt
rib
ut
es
 
to
 
th
e 
C
on
tin
ui
ng
 
Pr
of
es
si
on
al
 
D
ev
el
op
m
en
t 
st
ra
te
gy
 
at
 a
 l
oc
al
 (
ou
ts
id
e 
of
 d
is
ci
pl
in
e)
 o
r 
ex
te
rn
al
 (w
ith
in
 d
is
ci
pl
in
e)
 le
ve
ls
.  
Ev
id
en
ce
 
 
 
I h
av
e 
de
ve
lo
pe
d 
ca
se
 s
tu
di
es
 f
or
 
C
PP
E 
tr
ai
ni
ng
 p
ac
ka
ge
s.
 
 I 
co
nt
rib
ut
e 
to
 
U
K
C
PA
 
ne
ur
os
ci
en
ce
s 
st
ud
y 
da
ys
 a
nd
 I
 
fr
eq
ue
nt
ly
 
de
si
gn
 
an
d 
de
liv
er
 
w
or
ks
ho
ps
 
fo
r 
ph
ar
m
ac
is
ts
 
at
te
nd
in
g 
th
e 
U
K
C
PA
 
an
nu
al
 
co
nf
er
en
ce
. 
5 
Li
nk
s 
Pr
ac
tic
e 
an
d 
Ed
uc
at
io
n  
 
Pa
rti
ci
pa
te
s 
in
 
th
e 
fo
rm
al
 
ed
uc
at
io
n 
of
 
un
de
rg
ra
du
at
e 
an
d 
po
st
gr
ad
ua
te
 s
tu
de
nt
s 
Pa
rti
ci
pa
te
s 
in
 th
e 
ed
uc
at
io
n 
an
d 
tra
in
in
g 
of
 
fo
rm
al
 
sp
ec
ia
lis
t 
in
te
re
st
 g
ro
up
s 
in
 t
he
 e
xt
er
na
l 
en
vi
ro
nm
en
t 
Sh
ap
es
, 
co
nt
rib
ut
es
 
to
 
or
 
is
 
ac
co
un
ta
bl
e 
fo
r 
th
e 
cr
ea
tio
n 
or
 
de
ve
lo
pm
en
t 
of
 
hi
gh
er
 
ed
uc
at
io
n 
qu
al
ifi
ca
tio
n(
s)
 
Ev
id
en
ce
 
     
I 
de
si
gn
 
an
d 
de
liv
er
 
w
or
ks
ho
ps
 
fo
r 
th
e 
U
K
C
PA
 
an
nu
al
 c
on
fe
re
nc
es
.  
 I 
al
so
 d
el
iv
er
 s
es
si
on
s 
ab
ou
t 
to
pi
cs
 
re
la
te
d 
to
 
ne
ur
os
ci
en
ce
s 
at
 
th
e 
Yo
rk
sh
ire
 
C
om
m
un
ity
 
Ph
ar
m
ac
is
ts
 
an
nu
al
 
co
nf
er
en
ce
.  
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6 
Ed
uc
at
io
na
l P
ol
ic
y 
 
D
em
on
st
ra
te
s 
an
 
un
de
rs
ta
nd
in
g 
of
 
cu
rr
en
t 
ed
uc
at
io
na
l 
po
lic
ie
s 
in
 h
ea
lth
 
se
rv
ic
es
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 in
te
rp
re
t 
na
tio
na
l p
ol
ic
y 
in
 o
rd
er
 to
 d
es
ig
n 
st
ra
te
gi
c 
ap
pr
oa
ch
es
 
fo
r 
lo
ca
l 
w
or
kf
or
ce
 e
du
ca
tio
n 
Sh
ap
es
 a
nd
 c
on
tri
bu
te
s 
to
 n
at
io
na
l 
ed
uc
at
io
na
l p
ol
ic
y.
 
 
Ev
id
en
ce
 
 
Pi
ec
e 
of
 e
vi
de
nc
e 
pr
ov
id
ed
 b
y 
se
ct
io
n 
3 
in
 C
H
EP
 p
or
tfo
lio
. 
 
 N
o.
 
6.
 R
es
ea
rc
h 
&
 E
va
lu
at
io
n 
 
 
 
U
se
s 
re
se
ar
ch
 to
 d
el
iv
er
 e
ffe
ct
iv
e 
pr
ac
tic
e.
 Id
en
tif
ie
s 
an
d 
un
de
rt
ak
es
 re
se
ar
ch
 to
 in
fo
rm
 p
ra
ct
ic
e.
 
C
om
pe
te
nc
y 
C
om
pe
te
nc
y 
Le
ve
l D
es
cr
ip
to
rs
 
Fo
un
da
tio
n 
Ex
ce
lle
nc
e 
 
M
as
te
ry
 
 
1 
C
rit
ic
al
 E
va
lu
at
io
n 
  
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
cr
iti
ca
lly
 e
va
lu
at
e 
m
ed
ic
al
 a
nd
 
re
vi
ew
  
ph
ar
m
ac
ot
he
ra
pe
ut
ic
 
lit
er
at
ur
e 
D
em
on
st
ra
te
s 
ap
pl
ic
at
io
n 
of
 
cr
iti
ca
l 
ev
al
ua
tio
n 
sk
ills
 
in
 
th
e 
co
nt
ex
t o
f s
pe
ci
al
is
t p
ra
ct
ic
e  
Is
 r
ec
og
ni
se
d 
as
 u
nd
er
ta
ki
ng
 p
ee
r 
re
vi
ew
 a
ct
iv
iti
es
 w
ith
in
 th
e 
sp
ec
ia
lit
y.
 
Ev
id
en
ce
 
 
Pi
ec
es
 o
f 
ev
id
en
ce
 1
B
1 
an
d 
3/
C
/2
 
fr
om
 
D
Ph
ar
m
 
pr
og
ra
m
m
e.
 
 
2 
Id
en
tif
ie
s 
G
ap
s 
in
 T
he
 
Ev
id
en
ce
 B
as
e  
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
id
en
tif
y 
in
st
an
ce
s 
w
he
re
 th
er
e 
is
 a
 g
ap
 in
 th
e 
ev
id
en
ce
 b
as
e 
to
 s
up
po
rt 
pr
ac
tic
e 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
fo
rm
ul
at
e 
ap
pr
op
ria
te
 
an
d 
rig
or
ou
s 
re
se
ar
ch
 
qu
es
tio
ns
 
w
ith
in
 th
e 
sp
ec
ia
lit
y 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
de
si
gn
 
a 
su
cc
es
sf
ul
 
st
ra
te
gy
 
to
 
ad
dr
es
s 
re
se
ar
ch
 
qu
es
tio
ns
 
w
ith
in
 
th
e 
sp
ec
ia
lit
y.
 
Ev
id
en
ce
 
 
 
Th
is
 
is
 
de
m
on
st
ra
te
d 
in
 
th
e 
re
se
ar
ch
 p
ro
po
sa
l 
fo
r 
th
is
 t
he
si
s 
w
hi
ch
 
is
 
re
la
te
d 
to
 
a 
re
se
ar
ch
 
qu
es
tio
n 
w
ith
in
 t
he
 s
pe
ci
al
ity
 o
f 
ne
ur
ol
og
y.
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3 
D
ev
el
op
s 
an
d 
Ev
al
ua
te
s 
R
es
ea
rc
h 
Pr
ot
oc
ol
s  
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
de
sc
rib
e 
th
e 
co
re
 f
ea
tu
re
s 
of
 
re
se
ar
ch
 p
ro
to
co
ls
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 d
es
ig
n 
a 
rig
or
ou
s 
pr
ot
oc
ol
 
to
 
ad
dr
es
s 
pr
ev
io
us
ly
 
fo
rm
ul
at
ed
 
re
se
ar
ch
 
qu
es
tio
ns
 
D
em
on
st
ra
te
s 
ac
tiv
e 
in
vo
lv
em
en
t 
in
 
th
e 
cr
iti
ca
l 
re
vi
ew
 
of
 
re
se
ar
ch
 
pr
ot
oc
ol
s.
 
Ev
id
en
ce
 
    
 
Pi
ec
e 
of
 
ev
id
en
ce
 
3C
1 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
 M
y 
ro
le
 
in
vo
lv
es
 
re
vi
ew
in
g 
tr
ia
l 
pr
ot
oc
ol
s 
re
la
te
d 
to
 
tr
ia
ls
 
co
ns
id
er
in
g 
ph
ar
m
ac
ol
og
ic
al
 
in
te
rv
en
tio
ns
 
fo
r 
st
ro
ke
 
an
d 
ne
ur
os
ur
ge
ry
 
pa
tie
nt
s.
 
I 
id
en
tif
y 
ph
ar
m
ac
y 
is
su
es
 
an
d 
de
ve
lo
p 
ac
tio
n 
pl
an
s 
to
 
ad
dr
es
s 
th
es
e 
is
su
es
. 
4 
C
re
at
es
 E
vi
de
nc
e 
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
ge
ne
ra
te
 e
vi
de
nc
e 
su
ita
bl
e 
fo
r 
pr
es
en
ta
tio
n 
at
 lo
ca
l l
ev
el
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 g
en
er
at
e 
ne
w
 
ev
id
en
ce
 
su
ita
bl
e 
fo
r 
pr
es
en
ta
tio
n 
at
 
re
se
ar
ch
 
sy
m
po
si
um
 
D
em
on
st
ra
te
s 
au
th
or
sh
ip
 o
f 
pr
im
ar
y 
ev
id
en
ce
 
an
d 
ou
tc
om
es
 
in
 
pe
er
 
re
vi
ew
ed
 m
ed
ia
.  
Ev
id
en
ce
 
 
 
Ac
ce
pt
an
ce
 f
or
 p
ub
lic
at
io
n 
of
 a
 
pa
pe
r 
re
la
te
d 
to
 
re
se
ar
ch
 
un
de
rt
ak
en
 a
s 
pa
rt
 o
f 
st
ag
e 
2 
of
 
th
e 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
5 
R
es
ea
rc
h 
Ev
id
en
ce
 
In
to
 P
ra
ct
ic
e  
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 a
pp
ly
 
re
se
ar
ch
 
ev
id
en
ce
 in
to
 o
w
n 
pr
ac
tic
e 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
ap
pl
y 
ev
id
en
ce
-b
as
ed
 
pr
ac
tic
e 
w
ith
in
 
th
e 
te
am
 
Is
 a
bl
e 
to
 u
se
 r
es
ea
rc
h 
ev
id
en
ce
 t
o 
sh
ap
e 
or
ga
ni
sa
tio
na
l 
po
lic
y/
pr
oc
ed
ur
e.
 
Ev
id
en
ce
 
 
 
Pi
ec
e 
of
 
ev
id
en
ce
 
3C
2 
fr
om
 
D
Ph
ar
m
 p
ro
gr
am
m
e.
 
 W
hi
ls
t 
I 
w
as
 t
he
 a
ct
in
g 
C
PT
L 
fo
r 
pa
ed
ia
tr
ic
s 
I 
w
as
 
in
vi
te
d 
to
 
re
pr
es
en
t 
ph
ar
m
ac
y 
on
 
th
e 
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pa
ed
ia
tr
ic
 s
ub
-c
om
m
itt
ee
 o
f 
th
e 
D
 
an
d 
T 
co
m
m
itt
ee
. M
y 
ro
le
 in
vo
lv
ed
 
ev
al
ua
tin
g 
tr
ia
l d
at
a 
re
la
te
d 
to
 t
he
 
ef
fic
ac
y 
an
d 
sa
fe
ty
 
of
 
ne
w
 
m
ed
ic
in
es
 a
nd
 c
on
tr
ib
ut
in
g 
to
 t
he
 
de
ci
si
on
 p
ro
ce
ss
 a
bo
ut
 w
he
th
er
 
th
es
e 
m
ed
ic
in
es
 w
er
e 
ap
pr
op
ria
te
 
fo
r 
us
e 
in
 
th
e 
m
an
ag
em
en
t 
of
 
di
se
as
es
 in
 p
ae
di
at
ric
 p
at
ie
nt
s.
 
6 
Su
pe
rv
is
es
 O
th
er
s 
U
nd
er
ta
ki
ng
 R
es
ea
rc
h 
D
em
on
st
ra
te
s 
un
de
rs
ta
nd
in
g 
of
 t
he
 p
rin
ci
pl
es
 o
f 
re
se
ar
ch
 
go
ve
rn
an
ce
 
Is
 a
bl
e 
to
 c
on
tri
bu
te
 to
 r
es
ea
rc
h 
su
pe
rv
is
io
n 
in
 c
ol
la
bo
ra
tio
n 
w
ith
 
re
se
ar
ch
 e
xp
er
ts
. 
Is
 a
 r
es
ea
rc
h 
pr
oj
ec
t 
su
pe
rv
is
or
 f
or
 
po
st
gr
ad
ua
te
 
st
ud
en
ts
 
Ev
id
en
ce
 
     
I 
ha
ve
 
co
nt
rib
ut
ed
 
to
 
th
e 
su
pe
rv
is
io
n 
of
 a
 M
Sc
 s
tu
de
nt
 
re
se
ar
ch
 p
ro
je
ct
 e
xp
lo
rin
g 
a 
re
se
ar
ch
 
qu
es
tio
n 
th
at
 
I 
pr
op
os
ed
.  
 I 
ha
ve
 
co
nt
rib
ut
ed
 
to
 
th
e 
re
se
ar
ch
 
su
pe
rv
is
io
n 
of
 
a 
ph
ar
m
ac
y 
te
ch
ni
ci
an
 
un
de
rt
ak
in
g 
a 
qu
al
ita
tiv
e 
re
se
ar
ch
 s
tu
dy
 a
s 
pa
rt
 o
f 
he
r 
de
gr
ee
 c
ou
rs
e 
fo
r 
ph
ar
m
ac
y 
te
ch
ni
ci
an
s 
at
 
H
ud
de
rs
fie
ld
 
U
ni
ve
rs
ity
. 
 
7 
Es
ta
bl
is
he
s 
R
es
ea
rc
h 
Pa
rt
ne
rs
hi
ps
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 w
or
k 
as
 a
 m
em
be
r 
of
 t
he
 r
es
ea
rc
h 
te
am
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 e
st
ab
lis
h 
ne
w
 
m
ul
tid
is
ci
pl
in
ar
y 
lin
ks
 
to
 
co
nd
uc
t r
es
ea
rc
h 
pr
oj
ec
ts
 
D
em
on
st
ra
te
s 
ab
ilit
y 
to
 
sh
ow
 
le
ad
er
sh
ip
 
w
ith
in
 
re
se
ar
ch
 
te
am
s 
co
nc
er
ni
ng
 t
he
 c
on
du
ct
 o
f 
sp
ec
ia
lis
t 
re
se
ar
ch
 
Ev
id
en
ce
 
  
M
an
y 
of
 
th
e 
sm
al
l 
sc
al
e 
re
se
ar
ch
 
pr
oj
ec
ts
 
th
at
 
I 
 
 
 
- 3
23
 - 
   
un
de
rt
ak
e 
in
 m
y 
da
ily
 p
ra
ct
ic
e 
re
qu
ire
 a
n 
M
D
T 
ap
pr
oa
ch
 t
o 
ex
pl
or
e 
th
e 
to
pi
c 
of
 i
nt
er
es
t. 
D
ur
in
g 
m
y 
fo
ur
 y
ea
rs
 a
s 
le
ad
 
ph
ar
m
ac
is
t 
fo
r 
ne
ur
os
ci
en
ce
s 
I 
ha
ve
 d
ev
el
op
ed
 m
an
y 
M
D
T 
lin
ks
 w
hi
ch
 a
llo
w
 m
e 
to
 f
or
m
 
ap
pr
op
ria
te
 
gr
ou
ps
 
to
 
co
nd
uc
t a
 re
se
ar
ch
 p
ro
je
ct
. 
 I 
as
se
m
bl
ed
 
a 
gr
ou
p 
co
m
po
se
d 
of
 
ph
ar
m
ac
is
ts
, 
sp
ec
ia
lis
t n
ur
se
s 
w
ith
in
 L
TH
T,
 
co
m
m
un
ity
 
ba
se
d 
sp
ec
ia
lis
t 
nu
rs
es
, 
co
ns
ul
ta
nt
s 
w
ith
in
 
LT
H
T,
 
a 
co
ns
ul
ta
nt
 
co
m
m
un
ity
 g
er
ia
tr
ic
ia
n 
an
d 
a 
G
P 
to
 
ex
pl
or
e 
m
et
ho
ds
 
to
 
im
pr
ov
e 
th
e 
tr
an
sf
er
 
of
 
in
fo
rm
at
io
n 
w
he
n 
a 
pa
tie
nt
 
w
ith
 
Pa
rk
in
so
n’
s 
di
se
as
e 
is
 
ad
m
itt
ed
 to
 h
os
pi
ta
l. 
I h
ad
 n
ot
 
w
or
ke
d 
w
ith
 
an
y 
of
 
th
es
e 
in
di
vi
du
al
s 
pr
ev
io
us
ly
 
th
er
ef
or
e 
I 
ne
ed
ed
 
to
 
fo
rm
 
ne
w
 
m
ul
tid
is
ci
pl
in
ar
y 
re
la
tio
ns
hi
ps
. 
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